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EXECUTIVE SUMMARY 
 
The Hospital In-Patient Enquiry (HIPE) scheme, established in 1971, is a health 
information system designed to collect clinical and administrative data on 
discharges from, and deaths in, acute hospitals in Ireland. Since the 1st of January 
2014, the Healthcare Pricing Office (HPO) has overseen the administration and 
management of this scheme. The HPO is responsible for overseeing all functions 
associated with the operation of this database, including the development and 
support of the data collection and reporting software, training of coders and data 
quality audit, reporting, and responding to requests for information. 
 
This report relates to discharges that occurred in the 2017 calendar year. The aim 
of this report is to present an overview of discharge activity in acute public 
hospitals in Ireland. 
 
TOTAL DISCHARGES, 2017 
 
 
 
Discharge Overview 
• Over 1.7 million discharges were reported by participating hospitals in 2017. 
• Day patients accounted for 62.7 per cent of total discharges, an increase of 
1.5 per cent since 2016.  
• In-patients accounted for 37.3 per cent of total discharges, a decrease of 0.4 
per cent since 2016 and an increase of 3.1 per cent from 2013–2017. 
• Over the period 2013–2017, the number of elective in-patient discharges 
decreased by 6.9 per cent, maternity in-patients decreased by 6.3 per cent, 
while emergency in-patients increased by 8.5 per cent. 
 
Day Patients 
1,077,014 (62.7%) 
In-Patients – 641,509 (37.3%) 
Mean LOS: 5.7 Days Median LOS: 2 Days 
Overnight In-Patients: 518,756 (30.2%) Mean LOS: 6.9 Median LOS: 3  
Sameday In-patients: 122,753 (7.1%) 
 
 
Total Discharges 
1,718,523 (100%) 
 
 
Emergency 
434,214 
(25.3%) 
Mean LOS: 6.3  
Median LOS: 2  
Maternity 
111,195 
(6.5%) 
Mean LOS: 2.7  
Median LOS: 2 
Elective 
96,100  
(5.6%) 
Mean LOS: 6.7 
Median LOS: 2 
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Length of Stay 
• In-patient average length of stay was 5.7 days in 2017, this has remained the 
same since 2015.  
• Since 2013, average length of stay has remained relatively stable for elective, 
emergency and maternity in-patients at 6.7 days, 6.3 days and 2.7 days in 
2017 respectively.  
 
Sex 
• Similar to previous years, females accounted for 53.4 per cent of total 
discharges with males accounting for 46.6 per cent.  
• Excluding maternity discharges, females accounted for 49.5 per cent of 
discharges with males accounting for 50.5 per cent. 
 
Age 
• Discharges aged 65 years and over accounted for 36.9 per cent of total 
discharges, representing an increase of 2.8 per cent since 2016 and an 
increase of 19.7 per cent since 2013. 
• Discharges aged 65 years and over accounted for 53.8 per cent of total in-
patient bed days, an increase of 1.8 per cent since 2016 and an increase of 
10.3 per cent since 2013. 
 
Marital/Civil Status 
• Married discharges accounted for 48.7 per cent of total discharges. 
Public/Private Status 
• Over 84 per cent of total discharges were treated on a public basis, 
representing a 2.1 per cent increase since 2016 and an 11.7 per cent increase 
since 2013. Private patients accounted for 15.4 per cent of total discharges, 
representing a 4.6 per cent increase from 2013–2017. 
• The 25–34 years age group had the largest proportion of total discharges 
treated publicly (89.7 per cent) with only 10.3 per cent treated on a private 
basis.  
 
General Medical Service (GMS) Status 
• Of total discharges, 55.5 per cent were GMS discharges – an increase of 1.2 
per cent since 2016 and an increase of 13.0 per cent since 2013. 
• Of discharges in the 85 years and over age group, 83.5 per cent were GMS 
discharges compared to just 17.1 per cent of the less than 1 year age group 
(this excludes discharges where GMS status was ‘unknown’). 
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Hospital Group 
• The largest proportion of total discharges were hospitalised in the 
South/South West Hospital Group (19.3 per cent). 
• Total in-patient discharges were highest in the Ireland East Hospital Group 
where 20.7 per cent of discharges were hospitalised, while the Dublin 
Midlands Hospital Group accounted for the highest proportion of day 
patients (20.6 per cent). 
 
Admission Source 
• The majority of total discharges were admitted from home (96.7 per cent). 
 
Discharge Destination 
• The majority of total discharges were discharged home (95.1 per cent). 
• Of total emergency in-patients, 6.3 per cent were transferred to long stay 
accommodation, and 5.6 per cent were transferred to another hospital. 
 
Day of Admission 
• Over 60 per cent of elective in-patients were admitted between Monday and 
Wednesday, with only 6.0 per cent admitted at the weekend. 
 
Day of Discharge 
• The proportion of elective in-patients discharged increased throughout the 
week, from 10.5 per cent on Monday to 22.6 per cent on Friday, falling to 
10.1 per cent on Saturday and 4.8 per cent on Sunday. 
 
Month of Discharge 
• The largest numbers of emergency in-patients were discharged in March 
(38,679 discharges). 
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MORBIDITY ANALYSIS 
Day Patients 
• Day patients with a principal diagnosis of Other medical care (includes 
Chemotherapy and Radiotherapy encounters) and day patients with a 
principal diagnosis of Care involving dialysis accounted for 21.2 and 16.0 per 
cent of day patient discharges respectively. 1 
• At least one procedure was recorded for 93.3 per cent of day patient 
discharges.  
• The highest principal procedure block reported was Haemodialysis, 
accounting for 17.1 per cent of day patients with at least one procedure 
recorded. 
 
In-Patients 
• The highest principal diagnosis reported for in-patient discharges was Single 
spontaneous delivery which accounted for 4.5 per cent of in-patients. 
• At least one procedure was recorded for 57.4 per cent of in-patient 
discharges. 
• The highest principal procedure block reported was Generalised allied health 
interventions which accounted for 27.0 per cent of in-patient discharges with 
at least one procedure recorded.2  
 
Elective In-Patients 
• The highest principal diagnosis reported for elective in-patients was 
Coxarthrosis [arthrosis of hip], accounting for 3.8 per cent of elective in-
patient discharges. 
• At least one procedure was recorded for 89.1 per cent of elective in-patient 
discharges. 
• The highest principal procedure block reported for elective in-patients was 
Generalised allied health interventions, accounting for 10.8 per cent of 
elective in-patients who had at least one procedure reported. 
 
 
 
 
 
                                                                                                                                                                                                                              
1  From 2015 this includes activity from St. Luke’s Radiation Oncology Network centres located in Beaumont and St. 
James’s Hospitals. These centres are operational since 2011, but data has only been included in HIPE from 2015. 
2  This block includes interventions such as physiotherapy, pharmacy, dietetics, occupational therapy, speech pathology 
and social work. Together, these six interventions accounted for over 93 per cent of cases within this procedure 
block. 
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Emergency In-Patients 
• The highest principal diagnosis reported for emergency in-patients was Pain 
in throat and chest, accounting for 4.3 per cent of emergency in-patient 
discharges. 
• At least one procedure was recorded for 49.7 per cent of emergency in-
patient discharges. 
• The highest principal procedure block reported for emergency in-patients 
was Generalised allied health interventions, accounting for 40.3 per cent of 
emergency in-patient discharges who had at least one procedure reported. 
 
Maternity In-Patients – by Delivery Status3 
• Delivery discharges with a principal diagnosis of Single spontaneous delivery 
accounted for 48.0 per cent of delivery in-patient discharges. 
• For delivery discharges who had a procedure reported, 34.1 per cent 
reported the principal procedure block Caesarean section. 
• Non-delivery discharges with a principal diagnosis of Other maternal diseases 
classifiable elsewhere but complicating pregnancy; childbirth and the 
puerperium accounted for 27.0 per cent of non-delivery in-patient discharges.  
• For non-delivery discharges who had a procedure reported, 28.7 per cent 
reported the principal procedure block Curettage and evacuation of uterus. 
  
                                                                                                                                                                                                                              
3  Delivery discharges include discharges with a diagnosis of outcome of delivery (ICD-10-AM: Z37). Non-delivery 
discharges are maternity discharges where admission was related to their obstetrical experience but they did not 
deliver during that episode of care. 
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CASE MIX ANALYSIS 
 
The case mix classification presents analysis of patients who undergo similar 
treatment processes and incur similar levels of resource use.4 
• The MDC with the largest proportion of day patients reported was Neoplastic 
disorders (haematological and solid neoplasms) (MDC 17), which accounted for 
249,639 discharges or 23.2 per cent of day patients. 
∗ Chemotherapy (AR-DRG R63Z) accounted for 46.1 per cent of day 
patients within this MDC, and 10.7 per cent of total day patients; 
Other Neoplastic Disorders, Minor Complexity (AR-DRG R62C) 
accounted for 42.4 per cent of day patients within this MDC and 9.8 
per cent of total day patients. 
• The MDC with the largest proportion of in-patient discharges was Pregnancy, 
Childbirth and the Puerperium (MDC 14), which accounted for 17.2 per cent of 
in-patients. 
∗ Antenatal and Other Obstetric Admission (AR-DRGs O66A and O66B) 
accounted for 37.1 per cent of in-patients within this MDC and 6.4 per 
cent of total in-patient discharges. 
∗ Vaginal Delivery (AR-DRGs O60A, O60B and O60C) accounted for 36.2 
per cent of in-patients within this MDC and 6.2 per cent of total in-
patient discharges. 
                                                                                                                                                                                                                              
4  In 2016, the AR-DRG classification was updated from AR-DRG Version 6.0 to AR-DRG Version 8.0. See Appendix VIII for 
an overview of changes between Version 6.0 and Version 8.0 of the AR-DRG Classification System. 
  
 
 
 
 
 
 
 
 
 
 
Overview SECTION 
On
e  
 
2 |  Act ivi ty  in  Acute Pu bl i c  Hosp ita l s  2017  
 
Table of Contents 
1.1 Introduction ________________________________________________________________ 3 
1.2 Background_________________________________________________________________ 3 
1.3 Data Sources for Annual Report 2017 ____________________________________________ 4 
1.4 Structure of Annual Report 2017 ________________________________________________ 5 
1.5 Scope of HIPE Data ___________________________________________________________ 7 
1.6 Methods and Definitions ______________________________________________________ 8 
1.7 Discharges Reported to HIPE, 2013-2017 ________________________________________ 10 
 
 
Introd uct ion | 3  
 
1.1 INTRODUCTION 
This report aims to present an overview of discharge activity in acute public 
hospitals in Ireland during 2017 using data from the Hospital In-Patient Enquiry 
(HIPE) scheme. HIPE collects information on day patient and in-patient activity 
from participating hospitals.1 
 
Section One provides an overview of the 2017 report. It outlines briefly the 
background of the HIPE scheme, and highlights other data sources used 
throughout the report. The scope of the HIPE data and the methods used in the 
report are discussed. Finally, an analysis of the trends in the main HIPE variables 
is undertaken using data from the period 2013–2017. 
 
 
1.2 BACKGROUND 
From 1st January 2014 the Health Research and Information Division at the ESRI 
and the National Casemix Programme (HSE) became the Healthcare Pricing Office 
(HPO).2  While the HPO has initially been established on an administrative basis, 
attached to the HSE, it is planned that this Office will ultimately be established on 
a statutory basis.3 Part of the remit of the HPO is to oversee all functions 
associated with the operation of the HIPE database, including the development 
and support of the data collection and reporting software, training of coders, 
data quality, audit, data analysis and reporting, and responding to requests for 
information.4,5,6  
At the start of 2015, the classification used to code clinical information was 
updated from the 6th Edition to the 8th Edition of the International Statistical 
Classification of Diseases and Related Health Problems, Tenth Revision, Australian 
Modification (ICD-10-AM), Australian Classification of Health interventions 
(ACHI), Australian Coding Standards (ACS).7,8 Ireland updates the clinical 
classification every four to five years to ensure the classifications remain current 
for national and international use. Extensive training of all HIPE staff was 
undertaken in 2014 and 2015 to ensure understanding of the changes in the new 
                                                                                                                                                                                                                              
1 See Appendix I for a list of hospitals participating in HIPE in 2017. 
2 From 1990 until 2013 the Economic and Social Research Institute (ESRI) oversaw the administration and management 
of the HIPE scheme on behalf of the Health Service Executive (HSE) and the Department of Health (DoH). 
3 This development is in line with the proposals in the ‘Money Follows the Patient’ policy paper published by the 
Department of Health in February 2013. 
4 The HIPE Portal is a web-based software application designed and developed at the HPO for the collection and 
reporting of HIPE data within public hospitals. 
5 For further information on the role of the coder, see Section 3.2. 
6  The Healthcare Pricing Office also oversees the administration and management of the National Perinatal Reporting 
System (NPRS). 
7 National Casemix and Classification Centre (NCCC), 2013: The International Statistical Classification of Diseases and 
Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Australian Classification of Health 
Interventions (ACHI) and Australian Coding Standards (ACS) – ICD-10-AM/ACHI/ACS (8th Ed): NCCC, Australian Health 
Services Research Institute, University of Wollongong. 
8 The spelling conventions of ICD-10-AM comply with the Macquarie Dictionary, as recommended by the Australian 
government style manual. 
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classification. Use of ICD-10-AM/ACHI/ACS is complemented by the Irish Coding 
Standards (ICS).9 The ICS are developed for use with the Australian Classifications 
and Coding Standards (ACS) and are revised regularly to reflect changing clinical 
practice and to ensure that the classification and its application are relevant to 
the Irish healthcare system. Due to the update in the classification, caution must 
be exercised when comparing procedure and diagnosis categories presented in 
reports from 2015 onwards compared to previous reports, due to changes in 
sequencing of codes, addition of new codes, deletion of codes, and updates to 
ACS and ICS.10  
In 2016, the Australian Refined Diagnosis Related Groups (AR-DRG) classification 
was updated from AR-DRG Version 6.0 to AR-DRG Version 8.0. The update to AR-
DRG Version 8.0 included a revision of the complexity model used to assign AR-
DRGs to discharges. In addition to this, it included a review of existing AR-DRGs, 
the removal of some AR-DRGs and the inclusion of new AR-DRGs. The naming 
convention for AR-DRGs was also updated. Due to the update in this 
classification, AR-DRGs in this report are not comparable with those in reports 
prior to 2016.11  
Given the comprehensive coverage achieved by this information system, the data 
gathered by HIPE are used by policymakers, clinical teams and researchers. In 
addition to responding to requests for HIPE information, the HPO also manages 
the HIPE Statistics Reporter which is available online.12 
 
1.3 DATA SOURCES FOR ANNUAL REPORT 2017 
HIPE: The Hospital In-Patient Enquiry (HIPE) scheme, established in 
1971, is a health information system designed to collect clinical 
and administrative data on discharges from, and deaths in, acute 
hospitals in Ireland.13,14 In 2017, 53 public hospitals in Ireland 
participated in HIPE (see Appendix I).15,16 
Population 
Estimates: 
Population estimates for 2013–2017 are based on Census 2016 
data published by the Central Statistics Office. 
                                                                                                                                                                                                                              
9  Irish Coding Standards (ICS) provide guidelines for the collection of HIPE data for all discharges and are to be used in 
conjunction with 8th Edition ICD-10-AM/ACHI/ACS and the relevant HIPE Instruction Manual. For further information, 
see www.hpo.ie 
10 See Appendix VII for an overview of changes from ICD-10-AM/ACHI/ACS 6th edition (in use from 2009–2014) to 8th 
Edition (in use from 1st January 2015). 
11  See Appendix VIII for an overview of changes between AR-DRG Version 6.0 and Version 8.0. 
12 Available at www.hpo.ie  
13 See Appendix II for details of data collected by HIPE, see also the HIPE Data Dictionary 2017 Version 9.1 available at 
www.hpo.ie 
14 A copy of the HIPE data entry form for 2017 is contained in Appendix III. 
15 For historical reasons, a small number of non-acute hospitals also reported to HIPE in 2017. Discharges from these 
hospitals have been included in this report. 
16  St. Luke’s Hospital, Rathgar includes activity from St. Luke’s Radiation Oncology Network centres located in Beaumont 
and St. James’s Hospitals. These centres are operational since 2011 but activity has only been included in HIPE from 
2015. 
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1.4 STRUCTURE OF ANNUAL REPORT 2017 
Figure 1.1 outlines the changes to the structure of the Activity in Acute Public 
Hospitals in Ireland Annual Reports 2010–2017.17 As shown in Figure 1.1, 
discharges with admission type ‘Maternity’ are no longer presented separately in 
Section Four from 2015.18 In lieu of this, maternity discharges are separated out 
in selected tables in Section Two and Section Three (see Section 1.6 for more 
detail).  
 
FIGURE 1.1 Changes to structure of the Activity in Acute Public Hospitals in Ireland Annual Report, 2010-
2017 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The remainder of the report is structured as follows: 
Section Two 
In Section Two the report is concerned with providing a demographic (WHO), 
regional (WHERE) and temporal (WHEN) profile of discharges reported to HIPE in 
2017. Section Two includes many of the administrative variables reported to 
HIPE, including age, sex, marital/civil status, GMS status, and discharge status. 
The regional analysis uses Hospital Group to see where discharges are being 
hospitalised, while the temporal analysis looks at day of admission, day of 
discharge, and month of discharge. 
                                                                                                                                                                                                                              
17 See www.hpo.ie for the latest versions of these reports. 
18  It was decided that these discharges could be represented adequately in Section Two and Section Three. The National 
Perinatal Reporting System provides more detailed analysis of activity in Maternity hospitals (www.hpo.ie). 
Section One: Overview 
Total Discharges  
Section Two & 
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Total Discharges  
 
Section 
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Profile 
 
Section Three: Morbidity 
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Section Four: Casemix 
 
Total Discharges 
 
2010-2014 2015-2017 
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Section Three 
Section Three focuses on the diagnoses and procedures recorded for discharges 
reported to HIPE. Section Three presents analysis of hospital activity by patient 
type with top 20 principal diagnoses and procedure blocks presented for day 
patients and for total, elective and emergency in-patients. The top 10 principal 
diagnoses and procedure blocks are presented by delivery status for maternity in-
patients. Further analysis is presented for diagnoses and procedures reported for 
total discharges by sex and age group. The mean and median length of stay for in-
patient discharges is presented by principal diagnoses and principal procedures. 
Section Four 
Section Four provides analysis of all HIPE data by case mix. Each Major Diagnostic 
Category (MDC) is presented with its associated Australian Refined Diagnosis 
Related Groups (AR-DRG) for total discharges. The analyses provide a breakdown 
of MDCs and AR-DRGs by patient type, with in-patient mean and median length 
of stay also provided. The version of the AR-DRG Classification used for the 2016 
and 2017 reports is Version 8.0. The update to AR-DRG Version 8.0 included a 
revision of the complexity model used to assign AR-DRGs to episodes of care. In 
addition to this, it included a review of existing AR-DRGs, the removal of some 
AR-DRGs and the inclusion of new AR-DRGs. The naming convention for AR-DRGs 
was also updated.19 
Annex 
The annex is designed to highlight particular topics of interest that merit further 
analysis. This year's topic of interest is discharges with a principal diagnosis of 
diabetes.  
Glossary and Abbreviations 
This section provides definitions of the terminology used in this report along with 
explanations of the abbreviations.  
                                                                                                                                                                                                                              
19  Further information on AR-DRG Version 8.0 can be found on the Australian Consortium for Classification 
Development website https://www.accd.net.au/ArDrg.aspx?page=2 [Accessed 26th July 2018]. 
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1.5 SCOPE OF HIPE DATA 
• Each HIPE discharge record represents one episode of care. Patients may be 
admitted to hospital more than once in any given time period with the same 
or different diagnoses. In the absence of a unique health identifier, therefore, 
the data reported to HIPE facilitate analysis of hospital discharge activity but 
do not permit analysis of certain parameters, such as the number of hospital 
encounters per patient; or estimate the incidence or prevalence of a 
particular disease. 
• Emergency In-Patient Admissions: HIPE includes patients who attended the 
Emergency Department and were subsequently admitted to hospital. As just 
a proportion of those attending the Emergency Department will subsequently 
be admitted to hospital, it is not possible to use emergency admissions 
reported to HIPE to draw conclusions about the total volume of activity in 
Emergency Departments.  
• Coverage of data: Coverage of the HIPE system is calculated using the 
discharges returned as 'coded' as a proportion of total discharges reported 
within each hospital. The data available from participating hospitals for 2017 
indicate that for day patient and in-patient discharges appropriate for 
inclusion in the HIPE data set, 99.74 per cent of the discharges reported from 
hospital systems were coded and returned for inclusion in the national HIPE 
data set.  
• Hospital factors: Restructuring of the hospital system is reflected in the 
analysis presented in this report. From April 2011 St. Luke's Radiation 
Oncology Network commenced providing services at centres located in 
Beaumont and St. James’s Hospitals, as well as continuing to provide services 
at St. Luke’s Hospital, Rathgar. For 2011–2014 these data were not included 
in the HIPE national file, and 2015 was the first year these data were returned 
to HIPE.  
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1.6 METHODS AND DEFINITIONS 
Some of the methods and definitions used to present data in the report are 
detailed below. 
Patient Type: HIPE collects data on day patients and in-patients.  
• A day patient is admitted to hospital for treatment on an elective (rather 
than an emergency) basis and is discharged alive, as scheduled, on the 
same day. 20 Deliveries are not included.  
• An in-patient is admitted to hospital for treatment or investigation on an 
elective or emergency basis. Sameday in-patients are admitted as in-
patients and discharged on the same day, while overnight in-patients stay 
at least one night in hospital.  
Unlike reports prior to 2015, sameday in-patients and overnight in-patients are 
presented separately for selected tables in this report. The HSE and Department 
of Health have developed a number of initiatives in recent years to improve 
patient flow throughout the system. One such initiative has been the introduction 
of Acute Medical Units.21 This has led to an increase in discharges recorded as 
sameday in-patients (in-patients admitted and discharged on the same day) who 
accounted for 7.1 per cent of total discharges in 2017. The separate presentation 
of sameday in-patients throughout the report allows for monitoring of this 
particular group and distinguishes them from overnight in-patients. 
In-Patient Length of Stay:  The presentation of in-patient length of stay 
underwent review prior to the publication of the 2015 report. Prior to this, the 
HIPE annual report presented data for discharges with an ‘acute’ or ‘extended’ 
length of stay (0–30 days for acute in-patients and 31 days and over for extended 
stay in-patients). This split of in-patient discharges based on their length of stay 
was used in previous reports as HIPE collects data from a small number of non-
acute hospitals, resulting in longer lengths of stays.   
The OECD defines an in-patient discharge as “the release of a patient who was 
formally admitted into a hospital for treatment and/or care and who stayed for a 
minimum of one night”.22 In HIPE, discharges who do not meet the definition of a 
day patient are classified as in-patients; therefore there are discharges who did 
not stay overnight that are classified as in-patients. This results in the inclusion of 
sameday in-patients in the calculation of in-patient average length of stay. In this 
report one bed day is assigned to in-patients discharged on the same day 
(sameday in-patients) and one bed day is also assigned to in-patients who stayed 
one night in hospital. 
                                                                                                                                                                                                                              
20  Definition is based on: Department of Health and Children, 2001. Quality and Fairness A Health System for You: 
Health Strategy, Department of Health and Children, 2001. 
21 For more information see www.hse.ie/eng/about/Who/clinical/natclinprog/acutemedicineprogramme/about/ 
22 Source: http://stats.oecd.org/ 
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For comparability with international reporting, overnight in-patient length of stay 
is presented alongside the total in-patient length of stay.23  The former will result 
in a higher average length of stay as it excludes sameday in-patients. Median 
length of stay is also provided for both groups of in-patients to highlight the 
effect of outlier cases.   
Hospital Groups: Increased reporting of Hospital Groups. In May 2013, the 
Government approved the report on The Establishment of Hospital Groups as a 
Transition to Independent Hospital Trusts.24 This resulted in the reorganisation of 
hospitals into seven groups. These hospital groups have been reported on from 
2014 onwards.25 
Derived Variables: For some of the categorical administrative variables, 
aggregation of categories has been necessary to ensure confidentiality. These 
derivations are presented in Appendix IV for admission type, admission source, 
and discharge destination. 
Reporting of small numbers:  The HPO does not report cells where the number of 
discharges reported to HIPE is five or fewer. The tables contained in this report 
have been suppressed in this manner by replacing such cells with the symbol ~. 
Where further suppression is necessary to ensure that cells with five or fewer 
discharges are not disclosed, the cell with the next lowest number of discharges 
has been replaced with the symbol *. Where cells containing five or fewer 
discharges have been suppressed, the associated mean and median in-patient 
length of stay figures have been suppressed using the symbol ^. In Section Three, 
the symbol ⱡ is used to denote where the sex and/or age group breakdown for a 
particular diagnosis or procedure has not been provided, as the numbers 
reported would result in suppression across the majority of categories. 
  
                                                                                                                                                                                                                              
23 This method of presenting both overnight and total length of stay is primarily in Section Two of the report. As it was 
not practicable to present this for all tables, Section Three and Section Four continue to present total in-patient 
length of stay. 
24  http://health.gov.ie/wp-content/uploads/2014/03/IndHospTrusts.pdf 
25 See Appendix I for a list of hospitals and their associated groups participating in HIPE in 2017. There are a small 
number of non-acute HIPE hospitals that do not belong to a group which are categorised as ‘No group’. 
10 |  Act iv i ty  in  Acute Publ i c  Hosp ita l s  2017 
 
1.7 DISCHARGES REPORTED TO HIPE, 2013-2017 
In 2017, 1,718,523 discharges were reported to HIPE by participating acute public 
hospitals,26 representing an increase of 10.6 per cent over the period 2013–2017 
and an increase of 0.8 per cent over the period 2016–2017.  
 
Table 1.1 and Figures 1.2 to 1.3 show the distribution of discharges over the 
period 2013–2017 by selected variables. The following points provide a summary 
of changes over the period 2013–2017: 
• The male-female split in 2017 has remained consistent with previous years, 
with a larger proportion of female discharges (53.4 per cent). 
• The 65 years and over age group accounted for the largest proportion of total 
discharges in 2017 (36.9 per cent), representing an increase of 19.7 per cent 
for this age group from 2013–2017.  
• From 2013–2017 there was an increase of 11.7 per cent for public discharges 
and an increase of 4.6 per cent for private discharges.  
• The number of GMS discharges increased by 13.0 per cent between 2013 and 
2017, from 843,727 to 953,030 discharges. 
• The proportion of total discharges treated by each Hospital Group remained 
similar between 2016 and 2017. The largest percentage increase was in the 
UL Hospital Group with a 4.7 per cent increase between 2016 and 2017.    
• The number of day patient discharges has increased from 932,073 in 2013 to 
1,077,014 in 2017, an increase of 15.6 per cent, with an increase of 1.5 per 
cent between 2016 and 2017.27 
• The number of in-patient discharges has increased from 622,217 in 2013 to 
641,509 in 2017, an increase of 3.1 per cent. Between 2016 and 2017 there 
was a decrease of 0.4 per cent in the number of in-patient discharges. 
• Emergency in-patient discharges comprised 64.3 per cent of total in-patient 
discharges in 2013, increasing to 67.7 per cent in 2017.  
• Maternity in-patient discharges decreased by 6.3 per cent over the period 
2013–2017 from 118,708 to 111,195 discharges. Between 2016 and 2017 
there was a 3.7 per cent decrease in the proportion of maternity in-patient 
discharges reported to HIPE. 
• Sameday in-patient discharges have increased by 14.8 per cent over the 
period 2013–2017 from 106,887 to 122,753 discharges. 
 
                                                                                                                                                                                                                              
26  In 2017 there were <5 cases with sex recorded as ‘unknown’. These cases were verified with the hospitals. For 
reasons of confidentiality these cases are not included in this report. 
27  From 2015 this includes activity from St. Luke's Radiation Oncology Network centres located in Beaumont and St. 
James’s Hospitals. These centres are operational since 2011, but data has only been included in HIPE from 2015. 
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• Over the period 2013–2017, the average length of stay has remained 
relatively constant for emergency and maternity in-patients at 6.3 days and 
2.7 days in 2017 respectively, while the average length of stay for elective in-
patients has varied between 6.6 days and 6.9 days over the period, and was 
reported at 6.7 days in 2017. 
• Overnight in-patient discharges stayed on average 6.5 days in 2013 which has 
increased to 6.9 days in 2017, an increase of 6.2 per cent. The median has 
remained constant at 3 days over the period. 
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TABLE 1.1 Acute Public Hospital Discharges in HIPE (N, %), 2013-2017 
 
 2013 2014 2015 2016 2017 % Change % Change 
N (%) N (%) N (%) N (%) N (%) 2013–2017 2016–2017 
Total Discharges 1,554,290 1,592,672 1,664,066 1,704,452 1,718,523 10.6 0.8 
100 100 100 100 100     
Discharge Ratea 336.8 342.8 355 359.6 358.6  6.5 -0.3 
Sex        
Males 713,652 730,361 763,844 788,702 800,443 12.2 1.5 
 45.9 45.9 45.9 46.3 46.6     
Females 840,638 862,311 900,222 915,750 918,080 9.2 0.3 
 54.1 54.1 54.1 53.7 53.4     
Age Group               
Under 15 Years 131,439 132,608 133,638 132,677 127,545 -3.0 -3.9 
 8.5 8.3 8 7.8 7.4     
15–44 Years 459,158 465,626 464,203 471,123 465,383 1.4 -1.2 
29.5 29.2 27.9 27.6 27.1     
45–64 Years 433,535 442,054 470,145 483,587 490,964 13.2 1.5 
 27.9 27.8 28.3 28.4 28.6     
65 Years and Over 530,158 552,384 596,080 617,065 634,631 19.7 2.8 
34.1 34.7 35.8 36.2 36.9     
Public/Private Statusb               
Public Discharges 1,301,481 1,336,317 1,398,932 1,424,290 1,454,057 11.7 2.1 
 83.7 83.9 84.1 83.6 84.6     
Private Discharges 252,809 256,355 265,134 280,162 264,466 4.6 -5.6 
16.3 16.1 15.9 16.4 15.4     
GMS Status               
GMS 843,727 854,249 892,584 942,022 953,030 13.0 1.2 
 54.3 53.6 53.6 55.3 55.5     
Non-GMS 699,003 726,530 748,461 744,344 740,996 6.0 -0.4 
45 45.6 45 43.7 43.1     
Unknown 11,560 11,893 23,021 18,086 24,497 111.9 35.4 
 0.7 0.8 1.4 1.1 1.4     
Hospital Groupc               
Ireland East – 314,334 320,647 325,110 329,543 – 1.4 
   19.7 19.3 19.1 19.2     
RCSI – 245,979 244,242 254,227 258,768 – 1.8 
  15.4 14.7 14.9 15.1     
Dublin Midlandsd – 267,077 310,649 318,725 319,373 – 0.2 
  16.8 18.7 18.7 18.6     
South/South West – 320,534 327,700 329,632 331,619 – 0.6 
  20.1 19.7 19.3 19.3     
UL  – 97,738 102,762 106,749 111,771 – 4.7 
  6.1 6.2 6.3 6.5     
Saolta – 287,774 299,245 310,448 309,209 – -0.4 
  18.1 18 18.2 18.0     
Children’s – 53,038 52,841 54,234 53,211 – -1.9 
   3.3 3.2 3.2 3.1     
No group – 6,198 5,980 5,327 5,029 – -5.6 
  0.4 0.4 0.3 0.3     
Day Patientsd 932,073 960,786 1,029,860 1,060,602 1,077,014 15.6 1.5 100 100 100 100 100 
  Dialysis/Radiotherapyd/ 
  Chemotherapye 
327,249 339,480 393,868 399,895 396,925 21.3 -0.7 
35.1 35.3 38.2 37.7 36.9     
  Maternityf 13,914 19,043 19,838 20,763 20,831 49.7 0.3 
1.5 2 1.9 2 1.9     
  Other  590,910 602,263 616,154 639,944 659,258 11.6 3.0 
63.4 62.7 59.8 60.3 61.2     
In-Patients 
 
622,217 631,886 634,206 643,850 641,509 3.1 -0.4 
100 100 100 100 100     
Elective 103,237 100,287 99,086 95,870 96,100 -6.9 0.2 
 16.6 15.9 15.6 14.9 15.0     
Emergencyg,h 400,272 412,394 417,330 432,490 434,214 8.5 0.4 
 64.3 65.3 65.8 67.2 67.7     
Maternity 118,708 119,205 117,790 115,490 111,195 -6.3 -3.7 
 19.1 18.9 18.6 17.9 17.3     
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TABLE 1.1   Acute Public Hospital Discharges in HIPE (N, %), 2013–2017 (contd.) 
 
 2013 2014 2015 2016 2017 % Change % Change 
N (%) N (%) N (%) N (%) N (%) 2013–2017 2016–2017 
Overnight In-Patients  515,330 515,619 516,604 519,738 518,756 0.7 -0.2 
82.8 81.6 81.5 80.7 80.9     
Sameday In-Patients  106,887 116,267 117,602 124,112 122,753 14.8 -1.1 
 17.2 18.4 18.5 19.3 19.1     
In-Patient Length of Stay         
In-Patients Mean 5.6 5.6 5.7 5.7 5.7 1.8 0.0 
Median 2 2 2 2 2     
Elective Mean 6.6 6.7 6.7 6.9 6.7 1.5 -2.9 
Median 3 2 2 2 2     
Emergencyg Mean 6.2 6.2 6.3 6.2 6.3 1.6 1.6 
Median 2 2 2 2 2     
Maternity  Mean 2.7 2.6 2.6 2.7 2.7 0.0 0.0 
Median 2 2 2 2 2     
Overnight 
In-Patients 
Mean 6.5 6.6 6.8 6.8 6.9 6.2 1.5 
Median 3 3 3 3 3     
In-Patient Bed Daysh        
Total In-Patients 3,480,802 3,531,563 3,622,860 3,651,438 3,679,625 5.7 0.8 
100 100 100 100 100     
Under 15 Years 294,238 293,387 292,948 284,997 276,584 -6.0 -3.0 
8.5 8.3 8.1 7.8 7.5     
15 to 44 Years 718,445 722,104 713,848 717,761 709,097 -1.3 -1.2 
20.6 20.4 19.7 19.7 19.3     
45 to 64 Years 672,759 672,162 697,640 702,640 712,827 6.0 1.4 
19.3 19 19.3 19.2 19.4     
65 Years and Over 1,795,360 1,843,910 1,918,424 1,946,040 1,981,117 10.3 1.8 
51.6 52.2 53 53.3 53.8     
Overnight In-Patients 3,373,915 3,415,296 3,505,258 3,527,326 3,556,872 5.4 0.8 
 96.9 96.7 96.8 96.6 96.7     
 
Notes: Percentage columns are subject to rounding. 
a These rates are based on population estimates published by the CSO which are based on the 'usual residence' concept. 
Crude discharge rate is calculated as the ratio of total discharges to the population of Ireland, multiplied by 1,000. 
When those discharges with no fixed abode and who were living outside Ireland are excluded, the crude discharge rate 
is 357.6 per 1,000 population. 
b Public/Private status refers to whether the patient saw the consultant on a private or public basis. It does not relate to 
the type of bed occupied nor is it an indicator of private health insurance. 
c Hospital Groups were established during 2013. Data is reported from 2014 as this was the first complete year that the 
groups were operational. See Appendix I for the list of hospitals by Group in 2017. 
d Includes additional day patients for radiotherapy that were collected from St. Luke's Radiation Oncology Network 
centres located in Beaumont and St. James’s Hospitals from 2015 onwards. These centres are operational since 2011, 
but data has only been included in HIPE from 2015. 
e The Dialysis category includes day patient discharges with a principal procedure of haemodialysis (ACHI procedure block 
1060), the Chemotherapy category includes day patient discharges with a principal diagnosis of pharmacotherapy 
session for neoplasm (ICD-10-AM diagnosis code Z51.1), the Radiotherapy category includes day patient discharges with 
a principal diagnosis of radiotherapy session (ICD-10-AM diagnosis code Z51.0). 
f Caution should be exercised when analysing the increase in Maternity day patients reported between 2013 and 2014. A 
large proportion of the increase from 2013 to 2014 can be attributed to a reorganisation of beds in one hospital, with a 
number of in-patient beds being converted to day beds. 
g HIPE includes patients who attended the Emergency Department and were subsequently admitted to hospital. As just a 
proportion of those attending the Emergency Department will subsequently be admitted to hospital, it is not possible to 
use emergency admissions reported to HIPE to draw conclusions about the total volume of activity in Emergency 
Departments.  
h Bed Days are presented as a proportion of total in-patient bed days. This assigns one bed day to in-patients discharged 
on the same day (sameday in-patients) and one bed day to in-patients who stayed one night in hospital. 
 
Sources: Data on discharges, length of stay and bed days for 2013-2017 were obtained from HIPE. 
Population estimates for 2013-2017 were obtained from the Central Statistics Office.  
www.cso.ie/px/pxeirestat/Statire/SelectVarVal/Define.asp?maintable=PEA01&PLanguage=0 [Accessed 16th July 2018]. 
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FIGURE 1.2 Total Discharges by Patient Type and Admission Type (N), 2013–2017 
 
  
 
    2013  2014  2015  2016  2017 
 
Notes:  See Appendix I for a list of hospitals that participated in HIPE in 2017. 
 * From 2015 this includes activity from St. Luke's Radiation Oncology Network centres located in Beaumont and St. James’s 
Hospitals. These centres are operational since 2011, but data has only been included in HIPE from 2015. 
 ^ Includes day patient maternity discharges (see Table 1.1). 
 ⱡ Emergency admissions do not capture patients who attended the Emergency Department but were not subsequently 
admitted to hospital. For this reason, it is not possible to use emergency admissions reported to HIPE to draw conclusions 
about the volume of activity in Emergency Departments. 
Source:  Data for 2013–2017 were obtained from HIPE. 
   
   
FIGURE 1.3 Total Discharges by Age Group (N), 2013–2017 
 
 
    2013  2014  2015  2016  2017 
 
Source:  Data for 2013–2017 were obtained from HIPE. 
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2.1 INTRODUCTION 
Section Two provides an overview of the demographic and temporal distribution 
of day patient and in-patient discharges.1 Section Two is divided into three main 
sections. 
• Section 2.2 reports on who the discharges were (age, sex, marital/civil status, 
public/private status, and GMS status). 
• Section 2.3 reports on where discharges were hospitalised, where they came 
from, and where they were discharged to (Hospital Group, admission source, 
and discharge destination). 
• Section 2.4 reports on when discharges were admitted to, and discharged 
from, hospital (day of admission, day of discharge, and month of discharge). 
  
                                                                                                                                                                                                                              
1 The presentation of in-patient length of stay differs from reports prior to 2015 which presented acute and total in-
patient mean length of stay. This report presents mean and median total in-patient length of stay only (see Section 
1.6). 
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2.2 WHO 
Section 2.2 examines patient characteristics. Total discharges are disaggregated 
in the following tables and figures by age, sex, marital/civil status, public/private 
status, and GMS status. 
 
A day patient is admitted to hospital for treatment on an elective (rather than an 
emergency) basis and is discharged alive, as scheduled, on the same day. In 2017, 
day patient discharges accounted for 62.7 per cent of total discharges. In-patient 
discharges accounted for the remaining 37.3 per cent of total discharges with 
67.7 per cent of in-patients admitted on an emergency basis, 15.0 per cent 
admitted on an elective basis and 17.3 per cent admitted as maternity in-
patients. 
 
2.2.1 Age 
Table 2.1a disaggregates total discharges by patient type (day patient and in-
patient) and age group. For the length of stay analysis, in-patient discharges are 
disaggregated into sameday in-patient and overnight in-patient discharges. 
Sameday in-patients are admitted as in-patients and discharged on the same day, 
while overnight in-patients stay at least one night in hospital. Overnight in-
patient discharges and their associated length of stay are displayed in Figure 2.1. 
 
Discharges 
• The largest proportion of total discharges were in the 65–74 years age group 
(19.0 per cent). This age group accounted for the largest proportion of day 
patient discharges (22.1 per cent). 
• Discharges in the older age groups accounted for a relatively large proportion 
of bed days; those aged 65 years and over accounted for 32.8 per cent of in-
patient discharges and 53.8 per cent of in-patient bed days. 
• The 1–14 years age group accounted for 8.2 per cent of in-patient discharges 
and 3.4 per cent of in-patient bed days. 
 
Length of Stay 
• Discharges aged 25–34 years accounted for 17.7 per cent of total sameday in-
patients, the largest amongst all age groups. 
• Apart from those aged less than one year, mean length of stay increased with 
age for overnight in-patient discharges rising from 2.7 days for discharges 
aged 1–14 years to 13.5 days for discharges aged 85 years and over. Median 
length of stay ranged between 2 to 7 days across all age groups. 
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TABLE 2.1a Total Discharges: Patient Type by Age Group (N, %, Bed Days, %, and In-Patient Length of Stay) 
 
 
Discharges and Bed Days 
Day Patients In-Patients  Total Discharges 
N % N % Bed Days % N % 
< 1 Year 3,853 0.4 26,064 4.1 150,016 4.1 29,917 1.7 
1–14 Years 44,963 4.2 52,665 8.2 126,568 3.4 97,628 5.7 
15–24 Years 36,498 3.4 47,009 7.3 132,571 3.6 83,507 4.9 
25–34 Years 79,592 7.4 92,528 14.4 269,867 7.3 172,120 10.0 
35–44 Years 124,134 11.5 85,622 13.3 306,659 8.3 209,756 12.2 
45–54 Years 159,631 14.8 57,159 8.9 276,492 7.5 216,790 12.6 
55–64 Years 203,993 18.9 70,181 10.9 436,335 11.9 274,174 16.0 
65–74 Years 237,716 22.1 88,325 13.8 672,923 18.3 326,041 19.0 
75–84 Years 152,350 14.1 81,178 12.7 806,664 21.9 233,528 13.6 
85 Years and Over 34,284 3.2 40,778 6.4 501,530 13.6 75,062 4.4 
Total Discharges 1,077,014 100 641,509 100 3,679,625 100 1,718,523 100 
 
 
In-Patient Length of Stay 
Sameday 
In-Patients Overnight In-Patients Total In-Patients 
N N Mean Median N Mean Median 
< 1 Year 2,899 23,165 6.4 2 26,064 5.8 2 
1–14 Years 9,646 43,019 2.7 2 52,665 2.4 1 
15–24 Years 12,296 34,713 3.5 2 47,009 2.8 1 
25–34 Years 21,674 70,854 3.5 2 92,528 2.9 2 
35–44 Years 19,416 66,206 4.3 3 85,622 3.6 2 
45–54 Years 13,808 43,351 6.1 3 57,159 4.8 2 
55–64 Years 13,954 56,227 7.5 4 70,181 6.2 3 
65–74 Years 14,398 73,927 8.9 5 88,325 7.6 4 
75–84 Years 10,623 70,555 11.3 6 81,178 9.9 5 
85 Years and Over 4,039 36,739 13.5 7 40,778 12.3 7 
Total Discharges 122,753 518,756 6.9 3 641,509 5.7 2 
 
Note:  Percentage columns are subject to rounding. 
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FIGURE 2.1 Overnight In-Patients: Discharges and Mean Length of Stay (Days) by Age group  
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2.2.1.1 Age and Sex 
The data presented in Table 2.1a are disaggregated by sex in Table 2.1b–Table 
2.1d. Table 2.1b presents male discharges, while Table 2.1c presents female 
discharges (excl. maternity) and Table 2.1d presents female discharges 
(maternity). In 2017, there were 918,080 female discharges, and of these 14.4 per 
cent were maternity discharges. 
 
Discharges 
• The 65–74 years age group accounted for the largest proportion of both male 
and female (excl. maternity) discharges, 22.9 per cent and 18.1 per cent 
respectively. 
• Discharges aged 65 years and over accounted for 39.2 per cent of male in-
patient discharges and 56.5 per cent of male in-patient bed days, while for 
females (excl. maternity) this group accounted for 40.1 per cent of female in-
patient discharges and 60.7 per cent of female in-patient bed days. 
• The 75–84 years age group accounted for the largest proportion of in-patient 
bed days for both males (23.5 per cent) and females (excl. maternity) (24.2 
per cent). 
• Females aged between 25 and 34 years accounted for over half of maternity 
in-patient discharges (52.3 per cent), while those aged 35–44 years 
accounted for approximately a third of in-patient discharges in this group 
(34.3 per cent). 
 
Length of Stay 
• Male overnight in-patient discharges had a mean length of stay of 7.7 days 
and female (excl. maternity) overnight in-patient discharges had a mean 
length of stay of 7.6 days. As displayed in Figure 2.2, overnight in-patient 
mean length of stay generally increased with age for both sexes. 
• For all age groups aged between 15 and 74 years, females (excl. maternity) 
had a lower overnight in-patient mean length of stay compared to males. 
Median overnight in-patient length of stay was similar across all age groups, 
ranging between 1 to 7 days for males and 2 to 8 days for females. 
• For maternity discharges, total overnight in-patient mean length of stay was 
3.1 days, increasing with age, from 2.9 days for females aged less than 25 
years to 4.5 days for those aged 45 years and over. 
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TABLE 2.1b Total Male Discharges: Patient Type by Age Group (N, %, Bed Days, % and In-Patient Length of 
Stay) 
 
 
Discharges and Bed Days 
Day Patients Total In-Patients  Total Discharges 
N % N % Bed Days % N % 
< 1 Year 2,149 0.4 14,583 5.4 79,644 4.6 16,732 2.1 
1–14 Years 25,769 4.8 28,940 10.8 68,081 3.9 54,709 6.8 
15–24 Years 17,116 3.2 15,266 5.7 47,392 2.7 32,382 4.0 
25–34 Years 28,174 5.3 15,791 5.9 58,917 3.4 43,965 5.5 
35–44 Years 47,752 9.0 22,371 8.4 101,403 5.9 70,123 8.8 
45–54 Years 68,681 12.9 28,222 10.5 147,145 8.5 96,903 12.1 
55–64 Years 104,000 19.5 37,563 14.0 248,622 14.4 141,563 17.7 
65–74 Years 136,178 25.6 47,417 17.7 374,278 21.7 183,595 22.9 
75–84 Years 86,347 16.2 41,196 15.4 405,777 23.5 127,543 15.9 
85 Years and Over 16,661 3.1 16,267 6.1 196,590 11.4 32,928 4.1 
Total Discharges 532,827 100 267,616 100 1,727,849 100 800,443 100 
 
 
In-Patient Length of Stay 
Sameday    
In-Patients Overnight In-Patients Total In-Patients 
N N Mean Median N Mean Median 
< 1 Year 1,622 12,961 6.0 2 14,583 5.5 2 
1–14 Years 5,529 23,411 2.7 1 28,940 2.4 1 
15–24 Years 4,063 11,203 3.9 2 15,266 3.1 1 
25–34 Years 4,328 11,463 4.8 2 15,791 3.7 1 
35–44 Years 5,834 16,537 5.8 3 22,371 4.5 2 
45–54 Years 6,414 21,808 6.5 3 28,222 5.2 2 
55–64 Years 6,958 30,605 7.9 4 37,563 6.6 3 
65–74 Years 7,158 40,259 9.1 5 47,417 7.9 4 
75–84 Years 5,102 36,094 11.1 6 41,196 9.8 5 
85 Years and Over 1,547 14,720 13.3 7 16,267 12.1 6 
Total Discharges 48,555 219,061 7.7 3 267,616 6.5 2 
 
Note: Percentage columns are subject to rounding. 
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TABLE 2.1c Female Discharges (excl. Maternity): Patient Type by Age Group (N, %, Bed Days, % and In-
Patient Length of Stay) 
 
 
Discharges and Bed Days 
Day Patients Total In-Patients  Total Discharges 
N % N % Bed Days % N % 
< 1 Year 1,704 0.3 11,481 4.4 70,372 4.3 13,185 1.7 
1–14 Years 19,193 3.7 23,717 9.0 58,434 3.5 42,910 5.5 
15–24 Years 17,669 3.4 17,430 6.6 50,809 3.1 35,099 4.5 
25–34 Years 40,985 7.8 18,558 7.1 60,327 3.6 59,543 7.6 
35–44 Years 67,913 13.0 25,096 9.6 95,087 5.7 93,009 11.8 
45–54 Years 90,735 17.3 28,397 10.8 127,285 7.7 119,132 15.2 
55–64 Years 99,993 19.1 32,618 12.4 187,713 11.3 132,611 16.9 
65–74 Years 101,538 19.4 40,908 15.6 298,645 18.1 142,446 18.1 
75–84 Years 66,003 12.6 39,982 15.2 400,887 24.2 105,985 13.5 
85 Years and Over 17,623 3.4 24,511 9.3 304,940 18.4 42,134 5.4 
Total Discharges 523,356 100 262,698 100 1,654,499 100 786,054 100 
 
 
In-Patient Length of Stay 
Sameday    
In-Patients Overnight In-Patients Total In-Patients 
N N Mean Median N Mean Median 
< 1 Year 1,277 10,204 6.8 2 11,481 6.1 2 
1–14 Years 4,116 19,601 2.8 2 23,717 2.5 1 
15–24 Years 4,586 12,844 3.6 2 17,430 2.9 1 
25–34 Years 5,488 13,070 4.2 2 18,558 3.3 1 
35–44 Years 7,062 18,034 4.9 2 25,096 3.8 1 
45–54 Years 7,293 21,104 5.7 3 28,397 4.5 2 
55–64 Years 6,996 25,622 7.1 4 32,618 5.8 2 
65–74 Years 7,240 33,668 8.7 5 40,908 7.3 3 
75–84 Years 5,521 34,461 11.5 6 39,982 10.0 5 
85 Years and Over 2,492 22,019 13.7 8 24,511 12.4 7 
Total Discharges 52,071 210,627 7.6 3 262,698 6.3 2 
 
Note: Percentage columns are subject to rounding. 
 
TABLE 2.1d Female Discharges (Maternity): Patient Type by Age Group (N, %, Bed Days, % and In-Patient 
Length of Stay) 
 
 Discharges and Bed Days 
 Day Patients Total In-Patients  Total Discharges 
 N % N % Bed Days % N % <25 Years 1,714 8.2 14,321 12.9 34,423 11.6 16,035 12.1 
25–34 Years 10,433 50.1 58,179 52.3 150,623 50.7 68,612 52.0 
35–44 Years 8,469 40.7 38,155 34.3 110,169 37.1 46,624 35.3 
45 Years and Over 215 1.0 540 0.5 2,062 0.7 755 0.6 
Total Discharges 20,831 100 111,195 100 297,277 100 132,026 100 
 
 
In-Patient Length of Stay 
Sameday    
In-Patients Overnight In-Patients Total In-Patients 
N N Mean Median N Mean Median 
<25 Years 3,648 10,673 2.9 2 14,321 2.4 2 
25–34 Years 11,858 46,321 3.0 2 58,179 2.6 2 
35–44 Years 6,520 31,635 3.3 3 38,155 2.9 2 
45 Years and Over 101 439 4.5 4 540 3.8 3 
Total Discharges 22,127 89,068 3.1 3 111,195 2.7 2 
 
Note: Percentage columns are subject to rounding. 
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FIGURE 2.2 Overnight In-Patients: Mean Length of Stay (Days) by Age Group and Sex: Males, Females (excl. 
Maternity), Females (Maternity) 
 
 
 
Note: Length of stay is not presented for female maternity discharges where there were a small number of discharges reported 
within a particular age group. 
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2.2.1.2 Discharge Rates by Age and Sex 
Figure 2.3 shows the discharge rates per 1,000 population by sex and age group 
for total discharges. 
• Apart from the youngest age group, for both males and females, the 
discharge rate generally increased with age. Those aged 75 to 84 years 
recorded the highest discharge rate for both males and females (1,396.6 per 
1,000 population of males and 977.8 per 1,000 population of females).  
• Females aged between 15 and 54 years had a higher discharge rate per 1,000 
population than males; males had a higher discharge rate for all other age 
groups. 
 
FIGURE 2.3 Total Discharges: Sex by Age Group (Discharge Rate per 1,000 Population) 
 
 
 
Source: Population estimates for 2017 by sex and age group were obtained from the CSO. 
https://www.cso.ie/px/pxeirestat/Statire/SelectVarVal/Define.asp?maintable=PEA11 [accessed 17th July 2018] 
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2.2.2 Marital/Civil Status 
2.2.2.1 Marital/Civil Status by Patient Type 
Table 2.2 disaggregates total discharges by patient type and marital/civil status. 
• Married discharges accounted for 48.7 per cent of total discharges. 
• Discharges who were widowed accounted for 9.6 per cent of total in-patient 
discharges, and 17.0 per cent of in-patient bed days.  
• Overnight in-patient discharges with a marital status of single had the lowest 
mean length of stay of 5.5 days, compared to 11.5 days for discharges who 
were widowed.  
 
TABLE 2.2 Total Discharges: Patient Type by Marital/Civil Status (N, %, and In-Patient Length of Stay) 
 
 
Discharges and Bed Days 
Day Patients Total In-Patients  Total Discharges 
N % N % Bed Days % N % 
Single 322,643 30.0 263,891 41.1 1,218,074 33.1 586,534 34.1 
Married 564,054 52.4 272,950 42.5 1,524,553 41.4 837,004 48.7 
Widowed 91,754 8.5 61,572 9.6 626,218 17.0 153,326 8.9 
Other* 50,145 4.7 22,435 3.5 159,848 4.3 72,580 4.2 
Unknown 29,289 2.7 11,908 1.9 95,522 2.6 41,197 2.4 
Divorced 19,129 1.8 8,753 1.4 55,410 1.5 27,882 1.6 
Total Discharges 1,077,014 100 641,509 100 3,679,625 100 1,718,523 100 
 
 
In-Patient Length of Stay 
Sameday    
In-Patients Overnight In-Patients Total In-Patients 
N N Mean Median N Mean Median 
Single 52,739 211,152 5.5 2 263,891 4.6 2 
Married 53,713 219,237 6.7 3 272,950 5.6 2 
Widowed 7,988 53,584 11.5 6 61,572 10.2 5 
Other* 4,146 18,289 8.5 4 22,435 7.1 3 
Unknown 2,367 9,541 9.8 4 11,908 8.0 3 
Divorced 1,800 6,953 7.7 4 8,753 6.3 3 
Total Discharges 122,753 518,756 6.9 3 641,509 5.7 2 
 
Notes:  Percentage columns are subject to rounding. 
 * Other includes Separated, Civil Partner, Formal Civil Partner, and Surviving Civil Partner 
 
 
2.2.2.2 Marital/Civil Status by Admission Type 
Figure 2.4 shows the proportion of total discharges by marital/civil status and 
admission type. 
• Approximately a third of total discharges with a marital/civil status of 
widowed or single were admitted as emergency in-patients (34.4 per cent 
and 31.5 per cent respectively). 
• Approximately eight per cent of total discharges with a marital/civil status of 
single or married were admitted as maternity in-patients. 
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FIGURE 2.4 Total Discharges: Marital/Civil Status by Admission Type (%) 
 
Notes:  Percentages are subject to rounding. 
Other includes Separated, Civil Partner, Formal Civil Partner, and Surviving Civil Partner 
 
* 
   
2.2.3 Public/Private Status 
In HIPE, public/private status relates to whether the patient saw the consultant 
on a private or public basis. It does not relate to the type of bed occupied nor is it 
an indicator of possession of private health insurance.  
Table 2.3 and Figure 2.5 disaggregate total discharges by public/private status 
and age group. Of total discharges, 84.6 per cent were discharged on a public 
basis. 
• The 25–34 years age group had the largest proportion of total discharges 
treated publicly (89.7 per cent) with only 10.3 per cent treated on a private 
basis. 
• The 1–14 years age group had the largest proportion of total discharges that 
were treated on a private basis, accounting for 20.6 per cent of all discharges 
in this age group. 
 
Length of Stay 
• For the majority of age groups, the public overnight in-patient mean length of 
stay exceeded the private overnight in-patient mean length of stay. The 
difference is largest for discharges aged 55–64 years, where public discharges 
stayed on average 1.4 days longer than their private counterparts (see Table 
2.3 and Figure 2.6). Median length of stay for overnight in-patients was 4 
days for both public and private discharges aged 55–64 years.  
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FIGURE 2.5 Total Discharges: Public/Private Status by Age Group (%) 
 
 
 
 
FIGURE 2.6 Overnight In-Patients: Mean Length of Stay (Days) by Age Group and Public/Private Status 
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2.2.4 GMS Status 
GMS status refers to the medical card status of each HIPE discharge. Eligibility for a 
medical card is predominately dependent on income. It should be noted that where a 
discharge is recorded as having a medical card, this does not necessarily imply that the 
hospital discharge was publicly funded and vice versa. 
 
2.2.4.1 GMS Status by Age Group 
Table 2.4 disaggregates total discharges by GMS status and age group. 
• Of total discharges, those aged 65–74 years accounted for the largest proportion of 
GMS discharges (22.2 per cent). 
• The proportion of total discharges that were GMS discharges generally increased 
with age, with the largest proportion in the 85 years and over age group (83.5 per 
cent) – see Figure 2.7. 
 
TABLE 2.4 Total Discharges: GMS Status by Age Group (N, %) 
 
 
GMS Non-GMS Unknowna Total Discharges 
N % N % N % N % 
< 1 Year 5,078 0.5 24,579 3.3 260 1.1 29,917 1.7 
1–14 Years 48,440 5.1 48,831 6.6 357 1.5 97,628 5.7 
15–24 Years 38,178 4.0 44,732 6.0 597 2.4 83,507 4.9 
25–34 Years 63,967 6.7 106,535 14.4 1,618 6.6 172,120 10.0 
35–44 Years 85,133 8.9 122,373 16.5 2,250 9.2 209,756 12.2 
45–54 Years 106,864 11.2 106,036 14.3 3,890 15.9 216,790 12.6 
55–64 Years 146,884 15.4 122,761 16.6 4,529 18.5 274,174 16.0 
65–74 Years 211,914 22.2 108,780 14.7 5,347 21.8 326,041 19.0 
75–84 Years 185,108 19.4 44,236 6.0 4,184 17.1 233,528 13.6 
85 Years and Over 61,464 6.4 12,133 1.6 1,465 6.0 75,062 4.4 
Total Discharges 953,030 100 740,996 100 24,497 100 1,718,523 100 
 
Notes:  
a 
Percentage columns are subject to rounding. 
Relates to discharges for whom GMS status was not known. 
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FIGURE 2.7 Total Discharges: GMS Status by Age Group (%) 
 
Note: Data for discharges whose GMS status was 'unknown' are not included in the calculations for this figure.  
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2.3 WHERE 
Section 2.3 examines where discharges were hospitalised, and where they were 
admitted from and discharged to. Data are presented in the following tables and figures 
by hospital group, admission source and discharge destination. 
2.3.1 Hospital Group  
Hospitals in Ireland are organised into seven hospital groups (see Appendix I). HIPE data 
is collected for all of the acute hospitals in these groups, along with a small number of 
non-acute hospitals that are not assigned to a group and are presented together as ‘No 
group’. Table 2.5 disaggregates total discharges by hospital group and patient type. 
Discharges 
• The largest proportion of total discharges were hospitalised in the South/South 
West Hospital Group (19.3 per cent).  
• Total in-patient discharges were highest in the Ireland East Hospital Group where 
20.7 per cent of discharges were hospitalised, while the Dublin Midlands Hospital 
Group accounted for the highest proportion of day patients (20.6 per cent). 
 
Length of Stay 
• The overnight in-patient mean length of stay ranged from 4.6 days (Children’s) to 
7.8 days (Dublin Midlands) – see Figure 2.8.  
TABLE 2.5 Total Discharges: Hospital Group by Patient Type (N, %, Bed Days, %, and In-Patient Length of Stay) 
 
 Discharges and Bed Days 
 Day Patients Total In-Patients  Total Discharges 
 N % N % Bed Days % N % Ireland East 196,715 18.3 132,828 20.7 762,684 20.7 329,543 19.2 
RCSI 156,242 14.5 102,526 16.0 571,568 15.5 258,768 15.1 
Dublin Midlands 222,388 20.6 96,985 15.1 655,506 17.8 319,373 18.6 
South/South West 214,931 20.0 116,688 18.2 645,478 17.5 331,619 19.3 
UL 60,901 5.7 50,870 7.9 248,360 6.7 111,771 6.5 
Saolta 196,036 18.2 113,173 17.6 577,516 15.7 309,209 18.0 
Children’s 28,438 2.6 24,773 3.9 101,120 2.7 53,211 3.1 
No group^ 1,363 0.1 3,666 0.6 117,393 3.2 5,029 0.3 
Total Discharges 1,077,014 100 641,509 100 3,679,625 100 1,718,523 100 
 
 
In-Patient Length of Stay 
Sameday    
In-Patients Overnight In-Patients Total In-Patients 
N N Mean Median N Mean Median 
Ireland East 30,040 102,788 7.1 3 132,828 5.7 2 
RCSI 21,944 80,582 6.8 3 102,526 5.6 2 
Dublin Midlands 15,072 81,913 7.8 3 96,985 6.8 3 
South/South West 19,320 97,368 6.4 3 116,688 5.5 2 
UL 11,269 39,601 6.0 3 50,870 4.9 2 
Saolta 21,437 91,736 6.1 3 113,173 5.1 2 
Children’s 3,665 21,108 4.6 2 24,773 4.1 2 
No group^ 6 3,660 32.1 21 3,666 32.0 21 
Total Discharges 122,753 518,756 6.9 3 641,509 5.7 2 
 
Notes:  Percentage columns are subject to rounding. 
 ^ Discharges allocated to ‘No group’ are not referred to in the text of this report as they refer to the small group of discharges in 
non-acute hospitals and would not be considered to be comparable to other groups. See Appendix I for the list of hospitals by 
Group in 2017. 
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FIGURE 2.8 Overnight In-Patients: Discharges (N) and Mean Length of Stay (Days) by Hospital Group 
 
 
Note:  Data for discharges hospitalised in ‘No group’ are not displayed in this figure. 
 
 
 
2.3.1.1 Hospital Group by Admission Type 
Table 2.6 disaggregates total discharges by hospital group and admission type. 
Discharges 
• The largest proportion of elective in-patients were treated in the South/South West 
Hospital Group (20.4 per cent), accounting for 15.9 per cent of total elective in-
patient bed days. 
• The Ireland East Hospital Group treated the largest proportion of both emergency 
in-patients (20.6 per cent) and maternity in-patients (22.4 per cent) compared to 
other groups. 
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
90,000
100,000
110,000
Ireland East RCSI Dublin
Midlands
South/South
West
UL Saolta Children
Overnight In-patient M
ean Length of Stay (Days)
Ov
er
ni
gh
t I
n-
Pa
tie
nt
 D
isc
ha
rg
es
 (N
)
Hospital Group
Discharges Mean Length of Stay
34
 |
 A
ct
iv
it
y 
in
 A
cu
te
 P
ub
lic
 H
os
pi
ta
ls
 2
01
7 
TA
BL
E 
2.
6 
To
ta
l D
isc
ha
rg
es
: H
os
pi
ta
l G
ro
up
 b
y 
Ad
m
iss
io
n 
Ty
pe
 (N
, %
, B
ed
 D
ay
s, 
%
) 
 
 
Di
sc
ha
rg
es
 a
nd
 B
ed
 D
ay
s 
 
Da
y 
Pa
tie
nt
s 
In
-P
at
ie
nt
s 
To
ta
l D
isc
ha
rg
es
 
 
 
El
ec
tiv
e 
 
Em
er
ge
nc
ya
 
M
at
er
ni
ty
 
 
N 
%
 
N 
%
 
Be
d 
Da
ys
 
%
 
N 
%
 
Be
d 
Da
ys
 
%
 
N 
%
 
Be
d 
Da
ys
 
%
 
N 
%
 
Ire
la
nd
 E
as
t 
19
6,
71
5 
18
.3
 
18
,5
09
 
19
.3
 
11
2,
61
3 
17
.4
 
89
,3
84
 
20
.6
 
58
9,
31
4 
21
.5
 
24
,9
35
 
22
.4
 
60
,7
57
 
20
.4
 
32
9,
54
3 
19
.2
 
RC
SI
 
15
6,
24
2 
14
.5
 
11
,0
00
 
11
.4
 
62
,8
72
 
9.
7 
69
,5
75
 
16
.0
 
44
9,
46
4 
16
.4
 
21
,9
51
 
19
.7
 
59
,2
32
 
19
.9
 
25
8,
76
8 
15
.1
 
Du
bl
in
 M
id
la
nd
s 
22
2,
38
8 
20
.6
 
13
,5
07
 
14
.1
 
98
,2
78
 
15
.2
 
61
,7
02
 
14
.2
 
50
6,
37
0 
18
.5
 
21
,7
76
 
19
.6
 
50
,8
58
 
17
.1
 
31
9,
37
3 
18
.6
 
So
ut
h/
So
ut
h 
W
es
t 
21
4,
93
1 
20
.0
 
19
,6
20
 
20
.4
 
10
2,
93
3 
15
.9
 
78
,8
19
 
18
.2
 
48
4,
70
8 
17
.7
 
18
,2
49
 
16
.4
 
57
,8
37
 
19
.5
 
33
1,
61
9 
19
.3
 
UL
 
60
,9
01
 
5.
7 
7,
41
4 
7.
7 
35
,5
53
 
5.
5 
36
,9
73
 
8.
5 
18
9,
40
2 
6.
9 
6,
48
3 
5.
8 
23
,4
05
 
7.
9 
11
1,
77
1 
6.
5 
Sa
ol
ta
 
19
6,
03
6 
18
.2
 
16
,1
40
 
16
.8
 
91
,9
37
 
14
.2
 
79
,2
32
 
18
.2
 
44
0,
39
1 
16
.1
 
17
,8
01
 
16
.0
 
45
,1
88
 
15
.2
 
30
9,
20
9 
18
.0
 
Ch
ild
re
n’
s 
28
,4
38
 
2.
6 
* 
- 
^ 
- 
* 
- 
^ 
- 
0 
- 
0 
 
- 
53
,2
11
 
3.
1 
No
 g
ro
up
ⱡ  
1,
36
3 
0.
1 
* 
- 
^ 
- 
~ 
- 
^ 
- 
0 
- 
0 
 
- 
5,
02
9 
0.
3 
To
ta
l D
isc
ha
rg
es
 
1,
07
7,
01
4 
10
0 
96
,1
00
 
10
0 
64
7,
59
5 
10
0 
43
4,
21
4 
10
0 
2,
73
4,
75
3 
10
0 
11
1,
19
5 
10
0 
29
7,
27
7 
10
0 
1,
71
8,
52
3 
10
0 
 
No
te
s:
 
~ 
De
no
te
s f
iv
e 
or
 fe
w
er
 d
isc
ha
rg
es
 re
po
rt
ed
 to
 H
IP
E.
 
 
* 
Fu
rt
he
r s
up
pr
es
sio
n 
re
qu
ire
d 
to
 p
re
ve
nt
 d
isc
lo
su
re
 o
f f
iv
e 
or
 fe
w
er
 d
isc
ha
rg
es
. 
 
^ 
De
no
te
s t
ha
t b
ed
 d
ay
s a
re
 su
pp
re
ss
ed
 w
he
re
 th
e 
nu
m
be
r o
f d
isc
ha
rg
es
 is
 n
ot
 re
po
rt
ed
. 
 
 
Pe
rc
en
ta
ge
 co
lu
m
ns
 a
re
 su
bj
ec
t t
o 
ro
un
di
ng
 
 
a 
HI
PE
 in
clu
de
s 
pa
tie
nt
s 
w
ho
 a
tte
nd
ed
 t
he
 E
m
er
ge
nc
y 
De
pa
rt
m
en
t 
an
d 
w
er
e 
su
bs
eq
ue
nt
ly
 a
dm
itt
ed
 t
o 
ho
sp
ita
l. 
As
 ju
st
 a
 p
ro
po
rt
io
n 
of
 t
ho
se
 a
tte
nd
in
g 
th
e 
Em
er
ge
nc
y 
De
pa
rt
m
en
t 
w
ill
 
su
bs
eq
ue
nt
ly
 b
e 
ad
m
itt
ed
 to
 h
os
pi
ta
l, 
it 
is 
no
t p
os
sib
le
 to
 u
se
 e
m
er
ge
nc
y 
ad
m
iss
io
ns
 re
po
rt
ed
 to
 H
IP
E 
to
 d
ra
w
 co
nc
lu
sio
ns
 a
bo
ut
 th
e 
to
ta
l v
ol
um
e 
of
 a
ct
iv
ity
 in
 E
m
er
ge
nc
y 
De
pa
rt
m
en
ts
. 
 
ⱡ 
Di
sc
ha
rg
es
 a
llo
ca
te
d 
to
 ‘N
o 
gr
ou
p’
 a
re
 n
ot
 re
fe
rr
ed
 to
 in
 th
e 
te
xt
 a
s t
he
y 
re
fe
r t
o 
th
e 
sm
al
l g
ro
up
 o
f d
isc
ha
rg
es
 in
 n
on
-a
cu
te
 h
os
pi
ta
ls 
an
d 
w
ou
ld
 n
ot
 b
e 
co
ns
id
er
ed
 to
 b
e 
co
m
pa
ra
bl
e 
to
 o
th
er
 
gr
ou
ps
. S
ee
 A
pp
en
di
x I
 fo
r t
he
 li
st
 o
f h
os
pi
ta
ls 
by
 G
ro
up
 in
 2
01
7.
 
  
 
Discharge Overview 2017 | 35  
Figure 2.9 disaggregates total discharges in each hospital group by admission 
type. 
• Across all hospital groups, the largest proportion of total discharges were 
treated as day patients, ranging from 53.4 per cent in the Children’s Hospital 
Group to 69.6 per cent in the Dublin Midlands Hospital Group. 
• The RCSI Hospital Group treated 8.5 per cent of total discharges as maternity 
in-patients, the highest amongst all hospital groups. 
• The Children’s Hospital Group treated the highest proportion of total 
discharges as emergency in-patients (34.8 per cent). 
 
FIGURE 2.9 Total Discharges: Hospital Group by Admission Type (%) 
 
 
 
Notes: * HIPE includes patients who attended the Emergency Department and were subsequently admitted to hospital. As just a 
proportion of those attending the Emergency Department will subsequently be admitted to hospital, it is not possible to 
use emergency admissions reported to HIPE to draw conclusions about the total volume of activity in Emergency 
Departments. 
Data for discharges hospitalised in ‘No group’ are not displayed in this figure. 
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2.3.1.2 Hospital Group by Public/Private Status  
Table 2.7 disaggregates total discharges by hospital group, public/private status 
and patient type. 
 
Discharges 
• The RCSI Hospital Group treated the largest proportion of total discharges on 
a public basis (89.7 per cent), while the University of Limerick Hospital Group 
treated the smallest proportion of total discharges on a public basis (72.8 per 
cent). 
• A larger proportion of total day patients were treated as public day patients, 
exceeding 90 per cent in both the Ireland East and RCSI Hospital Groups. The 
smallest proportion was in the University of Limerick Hospital Group where 
72.3 per cent of total day patients were treated on a public basis. 
• The proportion of total in-patients treated on a public basis exceeded 80 per 
cent in the Ireland East, RCSI, Dublin Midlands and Saolta Hospital Groups. 
 
Length of Stay 
• Overnight in-patient mean length of stay was 7.0 days for public discharges 
compared to 6.3 days for private discharges. 
• The Dublin Midlands Hospital Group recorded the longest overnight in-
patient mean length of stay for both public and private discharges (7.8 days) 
compared to the other groups. 
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2.3.2 Admission Source 
Admission source describes where the patient was admitted from. It does not 
refer to where an emergency or accident occurred. Table 2.8 disaggregates total 
discharges by patient type, admission type and admission source. 
• The majority of total discharges were admitted from home (96.7 per cent). 
• Of total emergency in-patients, 2.6 per cent were transferred in from long 
stay accommodation. 
• Almost 11 per cent of elective in-patients were transferred from another 
hospital. 
 
TABLE 2.8 Total Discharges: Admission Source by Patient Type and Admission Type (N, %) 
 
 Day Patients 
In-Patients Total Discharges Elective Emergencya Maternity 
N % N % N % N % N % 
Home 1,070,519 99.4 85,179 88.6 395,132 91.0 110,325 99.2 1,661,155 96.7 
Long stay 
accommodation 1,411 0.1 411 0.4 11,176 2.6 0 0.0 12,998 0.8 
Transfer from 
other hospital 4,857 0.5 10,435 10.9 16,654 3.8 790 0.7 32,736 1.9 
Other 227 0.0 75 0.1 11,252 2.6 80 0.1 11,634 0.7 
Total 1,077,014 100 96,100 100.0 434,214 100 111,195 100.0 1,718,523 100 
 
Notes  Percentage columns are subject to rounding. 
See Appendix IV for information on how the HIPE variable 'Admission Source' was grouped for this report. 
 a HIPE includes patients who attended the Emergency Department and were subsequently admitted to hospital. As just a 
proportion of those attending the Emergency Department will subsequently be admitted to hospital, it is not possible to use 
emergency admissions reported to HIPE to draw conclusions about the total volume of activity in Emergency Departments. 
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2.3.3 Discharge Destination 
Discharge destination identifies the destination of the discharge upon completion 
of their episode of care. Table 2.9 disaggregates total discharges by patient type, 
admission type and discharge destination. 
• The majority of total discharges were discharged home (95.1 per cent). 
• Of total emergency in-patients, 6.3 per cent were transferred to long stay 
accommodation, and 5.6 per cent were transferred to another hospital. 
 
TABLE 2.9  Total Discharges: Discharge Destination by Patient Type and Admission Type (N, %) 
 
 Day Patients 
In-Patients Total Discharges Elective Emergencya Maternity 
N % N % N % N % N % 
Home 1,069,973 99.3 88,027 91.6 366,291 84.4 109,689 98.6 1,633,980 95.1 
Long stay 
accommodation 1,762 0.2 * - 27,270 6.3 ~ - 32,248 1.9 
Transfer to other 
hospital 5,020 0.5 3,629 3.8 24,247 5.6 715 0.6 33,611 2.0 
Died 0 0.0 * - 10,364 2.4 ~ - 11,082 0.6 
Other 259 0.0 516 0.5 6,042 1.4 785 0.7 7,602 0.4 
Total Discharges 1,077,014 100 96,100 100 434,214 100 111,195 100 1,718,523 100 
 
 
Notes:  Percentage columns are subject to rounding. 
See Appendix IV for information on how the HIPE variable 'Discharge Destination' was grouped for this report. 
 a HIPE includes patients who attended the Emergency Department and were subsequently admitted to hospital. As just a 
proportion of those attending the Emergency Department will subsequently be admitted to hospital, it is not possible to 
use emergency admissions reported to HIPE to draw conclusions about the total volume of activity in Emergency 
Departments. 
 ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges. 
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2.3.4 Admission Source by Discharge Destination 
Figure 2.10 disaggregates the proportion of in-patient discharges by discharge 
destination and admission source. 
• Of in-patients who were admitted from home, 90.9 per cent were discharged 
home. 
• In-patients admitted from long stay accommodation were primarily 
discharged back to long stay accommodation (85.5 per cent). 
• Over a quarter of in-patients (25.4 per cent) who were admitted from 
another hospital were transferred to another hospital, while 62.6 per cent 
were discharged home. 
 
FIGURE 2.10 In-Patient Discharges: Discharge Destination by Admission Source (%)
 
 
Notes:  See Appendix IV for information on how the HIPE variables 'Discharge Destination' and ‘Admission Source’ were grouped 
for this report. 
Percentages are subject to rounding. 
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2.4 WHEN 
Section 2.4 profiles when discharges were admitted to and discharged from 
hospital. Activity is presented by day of admission, day of discharge, and month 
of discharge for total discharges. 
 
2.4.1 Day of Admission 
Table 2.10 disaggregates total discharges by patient type, admission type, and 
day of admission (see also Figure 2.11). 
 
Discharges 
• Over 60 per cent of elective in-patients were admitted between Monday and 
Wednesday, with only 6.0 per cent admitted at the weekend. 
• The proportion of in-patient discharges admitted as emergency in-patients 
remained relatively constant throughout the week at approximately 16 per 
cent per day, but fell at weekends when approximately 10 per cent were 
admitted per day. 
• The majority of day patients were admitted mid-week, ranging from 21.4 per 
cent on Wednesday to only 2.4 per cent on Saturday and 1.0 per cent on 
Sunday. 
 
Length of Stay2 
• Mean length of stay for elective in-patients ranged from 6.1 days for those 
admitted on a Tuesday to 10.3 days for those admitted on a Saturday. 
• Mean length of stay for emergency in-patients ranged from 6.0 days for those 
admitted on a Monday to 6.7 days for those admitted on a Saturday. 
  
                                                                                                                                                                                                                              
2  Where length of stay is analysed by admission type, a breakdown of sameday and overnight in-patient length of stay is 
not provided. 
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TABLE 2.10 Total Discharges: Patient Type and Admission Type by Day of Admission (N, % and In-Patient 
Length of Stay) 
 
 
Discharges 
Day Patients In-Patients Total Discharges 
 Elective Emergencya Maternity 
N % N % N % N % N % 
Monday 192,143 17.8 20,023 20.8 64,964 15.0 18,028 16.2 295,158 17.2 
Tuesday 216,899 20.1 20,104 20.9 72,574 16.7 18,569 16.7 328,146 19.1 
Wednesday 229,956 21.4 19,395 20.2 71,322 16.4 17,932 16.1 338,605 19.7 
Thursday 212,806 19.8 18,209 18.9 69,632 16.0 18,398 16.5 319,045 18.6 
Friday 188,480 17.5 12,596 13.1 69,143 15.9 15,984 14.4 286,203 16.7 
Saturday 26,104 2.4 1,725 1.8 46,302 10.7 10,814 9.7 84,945 4.9 
Sunday 10,626 1.0 4,048 4.2 40,277 9.3 11,470 10.3 66,421 3.9 
Total 
Discharges 1,077,014 100 96,100 100 434,214 100 111,195 100 1,718,523 100 
 
 
In-Patient Length of Stay 
Elective Emergencya Maternity Total In-Patients 
Mean Median Mean Median Mean Median N Mean Median 
Monday 6.7 3 6.0 2 2.7 2 103,015 5.5 2 
Tuesday 6.1 2 6.2 2 2.8 2 111,247 5.6 2 
Wednesday 6.4 2 6.2 2 2.8 2 108,649 5.7 2 
Thursday 6.6 2 6.3 2 2.7 2 106,239 5.7 2 
Friday 7.4 3 6.5 3 2.6 2 97,723 6.0 3 
Saturday 10.3 4 6.7 3 2.4 2 58,841 6.0 3 
Sunday 8.2 4 6.3 3 2.6 2 55,795 5.7 3 
In-Patient Discharges 6.7 2 6.3 2 2.7 2 641,509 5.7 2 
 
Notes:  
a 
Percentage columns are subject to rounding. 
HIPE includes patients who attended the Emergency Department and were subsequently admitted to hospital. As just a 
proportion of those attending the Emergency Department will subsequently be admitted to hospital, it is not possible to 
use emergency admissions reported to HIPE to draw conclusions about the total volume of activity in Emergency 
Departments. 
 
 
FIGURE 2.11 Total Discharges: Patient Type and Admission Type by Day of Admission (%)
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2.4.2 Day of Discharge 
Table 2.11 disaggregates total discharges by patient type, admission type and day 
of discharge (see also Figure 2.12). 
Discharges 
• The proportion of elective in-patients discharged increased throughout the 
week, from 10.5 per cent on Monday to 22.6 per cent on Friday, falling to 
10.1 per cent on Saturday and 4.8 per cent on Sunday. 
• The largest proportion of emergency in-patients were discharged on Friday 
(20.3 per cent), with the smallest proportion discharged on Sunday (6.1 per 
cent). 
Length of Stay 
• Elective in-patients discharged on a Monday had the longest in-patient mean 
length of stay (10.2 days). 
• Emergency in-patient mean length of stay fell throughout the week from 6.9 
days for those discharged on a Monday to 4.2 days for those discharged on a 
Sunday. 
 
TABLE 2.11 Total Discharges: Patient Type and Admission Type by Day of Discharge (N, % and In-Patient 
Length of Stay) 
 
 Discharges 
 Day Patients In-Patients Total Discharges   Elective Emergency
a Maternity 
 N % N % N % N % N % Monday 192,143 17.8 10,097 10.5 66,004 15.2 16,196 14.6 284,440 16.6 
Tuesday 216,899 20.1 15,064 15.7 72,209 16.6 15,899 14.3 320,071 18.6 
Wednesday 229,956 21.4 17,008 17.7 74,312 17.1 15,076 13.6 336,352 19.6 
Thursday 212,806 19.8 17,937 18.7 74,078 17.1 16,432 14.8 321,253 18.7 
Friday 188,480 17.5 21,711 22.6 88,179 20.3 17,741 16.0 316,111 18.4 
Saturday 26,104 2.4 9,665 10.1 32,897 7.6 15,405 13.9 84,071 4.9 
Sunday 10,626 1.0 4,618 4.8 26,535 6.1 14,446 13.0 56,225 3.3 
Total Discharges 1,077,014 100 96,100 100 434,214 100 111,195 100 1,718,523 100 
 
 
In-Patient Length of Stay 
Elective Emergencya Maternity Total In-Patients 
Mean Median Mean Median Mean Median N Mean Median 
Monday 10.2 5 6.9 3 2.9 2 92,297 6.6 3 
Tuesday 7.2 2 6.6 3 2.7 2 103,172 6.1 2 
Wednesday 6.8 2 6.7 2 2.5 2 106,396 6.1 2 
Thursday 6.4 2 6.6 2 2.4 2 108,447 6.0 2 
Friday 6.5 2 6.2 3 2.6 2 127,631 5.7 2 
Saturday 3.9 2 4.6 2 2.7 2 57,967 4.0 2 
Sunday 6.0 4 4.2 2 2.9 2 45,599 4.0 2 
In-Patient Discharges 6.7 2 6.3 2 2.7 2 641,509 5.7 2 
 
 
Notes:  
a 
Percentage columns are subject to rounding. 
HIPE includes patients who attended the Emergency Department and were subsequently admitted to hospital. As just a 
proportion of those attending the Emergency Department will subsequently be admitted to hospital, it is not possible to 
use emergency admissions reported to HIPE to draw conclusions about the total volume of activity in Emergency 
Departments. 
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FIGURE 2.12 Total Discharges: Patient Type and Admission Type by Day of Discharge (%) 
 
 
 
Note: * See note under Table 2.10 
 
2.4.1 Month of Discharge 
Figure 2.13 shows total discharges by month of discharge disaggregated by 
patient type and admission type. 
• Hospital discharges peaked in March for elective in-patients (8,618 
discharges), while January recorded the smallest number of elective in-
patients with only 6,801 elective in-patients discharged in this month.  
• Emergency in-patient hospital discharges peaked in March (38,679 
discharges), while the smallest number of emergency in-patients were 
discharged in February with 33,869 discharges. 
• Maternity in-patient discharges were highest in July (9,603 discharges) and 
lowest in February (8,672 discharges). 
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FIGURE 2.13 Total Discharges: Month of Discharge by Patient Type and Admission Type (N) 
 
Notes: * HIPE includes patients who attended the Emergency Department and were subsequently admitted to hospital. As just a 
proportion of those attending the Emergency Department will subsequently be admitted to hospital, it is not possible to 
use emergency admissions reported to HIPE to draw conclusions about the total volume of activity in Emergency 
Departments. 
  Includes 9,073 discharges admitted prior to 2017 and discharged in 2017. 
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3.1 INTRODUCTION 
Section Three focuses on the diagnoses and procedures recorded for total 
discharges reported to HIPE by acute public hospitals.1,2 
 
• Section 3.2 outlines the clinical coding process, the classification and 
definitions used in the assignment of diagnosis and procedure codes to a 
discharge, and analysis of the mean number of diagnoses and procedures 
reported for discharges. 
• Section 3.3 provides a summary of related hospital activity. Top 20 diagnoses 
and procedure blocks, along with Top 10 Australian Refined Diagnosis Related 
Groups (AR-DRGs), are provided for day patient discharges and in-patient 
discharges (total, elective, emergency and maternity). Demographic data, 
including sex and age group, and administrative analyses including mode of 
emergency admission (for emergency in-patients only) are also presented. 
• Section 3.4 provides details of the diagnoses and procedures reported for 
total discharges, by sex and age group. The mean and median length of stay 
for total in-patient discharges is presented for principal diagnoses and 
principal procedures. 
 
3.2 CODING OF DIAGNOSES AND PROCEDURES 
Coding of HIPE hospital activity is performed by the HIPE Clinical Coder who 
translates medical terminology into alpha-numeric codes. The Coder performs an 
essential function in providing high quality, accurate, and uniform medical 
information and greatly contributes to the continuous growth of medical 
knowledge. The HPO is responsible for the training of all HIPE coders nationally.3,4 
Since 2014, the HPO have delivered certification courses for HIPE coders in 
collaboration with, and accredited by, the School of Computing in the Dublin 
Institute of Technology (DIT). To date, just over 100 coders have achieved this 
certification.  
The source document for coding for the HIPE system is the medical record or 
chart. The clinical coder uses the entire chart to extract the conditions and 
procedures to provide a complete record of the patient and their hospital stay. In 
addition to the discharge summary or letter, additional documentation 
referenced for coding a case include; nursing notes, consultation reports, 
                                                                                                                                                                                                                              
1  The National Psychiatric In-Patient Reporting System, supported by the Health Research Board, reports information 
on all admissions to psychiatric hospitals and units nationally. 
2  The presentation of in-patient length of stay differs from reports prior to 2015 which presented acute and total in-
patient mean length of stay. This report presents mean and median total in-patient length of stay only (see Section 
1.6). 
3  There are currently approximately 300 coders working full time and part time across all HIPE hospitals.  
4  For further information on training programmes see www.hpo.ie  
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progress notes, operative reports, pre- and post-operative reports, pathology 
reports and more recently the sepsis form. Appendix III shows the HIPE Data 
Entry Form for 2017, which details the information coded for each hospital 
discharge. No interpretation of test results may be presumed by the Coder and all 
diagnoses recorded must be documented by a clinician in the chart.  
All HIPE data are keyed in at the hospital using the HIPE Portal data entry system 
which runs an extensive number of validation edit checks to ensure the quality of 
the data. Other data quality activities and data quality tools are in use at local and 
national HPO level.5 
At the start of 2015, the classification used to code clinical information was 
updated from the 6th Edition to the 8th Edition of the International Statistical 
Classification of Diseases and Related Health Problems, Tenth Revision, Australian 
Modification (ICD-10-AM), Australian Classification of Health interventions 
(ACHI), Australian Coding Standards (ACS).6,7 Details of the ICD-10-AM diagnosis 
and ACHI procedure coding scheme are provided in Tables 3.1 and 3.2. ACS are 
developed to provide guidance in the application of ICD-10-AM and ACHI codes. 
Coding standards are provided with general guidelines and are categorised by site 
and/or body system according to the clinical specialty to which a disease or 
procedure relates. Use of ICD-10-AM/ACHI/ACS is complemented by the Irish 
Coding Standards (ICS); these are revised regularly to reflect changing clinical 
practice and to ensure the classification and its application are relevant to the 
Irish Healthcare system.8 
Due to the update in the classification, caution must be exercised when 
comparing procedure and diagnosis categories presented in reports from 2015 
onwards compared to previous reports, due to changes in sequencing of codes, 
addition of new codes, deletion of codes, and updates to ACS and ICS.9  
                                                                                                                                                                                                                              
5 In 2015, the HSE engaged Pavilion Health Australia Pty Ltd. by competitive tender to undertake a review of the quality 
of HIPE data in order to assess whether the quality of the data was sufficient to support the introduction of Activity 
Based Funding (ABF). The final report is available at www.hpo.ie 
6 National Casemix and Classification Centre (NCCC), 2013: The International Statistical Classification of Diseases and 
Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Australian Classification of Health 
Interventions (ACHI) and Australian Coding Standards (ACS) – ICD-10-AM/ACHI/ACS (8th Ed): NCCC, Australian Health 
Services Research Institute, University of Wollongong. 
7 The spelling conventions of ICD-10-AM comply with the Macquarie Dictionary, as recommended by the Australian 
government style manual. 
8  Irish Coding Standards (ICS) provide guidelines for the collection of HIPE data for all discharges and are to be used in   
conjunction with 8th Edition ICD-10-AM/ACHI/ACS and the relevant HIPE Instruction Manual. For further information, 
see www.hpo.ie 
9 See Appendix VII for an overview of changes from ICD-10-AM/ACHI/ACS 6th edition (in use from 2009–2014) to 8th 
Edition (in use from 1st January 2015). 
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Table 3.1 provides details of the structure of ICD-10-AM diagnosis codes and 
presents the chapter structure for these ICD-10-AM diagnosis codes.  
 
TABLE 3.1 ICD-10-AM Diagnosis Codes, Chapter and Title  
 
ICD-10-AM Diagnosis Codes 
The 'core' disease classification of ICD-10-AM is the three character code, which is the mandatory level of coding for 
international reporting to the World Health Organization (WHO) for general international comparisons. This core set of 
codes has been expanded to four and five character codes so that important specific disease entities can be identified, 
while also maintaining the ability to present data in broad groups to enable useful and understandable information to be 
obtained. 
 
The ICD-10-AM is a variable-axis classification. Its structure is designed principally to facilitate epidemiological analysis. 
Diseases are organised in the following groups: epidemic diseases; constitutional or general diseases; local disease 
arranged by site; developmental diseases; and injuries. 
 
Most of the tabular is taken up with the main disease classification composed of 22 chapters. The first character of the 
ICD-10-AM code is a letter, and each letter is associated with a particular chapter, except for the letter D, which spans 
both Chapter 2 Neoplasms and Chapter 3 Diseases of the blood and blood-forming organs and certain disorders involving 
the immune mechanism, and the letter H, which is used in both Chapter 7 Diseases of the eye and adnexa and Chapter 8 
Diseases of the ear and mastoid process. Four chapters (Chapters 1, 2, 19 and 20) use more than one letter in the first 
position of their codes. 
 
WHO intends the codes U00–U99 to be used for provisional assignment of new diseases of uncertain aetiology, for 
emergency use and for specific research purposes. U50–U73 are used in ICD-10-AM to classify activity and U90 classifies 
healthcare associated infections. 
 
Chapter and Title Code Prefix Chapter and Title 
Code 
Prefix 
1 Certain infectious and parasitic 
diseases 
A, B 12 Diseases of the skin and subcutaneous 
tissue 
L 
2 Neoplasms C, D 13 Diseases of the musculoskeletal system and 
connective tissue 
M 
3 Diseases of the blood and blood-
forming organs and certain disorders 
involving the immune mechanism 
D 14 Diseases of the genitourinary system N 
4 Endocrine, nutritional and metabolic 
diseases 
E 15 Pregnancy, childbirth and the puerperium O 
5 Mental and behavioural disorders F 16 Certain conditions originating in the 
perinatal period 
P 
6 Diseases of the nervous system G 17 Congenital malformations, deformations 
and chromosomal abnormalities 
Q 
7 Diseases of the eye and adnexa H 18 Symptoms, signs and abnormal clinical and 
laboratory findings, not elsewhere classified 
R 
8 Diseases of the ear and mastoid 
process 
H 19 Injury, poisoning and certain other 
consequences of external causes 
S, T 
9 Diseases of the circulatory system I 20 External causes of morbidity and mortality U, V, 
W, X, 
Y 
10 Diseases of the respiratory system J 21 Factors influencing health status and 
contact with health services 
Z 
11 Diseases of the digestive system K 22 Codes for special purposes U 
 
Source: National Casemix and Classification Centre (NCCC), 2013: Australian Coding Standards (ACS) (8th Ed): NCCC, Australian Health 
Services Research Institute, University of Wollongong.p. xv-xvi. 
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Table 3.2 provides details of the structure of ACHI procedure codes and presents 
the chapter structure for these ACHI procedure codes. 
 
TABLE 3.2 Australian Classification of Health Interventions (ACHI), Chapter and Title 
 
Australian Classification of Health Interventions (ACHI) 
The Australian Classification of Health Interventions (ACHI) was first developed by the National Centre for Classification 
in Health (NCCH) (the previous custodians of ICD-10-AM/ACHI/ACS) and is generally based on the Commonwealth 
Medicare Benefits Schedule (MBS). 
The main features of the classification are: 
1) The procedure classification captures procedures and interventions performed in public and private hospitals, day 
centres and ambulatory settings. Allied health interventions, dental services and procedures performed outside the 
operating theatre are included.10 
2) The intervention classification has been based on the Commonwealth Medicare Benefits Schedule (MBS) (with 
some exceptions). A two digit extension number has been attached to each MBS item number to represent 
individual procedural concepts (e.g., 36564-00). Other ACHI procedures and interventions which are not 
represented in MBS are allocated a code number from the 90000 series. Note: 97000 code numbers are reserved 
for dental services. 
3) The structure of the procedure classification is based on anatomy rather than surgical specialty. Chapters closely 
follow the chapter headings of the WHO ICD-10 to maintain parity with the disease classification. 
4) Nonsurgical procedures are listed separately from the surgical procedures, whenever feasible. 
5) A hierarchical structure with the following axes:  
• First level – anatomical site axis 
• Second level – procedure type axis 
• Third level – block axis 
6) Inclusion of many more procedures which can be utilised in non-institutional settings, such as community based 
health and ambulatory care. 
7) The interventions in the procedure classification are provider neutral. That is, the same code should be assigned for 
a specific intervention regardless of which health professional performs the intervention. 
 
Chapter and Title Chapter and Title 
1 Procedures on nervous system 11 Procedures on urinary system 
2 Procedures on endocrine system 12 Procedures on male genital organs 
3 Procedures on eye and adnexa 13 Gynaecological procedures 
4 Procedures on ear and mastoid process 14 Obstetric procedures 
5 Procedures on nose, mouth and pharynx 15 Procedures on musculoskeletal system 
6 Dental services 16 Dermatological and plastic procedures 
7  Procedures on respiratory system 17 Procedures on breast 
8 Procedures on cardiovascular system 18 Radiation oncology procedures 
9 Procedures on blood and blood-forming organs 19 Non-invasive, cognitive and other interventions, 
not elsewhere classified 
10 Procedures on digestive system 20 Imaging services 
 
Sources: National Casemix and Classification Centre (NCCC), 2013: Australian Coding Standards (ACS) (8th Ed): NCCC, Australian Health 
Services Research Institute, University of Wollongong. 
 p. xvii. 
National Casemix and Classification Centre (NCCC), 2013: Australian Classification of Health Interventions (ACHI) Tabular List of 
Interventions (8th Ed): NCCC, Australian Health Services Research Institute, University of Wollongong. 
 p. iii. 
  
                                                                                                                                                                                                                              
10  HIPE collects data on discharges from, and deaths in, acute public hospitals. 
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3.2.1 Definition of a Diagnosis 
In 2017, HIPE collected a principal diagnosis for each discharge, together with up 
to 29 additional diagnosis codes. 
 
DIAGNOSES 
A principal diagnosis is defined as, 'the diagnosis established after study to be chiefly 
responsible for occasioning an episode of admitted patient care, an episode of residential 
care or an attendance at the healthcare establishment, as represented by a code'.11 
An additional diagnosis is defined as, 'a condition or complaint either coexisting with the 
principal diagnosis or arising during the episode of admitted patient care, episode of 
residential care or attendance at a health care establishment, as represented by a code' 
and may be used as an indication of the level of comorbidity.12 
Additional diagnoses are interpreted as conditions that affect patient management in 
terms of requiring commencement, alteration or adjustment of therapeutic treatment, 
diagnostic procedures, increased clinical care, and/or monitoring. 
 
3.2.1.1 Mean Number of Diagnoses Reported 
Table 3.3 outlines the mean number of diagnoses collected for day patient, in-
patient, and total discharges, by sex and age group. 
• The mean number of diagnoses recorded for total discharges was 2.8. 
• The mean number of diagnoses recorded for in-patient discharges was 4.1, 
compared to 2.0 for day patients. 
• The mean number of diagnoses recorded for in-patient discharges was higher 
for males (4.3) compared with females (3.9).  
• The mean number of diagnoses recorded for in-patient discharges increased 
with age ranging from 2.7 in the less than 15 years age group to 5.3 in the 65 
years and over age group. 
 
TABLE 3.3 Total Discharges: Mean Number of All-Listed Diagnoses by Patient Type, Sex and Age Group 
 
 Day Patients In-Patients Total Discharges 
Total 2.0 4.1 2.8 
Sex    
Male 2.0 4.3 2.8 
Female 2.0 3.9 2.7 
   Maternity 1.8 3.7 3.4 
   Non-Maternity 2.0 3.9 2.6 
Age Group    
< 15 Years 1.9 2.7 2.4 
15–44 Years 1.7 3.4 2.5 
45–64 Years 2.1 3.9 2.5 
65 Years and Over 2.1 5.3 3.2 
                                                                                                                                                                                                                              
11 National Casemix and Classification Centre (NCCC), 2013: Australian Coding Standards (ACS) (8th Ed): NCCC, Australian 
Health Services Research Institute, University of Wollongong. p. 1.  
12 National Casemix and Classification Centre (NCCC), op. cit., p. 4. 
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3.2.2 Definition of a Procedure 
In 2017, a principal procedure and up to 19 additional procedure codes for each 
discharge could be reported to HIPE where appropriate. 
 
PROCEDURES 
The classification of procedures in ICD-10-AM uses the Australian Classification of Health 
Interventions (ACHI).13 Procedures are coded in HIPE in accordance with the following 
hierarchy: 
• procedure performed for treatment of the principal diagnosis 
• procedure performed for treatment of an additional diagnosis 
• diagnostic/exploratory procedure related to the principal diagnosis  
• diagnostic/exploratory procedure related to an additional diagnosis for the 
 episode of care.14 
 
A key feature of the ACHI procedure classification is a seven-character code in the format 
xxxxx-xx. The structure is organised on an anatomical basis and thus does not always 
appear in numerical order. Procedure blocks were introduced to provide a sequential 
framework for both coding and reporting purposes. The blocks represent homogenous 
groups of procedures, while the seven-digit codes allow for greater detail.15 For example, 
procedure block 0732 represents 'direct closure of vein', containing the procedures 
'direct closure of renal vein' (33833-04) and 'direct closure of vena cava' (90215-02). In 
this report, tables have been produced using the block framework.16 
 
3.2.2.1 Discharges with a Procedure 
Table 3.4 provides details of the number and percentage of discharges that had a 
principal procedure recorded by patient type and admission type.  
• Of the 1,718,523 total discharges, principal procedures were recorded for 
1,373,300 discharges (79.9 per cent).  
• Over 93 per cent of day patient discharges had a principal procedure 
recorded. 
• Over 57 per cent of in-patient discharges had a principal procedure recorded, 
with 89.1 per cent of elective in-patients, 49.7 per cent of emergency in-
patients, and 59.6 per cent of maternity in-patients undergoing a principal 
procedure.  
                                                                                                                                                                                                                              
13 National Casemix and Classification Centre (NCCC), 2013: Australian Classification of Health Interventions (ACHI) (8th 
Ed): NCCC, Australian Health Services Research Institute, University of Wollongong. 
14 National Casemix and Classification Centre (NCCC), 2013: Australian Coding Standards (ACS) (8th Ed): NCCC, Australian 
Health Services Research Institute, University of Wollongong. p. 21. 
15 National Casemix and Classification Centre (NCCC), 2013: Australian Classification of Health Interventions (ACHI) 
Tabular List of Interventions (8th Ed): NCCC, Australian Health Services Research Institute, University of Wollongong. p. 
viii. 
16 The move to the ACHI introduced significant changes to the collection of procedures from 2005, including the use of 
Australian Coding Standard (ACS) 0042 Procedures normally not coded (see Appendix V). 
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TABLE 3.4 Total Discharges: Number and Percentage of Discharges with a Principal Procedure by Patient Type 
and Admission Type 
 
 
Total Discharges Total Discharges with a Principal Procedure 
N N % 
Total Discharges  1,718,523 1,373,300 79.9 
Day Patients 1,077,014 1,005,388 93.3 
In-Patients 641,509 367,912 57.4 
Elective In-Patients 96,100 85,665 89.1 
Emergency In-Patients 434,214 215,937 49.7 
Maternity In-Patients 111,195 66,310 59.6 
 
3.2.2.2 Mean Number of Procedures Reported 
Table 3.5 outlines the mean number of procedures reported for day patients, in-
patients and total discharges, by sex and age group. The calculation of mean 
procedures is based on discharges with at least one procedure reported to 
HIPE.17 
• For those discharges who underwent at least one procedure, in-patient 
discharges had a mean number of 2.8 procedures recorded, compared to a 
mean of 1.5 procedures for day patients. 
• While the mean number of procedures increased with age for in-patient 
discharges, the day patient pattern differed. For those undergoing a 
procedure, day patient discharges aged less than 15 years recorded a mean 
of 1.9 procedures, which was larger than that reported for older age groups. 
 
TABLE 3.5 Total Discharges: Mean Number of All-Listed Procedures by Patient Type, Sex and Age Group 
 
 
Day Patients In-Patients Total Discharges 
Total  1.5 2.8 1.8 
Sex    
Male 1.4 2.9 1.8 
Female 1.5 2.8 1.9 
   Maternity 1.6 2.7 2.7 
   Non-Maternity 1.5 2.8 1.8 
Age Group    
< 15 Years 1.9 2.6 2.2 
15–44 Years 1.5 2.7 1.9 
45–64 Years 1.5 2.9 1.7 
65 Years and Over 1.4 3.0 1.8 
  
                                                                                                                                                                                                                              
17 Includes all anaesthesia except local anaesthesia. See ACS 0031 Anaesthesia in National Casemix and Classification 
Centre (NCCC), 2013: Australian Coding Standards (ACS) (8th Ed): NCCC, Australian Health Services Research Institute, 
University of Wollongong. p.29. 
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3.3 MORBIDITY ANALYSIS: SUMMARY OF DAY PATIENT AND 
IN-PATIENT ACTIVITY 
Section 3.3 provides a summary of the day patient and in-patient hospital activity 
reported to HIPE. This analysis reports on the most commonly recorded 
diagnoses, procedure blocks and diagnosis related groups, as well as providing 
demographic and administrative information for these discharges.  
 
3.3.1 Day Patient Activity 
A day patient is admitted to hospital for treatment on an elective (rather than an 
emergency) basis and is discharged alive, as scheduled, on the same day. 
Deliveries are not included. Table 3.6 presents a summary of day patient activity 
reported to HIPE. 
 
Day Patients – Profile 
• Day patient discharges accounted for 62.7 per cent of total discharges. 
• Day patients aged 65–74 years accounted for 22.1 per cent of day patient 
discharges. 
 
Day Patients – Top 20 Principal Diagnoses 
• Day patients with a principal diagnosis of Other medical care (includes 
Chemotherapy and Radiotherapy encounters)18 and those with a principal 
diagnosis of Care involving dialysis accounted for 21.2 and 16.0 per cent of 
day patient discharges respectively.  
 
Day Patients – Top 20 Principal Procedure Blocks 
• A principal procedure was recorded for 93.3 per cent of day patient 
discharges (see Table 3.4). 
• Procedures from the block Haemodialysis were reported as a principal 
procedure for 17.1 per cent of day patients with at least one procedure. 
 
Day Patients – Top 10 Australian Refined Diagnosis Related Groups (AR-DRGs) 
• The top three AR-DRGs accounted for 36.4 per cent of day patient discharges 
reported to HIPE when analysed by diagnosis related group.19,20 
• Haemodialysis accounted for 15.9 per cent, while Chemotherapy and Other 
Neoplastic Disorders, Minor Complexity accounted for 10.7 per cent and 9.8 
per cent of day patient discharges respectively.  
                                                                                                                                                                                                                              
18 From 2015 this data includes activity from St. Luke's Radiation Oncology Network centres located in Beaumont and St. 
James’s Hospitals. These centres are operational since 2011, but data has only been included in HIPE from 2015. 
19 See Section Four for details of the case mix classification.  
20  In 2016, the AR-DRG classification was updated from AR-DRG Version 6.0 to AR-DRG Version 8.0. See Appendix VIII for 
an overview of changes between Version 6.0 and Version 8.0 of the AR-DRG Classification System. 
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3.3.2 In-Patient Activity 
An in-patient is admitted to hospital for treatment or investigation on an elective 
or emergency basis. Sameday in-patients are admitted as in-patients and 
discharged on the same day, while overnight in-patients stay at least one night in 
hospital. Table 3.7 presents a summary of in-patient activity reported to HIPE. 
 
In-Patients – Profile 
• In-patient discharges accounted for 37.3 per cent of total discharges. 
• Overnight in-patient discharges accounted for 80.9 per cent (518,756) of in-
patient discharges and had a mean length of stay of 6.9 days.  
 
In-Patients – Top 20 Principal Diagnoses 
• In-patient discharges with a principal diagnosis of Single spontaneous delivery 
accounted for 4.5 per cent of in-patient discharges. 
• In-patient discharges with a principal diagnosis of Pain in throat and chest 
accounted for 3.0 per cent of in-patient discharges while those with a 
principal diagnosis of Single delivery by caesarean section accounted for 2.6 
per cent of in-patient discharges.  
 
In-Patients – Top 20 Principal Procedure Blocks 
• A principal procedure was recorded for 57.4 per cent of total in-patient 
discharges (see Table 3.4). 
• Procedures from the block Generalised allied health interventions were 
reported for 27.0 per cent of in-patient discharges with at least one 
procedure reported.21  
 
In-Patients – Top 10 Australian Refined Diagnosis Related Groups (AR-DRGs) 
• The top three AR-DRGs accounted for 10.3 per cent of in-patient discharges 
when analysed by diagnosis related group.22,23 
• Antenatal and Other Obstetric Admissions, Minor Complexity accounted for 
4.7 per cent of in-patient discharges. Vaginal Delivery, Intermediate 
Complexity and Vaginal Delivery, Minor Complexity each accounted for 2.8 
per cent of in-patient discharges. 
                                                                                                                                                                                                                              
21  This block includes interventions such as physiotherapy, pharmacy, dietetics, occupational therapy, speech pathology 
and social work. Together, these six interventions accounted for over 93 per cent of cases within this procedure 
block. 
22 See Section Four for details of the case mix classification. 
23 In 2016, the AR-DRG classification was updated from AR-DRG Version 6.0 to AR-DRG Version 8.0. See Appendix VIII for 
an overview of changes between Version 6.0 and Version 8.0 of the AR-DRG Classification System. 
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3.3.2.1 Elective In-Patient Activity  
An elective in-patient is an in-patient admission that has been arranged in 
advance. Table 3.8 presents a summary of elective in-patient activity reported to 
HIPE.  
 
Elective In-Patients – Profile 
• Elective in-patient discharges accounted for 5.6 per cent of total discharges 
and 15.0 per cent of in-patients. 
• Elective in-patient bed days accounted for 647,595 in-patient bed days, or 
17.6 per cent of total in-patient bed days (see Table 3.7).  
• Elective overnight in-patient discharges accounted for 95.2 per cent of total 
elective in-patient discharges and had a mean length of stay of 7.0 days.  
 
Elective In-Patients – Top 20 Principal Diagnoses 
• Elective in-patients with a principal diagnosis of Coxarthrosis [arthrosis of hip] 
accounted for 3.8 per cent of elective in-patient discharges. 
• Care involving use of rehabilitation procedures accounted for 3.6 per cent of 
elective in-patient discharges. 
 
Elective In-Patients – Top 20 Principal Procedure Blocks 
• A principal procedure was recorded for 89.1 per cent of elective in-patient 
discharges (see Table 3.4). 
• The procedure block Generalised allied health interventions was reported for 
10.8 per cent of elective in-patients who had a principal procedure reported. 
• The procedure blocks Arthroplasty of hip and Tonsillectomy or 
adenoidectomy were reported for 4.4 per cent and 3.8 per cent of elective in-
patient discharges with a principal procedure reported respectively. 
 
Elective In-Patients – Top 10 Australian Refined Diagnosis Related Groups (AR-DRGs) 
• The top three AR-DRGs accounted for 9.3 per cent of elective in-patient 
discharges reported to HIPE when analysed by diagnosis related group.24,25 
• Hip Replacement, Minor Complexity and Tonsillectomy and Adenoidectomy 
accounted for 3.7 per cent and 3.4 per cent of elective in-patient discharges 
respectively. Knee Replacement, Minor Complexity accounted 2.3 per cent of 
elective in-patient discharges. 
                                                                                                                                                                                                                              
24 See Section Four for details of the case mix classification. 
25  In 2016, the AR-DRG classification was updated from AR-DRG Version 6.0 to AR-DRG Version 8.0. See Appendix VIII for 
an overview of changes between Version 6.0 and Version 8.0 of the AR-DRG Classification System. 
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3.3.2.2 Emergency In-Patient Activity  
An emergency in-patient admission is unforeseen and requires urgent care. Table 
3.9 presents a summary of emergency in-patient activity reported to HIPE. 26 
 
Emergency In-Patients – Profile 
• Emergency in-patient discharges accounted for 25.3 per cent of total 
discharges and 67.7 per cent of in-patients.  
• Emergency in-patient bed days accounted for 2,734,753 in-patient bed days, 
or 74.3 per cent of total in-patient bed days (see Table 3.7).  
• Over 65 per cent of emergency in-patient discharges were admitted from an 
Emergency Department, with 8.3 per cent admitted via a medical assessment 
unit (where they were admitted as an in-patient). 
 
Emergency In-Patients – Top 20 Principal Diagnoses 
• Emergency in-patient discharges with a principal diagnosis of Pain in throat 
and chest accounted for 4.3 per cent of emergency in-patients. 
• Emergency in-patient discharges with a principal diagnosis of Unspecified 
acute lower respiratory infection and those with a principal diagnosis of Other 
chronic obstructive pulmonary disease each accounted for 3.3 per cent of 
emergency in-patient discharges.  
 
Emergency In-Patients – Top 20 Principal Procedure Blocks 
• A principal procedure was recorded for 49.7 per cent of emergency in-patient 
discharges (see Table 3.4). 
• Procedures from the block Generalised allied health interventions were 
reported for 40.3 per cent of emergency in-patient discharges with a 
procedure recorded. 
 
Emergency In-Patient – Top 10 Australian Refined Diagnosis Related Groups (AR-DRGs) 
• The top three AR-DRGs accounted for 7.2 per cent of emergency in-patient 
discharges reported to HIPE when analysed by diagnosis related group.27,28 
• Chest Pain, Minor Complexity accounted for 3.3 per cent of emergency in-
patient discharges.  Other Respiratory System Disorders, Major Complexity 
and Chronic Obstructive Airways Disease, Minor Complexity accounted for 2.1 
and 1.9 per cent of emergency in-patient discharges. 
                                                                                                                                                                                                                              
26 HIPE includes patients who attended the Emergency Department and were subsequently admitted to hospital. As just 
a proportion of those attending the Emergency Department will subsequently be admitted to hospital, it is not 
possible to use emergency admissions reported to HIPE to draw conclusions about the total volume of activity in 
Emergency Departments. 
27 See Section Four for details of the case mix classification.  
28  In 2016, the AR-DRG classification was updated from AR-DRG Version 6.0 to AR-DRG Version 8.0. See Appendix VIII for 
an overview of changes between Version 6.0 and Version 8.0 of the AR-DRG Classification System. 
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3.3.2.3 Maternity In-Patient Activity  
Maternity discharges are those who were admitted in relation to their obstetrical 
experience (from conception to six weeks post-delivery); that is, they were 
allocated to Admission Type ‘Maternity’.29 Table 3.10 presents a summary of 
maternity in-patient activity reported to HIPE; and presents diagnoses and 
procedures by delivery status. Delivery discharges include discharges with a 
diagnosis of outcome of delivery (ICD-10-AM: Z37). Non-delivery discharges are 
maternity discharges where admission was related to their obstetrical experience 
but they did not deliver during that episode of care. 
 
Maternity In-Patients – Profile 
• Maternity in-patient discharges accounted for 6.5 per cent of total discharges 
and 17.3 per cent of in-patients. 
• Of maternity in-patient discharges, 54.4 per cent reported a diagnosis of 
outcome of delivery i.e. delivery discharges; while 45.6 per cent were non-
delivery discharges.  
• Single deliveries accounted for 98.1 per cent of delivery discharges.  
• Over 61 percent of delivery discharges were multiparous deliveries. 30 
• Of delivery discharges, 35 per cent were aged between 30–34 years. 
 
Maternity In-Patients – Top 10 Principal Diagnoses by Delivery Status 
• Delivery discharges with a principal diagnosis of Single spontaneous delivery 
accounted for 48.0 per cent of delivery in-patient discharges. 
• Non-delivery discharges with a principal diagnosis of Other maternal diseases 
classifiable elsewhere but complicating pregnancy; childbirth and the 
puerperium accounted for 27.0 per cent of non-delivery in-patient discharges.  
 
Maternity In-Patients – Top 10 Principal Procedure Blocks by Delivery Status 
• For delivery discharges who had a procedure reported, 34.1 per cent 
reported the principal procedure block Caesarean section. 
• For non-delivery discharges who had a procedure reported, 28.7 per cent 
reported the principal procedure block Curettage and evacuation of uterus. 
 
Maternity In-Patient – Top 10 Australian Refined Diagnosis Related Groups (AR-DRGs) 
• The top three AR-DRGs accounted for 59.5 per cent of maternity in-patient 
discharges reported to HIPE when analysed by diagnosis related group.31,32 
• Antenatal and Other Obstetric Admission, Minor Complexity accounted for 
27.0 per cent of maternity in-patient discharges. Vaginal Delivery, 
Intermediate Complexity and Vaginal Delivery, Minor Complexity accounted 
for 16.4 and 16.1 per cent of maternity in-patient discharges respectively. 
                                                                                                                                                                                                                              
29  Hospital In-Patient Enquiry Scheme (HIPE) Data Dictionary 2017 Version 9.1 available at www.hpo.ie. 
30  See Table 3.10 notes for definition of multiparous deliveries. 
31  See Section Four for details of the case mix classification.  
32  In 2016, the AR-DRG classification was updated from AR-DRG Version 6.0 to AR-DRG Version 8.0. See Appendix VIII for 
an overview of changes between Version 6.0 and Version 8.0 of the AR-DRG Classification System. 
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3.4 MORBIDITY ANALYSIS: TOTAL DISCHARGE ACTIVITY  
The analysis presented in Section 3.4 is based on total discharges. Morbidity data 
are presented by chapter within the ICD-10-AM diagnosis coding scheme, with 
certain specific conditions within these chapters reported separately. Procedures 
are generally reported by block at chapter level with certain specific procedures 
reported separately. Discussion of morbidity analysis is limited to chapter level. 
Diagnosis and procedure tables are cross tabulated by sex and age group. 
 
3.4.1 Total Discharges by Principal Diagnosis, Sex and Age Group 
Table 3.11 presents the distribution of total discharges by sex, age group and 
principal diagnosis. 
• Almost 29 per cent of total discharges had a principal diagnosis of Factors 
influencing health status and contact with health services; this includes 
persons encountering health services for examination and investigation or for 
specific procedures and health care (e.g., Chemotherapy, Radiotherapy and 
Dialysis).33 
• The chapter Diseases of the digestive system had the second largest number 
of principal diagnoses, with 9.7 per cent of total discharges. 
• For discharges aged less than 15 years (including discharges aged less than 1 
year), the most common principal diagnosis came from the chapter Diseases 
of the respiratory system, which accounted for 12.8 per cent of total 
discharges within this age category. 
• Diagnoses from the chapter Factors influencing health status and contact 
with health services were the most common principal diagnoses for 
discharges in the 45-64 years and 65 years and over age groups. 
 
3.4.2 In-Patient Mean and Median Length of Stay by Principal Diagnosis, Sex 
and Age Group 
Table 3.12 presents the total in-patient mean and median length of stay for 
principal diagnosis by sex and age group. The analysis presented here includes 
total in-patient (sameday and overnight) discharges,34 and excludes day patients. 
It should also be noted that the analysis by length of stay does not take into 
account the status of the patient on discharge. For example, a patient with a 
length of stay of one day for a diagnosis of chronic ischaemic heart disease may 
be transferred to another facility on discharge.  
                                                                                                                                                                                                                              
33 From 2015 this data includes activity from St. Luke's Radiation Oncology Network centres located in Beaumont 
and St. James’s Hospitals. These centres are operational since 2011, but data has only been included in HIPE from 
2015. 
34  This differs from reports prior to 2015 where the analysis was limited to the mean length of stay for acute in-
patients (length of stay of 30 days or less). Median length of stay is also provided alongside the mean length of 
stay. 
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Care must be taken, therefore, in interpreting the data on length of stay 
presented in Table 3.12, in the absence of information on discharge destination.35 
Discussion of total in-patient mean length of stay is limited to ICD-10-AM chapter 
level. 
• The longest in-patient mean length of stay was recorded for in-patient 
discharges with a principal diagnosis from the chapter Factors influencing 
health status and contact with health services (11.6 days). When this 
diagnosis is analysed by sex, male discharges reported 15.2 days and females 
reported 9.7 days.  
• For discharges aged less than 15 years, those with a principal diagnosis from 
the chapter Congenital malformations, deformations and chromosomal 
abnormalities recorded an in-patient mean length of stay of 8.1 days. 
• The longest in-patient mean length of stay for discharges aged 15–44 years 
was reported for those with a principal diagnosis from the Neoplasms chapter 
(7.2 days).  
• The shortest in-patient mean length of stay for all ages was recorded for in-
patient discharges with a principal diagnosis from the chapter Diseases of the 
ear and mastoid process (2.4 days).  
 
3.4.3 All-Listed Diagnoses by Sex and Age Group 
Table 3.13 provides details of all-listed diagnoses reported by sex and age group. 
Over 4.7 million diagnoses were recorded for total discharges reported to HIPE. 
As one principal diagnosis and up to 29 secondary diagnoses may be collected per 
discharge, the number of diagnoses will not equal the number of discharges. 
• Excluding females aged 15-44 years, the chapter Factors influencing health 
status and contact with health services had the most frequently reported 
diagnoses across both sexes and all remaining age groups for total discharges. 
It accounted for 1,133,257 diagnoses, or 23.9 per cent of all-listed diagnoses 
reported.36 
• Neoplasms accounted for 577,441 diagnoses or 12.2 per cent of all-listed 
diagnoses reported for total discharges. 
                                                                                                                                                                                                                              
35 See Section Two for details of discharge destination. 
36      This chapter includes diagnoses such as Z51 Other medical care and Z49 Care involving dialysis. 
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3.4.4 Total Discharges by Principal Procedure, Sex and Age Group 
In 2017, 79.9 per cent of total discharges had a principal procedure recorded (see 
Table 3.4). Discussion of procedures is confined to ACHI chapter level. 
 
Table 3.14 provides a breakdown of principal procedure by sex and age group. 
• Procedures from the chapter Non-invasive, cognitive and other interventions, 
not elsewhere classified accounted for 26.0 per cent of total discharges with a 
principal procedure reported. Over 37 per cent of discharges aged less than 
15 years, 20.0 per cent aged between 15–44 years, 24.3 per cent aged 
between 45–64 years and 29.4 per cent aged 65 years and over had a 
procedure from this chapter recorded as a principal procedure.  
• Almost 65 per cent of total discharges with a principal procedure from the 
chapter Procedures on cardiovascular system were male discharges.  
• Over 74 per cent of total discharges with a principal procedure from the 
chapter Procedures on endocrine system were female discharges.  
• Over 71 per cent of total discharges with a principal procedure from the 
chapter Procedures on eye and adnexa were aged 65 years and over. 
 
3.4.5 In-Patient Mean and Median Length of Stay by Principal Procedure, Sex 
and Age Group 
Table 3.15 presents the in-patient mean and median length of stay for principal 
procedure by sex and age group. The analysis presented here includes total in-
patient (sameday and overnight) discharges,37 and excludes day patients. These 
measures include pre-operative and post-operative length of stay. It should also 
be noted that this analysis by length of stay does not take into account the status 
of the patient on discharge. For example, a patient may be transferred to another 
facility on discharge. Care must be taken, therefore, in interpreting the data on 
length of stay presented in Table 3.15, in the absence of information on discharge 
destination.38 
• At chapter level, Radiation oncology procedures reported the longest in-
patient mean length of stay at 19.1 days. It should be noted that the majority 
of discharges with Radiation oncology procedures recorded as a principal 
procedure were day patients39 and are therefore not included in Table 3.15. 
                                                                                                                                                                                                                              
37  This differs from reports prior to 2015 where the analysis was limited to the mean length of stay for acute in-patients 
(length of stay of 30 days or less). Median length of stay is also provided alongside the mean length of stay. 
38  See Section Two for details of discharge destination. 
39 From 2015 this data includes activity from St. Luke's Radiation Oncology Network centres located in Beaumont and St. 
James’s Hospitals. These centres are operational since 2011, but data has only been included in HIPE from 2015. 
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• The longest in-patient mean length of stay for those aged less than 15 years 
was reported for the chapter Procedures on respiratory system at 20.2 days. 
• The shortest in-patient mean lengths of stay were reported for the chapters 
Procedures on nose, mouth and pharynx at 2.4 days and Procedures on ear 
and mastoid process at 2.7 days for total discharges. 
 
3.4.6 All-Listed Procedures by Sex and Age Group 
Table 3.16 provides details of all-listed procedures reported by sex and age group 
for total discharges. As one principal procedure and up to 19 secondary 
procedures may be collected as applicable per discharge, the total number of 
procedures will not equal the number of total discharges. 
• Over 2.5 million procedures were reported for total discharges. 
• Procedures within the chapter Non-invasive, cognitive and other 
interventions, not elsewhere classified accounted for 1,102,645 of all-listed 
procedures or 43.9 per cent of all procedures reported for total discharges. 
• Total discharges aged 65 years and over accounted for almost 70 per cent of 
procedures from the chapter Procedures on eye and adnexa. 
• Total discharges aged less than 15 years accounted for over 45 per cent of 
procedures from the chapter Procedures on ear and mastoid process. 
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4.1 INTRODUCTION 
The analysis in this Section focuses on the case mix classification for all discharges 
reported to the Hospital In-Patient Enquiry (HIPE) scheme in 2017.1 Hospital case 
mix may be defined as 'the proportion of cases of each disease and health 
problem treated in the hospital'.2 
• Section 4.2 presents background to the applied case mix classification and 
details of the assignment of discharges to Major Diagnostic Categories (MDC) 
and Australian Refined Diagnosis Related Groups (AR-DRG). The AR-DRG 
Classification System has been updated from Version 6.0 to Version 8.0 for 
2016 onwards. The update to AR-DRG Version 8.0 included a revision of the 
complexity model used to assign AR-DRGs to episodes of care. In addition to 
this, it included a review of existing AR-DRGs, the removal of some AR-DRGs 
and the inclusion of new AR-DRGs. The naming convention for AR-DRGs was 
also updated. Due to the update in this classification, DRGs in this report are 
not comparable with those in reports prior to 2016.3  
• Section 4.3 presents analysis of HIPE data by case mix for day patients and in-
patients. 
  
4.2 OVERVIEW  
4.2.1 Case Mix Classification 
• The Diagnosis Related Group (DRG) scheme enables the disaggregation of 
patients into homogeneous groups, which undergo similar treatment 
processes and incur similar levels of resource use. 
• The data required for DRG assignment include principal and secondary 
diagnoses, procedures performed, age, sex, length of stay, admission weight, 
sameday status and patient destination on discharge from hospital. 
• Since the inception of the national case mix programme, the DRG 
classification scheme has been adopted as the national standard for Ireland.4  
One of the key features of this methodology is the classification of cases into 
different levels of complexity within AR-DRGs. ICD-10-AM/ACHI/ACS 8th 
Edition is the coding system used for AR-DRG grouping since 2015.5 As all of 
the data required for AR-DRG classification are available on the HIPE system, 
and since diagnoses and procedures are coded with ICD-10-AM/ACHI/ACS, 
                                                                                                                                                                                    
1  For information on how the DRG system is used in Activity Based Funding see http://health.gov.ie/wp-
content/uploads/2015/07/ABF_Implementation_Plan_20_05_2015.pdf 
2 Hornbrook, M.C., 1985. Techniques for Assessing Hospital Case Mix', Annual Review of Public Health, Vol. 6. pp. 295–
324. 
3        See Appendix VIII for an overview of changes between AR-DRG Version 6.0 and Version 8.0. 
4 Wiley, M.M., 2005. 'Diagnosis Related Groups (DRGs): Measuring Hospital Case Mix', in P. Armitage and T. Colton 
(eds.) Encyclopaedia of Biostatistics. Chichester: Wiley and Sons. See also Department of Health and Children, 2004, 
The Modernisation of the National Case Mix Programme in Ireland. Dublin: Department of Health and Children, for 
information on development of case mix in Ireland. 
5 See Section Three for further details on ICD-10-AM/ACHI/ACS. 
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discharges are assigned to the AR-DRG system from this database. AR-DRG 
Version 6.0 was used in Ireland from 2009-2015.6 In 2016, this classification 
was updated to AR-DRG Version 8.0.7  
4.2.2 Assignment of Discharges to MDC and AR-DRG 
Figure 4.1 shows the steps in AR-DRG assignment; 
• The first step in assignment is the classification of discharges by Major 
Diagnostic Category (MDC). There are 23 MDCs which are essentially primary 
diagnostic groupings based on the systems of the body, for example nervous 
system (MDC 1), eye (MDC 2), circulatory system (MDC 5), etc. As not all 
discharges can be assigned directly to a MDC, there is a category entitled 
'unassignable to MDC'. 
• To deal with certain categories of high cost discharges, the second step 
involves a Pre-MDC analysis which can override the initial MDC assignment. 
Examples of discharges affected include transplants, human 
immunodeficiency virus (HIV) disease, and multiple significant trauma.8 
• After assignment to the appropriate MDCs, discharges are assigned to an AR-
DRG. In total, there are 807 AR-DRGs in version 8.0 of the AR-DRG 
classification. 
 
FIGURE 4.1 Steps in AR-DRG Assignment 
 
 
 
In AR-DRG Version 8.0 an AR-DRG consists of four alphanumeric characters in the 
form of 'MAAD': 
• 'M' is either a letter (indicating the broad group of the DRG) or an '8' or a '9' 
(indicating an unrelated operating room procedure DRG or an error DRG, 
respectively).9 
• 'AA' identifies the partition to which the adjacent DRG belongs.10 Both 
characters are numbers whose values indicate whether the code is surgical, 
                                                                                                                                                                                    
6 For a more detailed description of case mix and its application in Ireland see O'Reilly J., McCarthy B., Wiley, M. M., 
'Ireland: A review of Casemix applications within the acute public hospital system' in R. Busse, A. Geissler, W. Quentin 
& M. M. Wiley (eds), Diagnosis-Related Groups in Europe: Moving Towards Transparency, Efficiency and Quality in 
Hospitals. Maidenhead: Open University Press and WHO Regional Office for Europe, 2011. 
7        See Appendix VIII for an overview of changes between AR-DRG Version 6.0 and Version 8.0. 
8 'Some episodes involving procedures that are particularly resource-intensive may be assigned to the Pre-MDC 
category, irrespective of the MDC that would have been assigned on the basis of the principal diagnosis.' Australian 
Institute of Health and Welfare (2009) Australian Hospital Statistics 2007–08. Canberra: Australian Institute of Health 
and Welfare. p. 276. 
9 'Episodes that contain clinically atypical or invalid information are assigned Error DRGs.' Australian Institute of Health 
and Welfare (2009) Australian hospital statistics 2007–08. Canberra: Australian Institute of Health and Welfare. p 276. 
Step 1: Assignment of 
discharges to Major Diagnostic 
Category (MDC) 
 
Step 2: Pre-MDC Analysis 
 
Step 3: Assignment of 
discharges to Australian Refined 
Diagnosis Related Group  
(AR-DRG)  
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medical or other.11 Discharges with a surgical procedure performed are 
assigned to the surgical AR-DRGs where classification is based on the most 
resource intensive procedure performed. Medical discharges are assigned to 
an AR-DRG on the basis of principal diagnosis. 
• 'D' is a complexity split indicator that ranks DRGs within adjacent DRGs on the 
basis of their level of complexity/resource use. It is either 'A', 'B', 'C', 'D' or 'Z' 
with 'A' being the most complex or 'Z' indicating that there is no complexity 
split.12 The complexity of the case is determined by particular variables, such 
as the presence of complications and/or comorbidities (CC), age, or discharge 
status, which influence the treatment process and/or the pattern of resource 
utilisation.13 
 
4.2.2.1 AR-DRG Complexity Split  
The AR-DRG complexity split for total discharges is presented in Table 4.1. Almost 
27 per cent of total discharges had no complexity split. For in-patient discharges, 
27.0 per cent were assigned to complexity group A ‘Highest consumption of 
resources’, and 57.8 per cent were assigned to complexity group B ‘Second 
highest consumption of resources’. 
 
TABLE 4.1 Total Discharges: AR-DRG Complexity Split by Patient Type (N, %) 
 
 Discharges 
 Day 
Patients 
In-Patientsa Total 
Discharges  
Sameday  
In-Patients 
Overnight  
In-Patients 
Total  
In-Patients 
 N % N % N % N % N % A Highest consumption of resources 36,731 3.4 15,144 12.3 157,937 30.4 173,081 27.0 209,812 12.2 
B Second highest consumption of 
resources 
416,942 38.7 90,748 73.9 279,997 54.0 370,745 57.8 787,687 45.8 
C Third highest consumption of 
resources 
190,376 17.7 4,883 4.0 56,904 11.0 61,787 9.6 252,163 14.7 
D Fourth highest consumption of 
resources 
312 0.0 882 0.7 6,510 1.3 7,392 1.2 7,704 0.4 
Z No complexity split 432,653 40.2 11,096 9.0 17,408 3.4 28,504 4.4 461,157 26.8 
Total Discharges 1,077,014 100 122,753 100 518,756 100 641,509 100 1,718,523 100 
 
Notes:  
a 
 
Percentage columns are subject to rounding. 
The sameday and overnight in-patient split is provided in this table for information purposes, this split is not provided in 
Tables 4.2 to 4.27. 
                                                                                                                                                                                    
10 'Adjacent Diagnosis Related Group (ADRGs) are clinically meaningful MDC partitions that are generally defined by the 
same (principal) diagnosis or intervention codes. Occasionally ADRGs may also be defined by age, length of stay (i.e. 
sameday) and separation mode (e.g. died or transfer). An ADRG consists of one or more end classes or DRGs.' 
Australian Consortium for Classification Development, 2015, Australian Refined Diagnosis Related Groups, Version 
8.0, Definitions Manual, Volume 1. Independent Hospital Pricing Authority. p. xiii. 
11  ‘The separate ranges - 01 to 39, 40 to 59 and 60 to 99 - are used to indicate the surgical, other and medical partitions 
respectively.’ Australian Consortium for Classification Development, 2015, Australian Refined Diagnosis Related 
Groups, Version 8.0, Definitions Manual, Volume 1. Independent Hospital Pricing Authority. p. 8. 
12 For a more detailed description of how AR-DRGs are numbered see Australian Consortium for Classification 
Development, 2015, Australian Refined Diagnosis Related Groups, Version 8.0, Definitions Manual, Volume 1. 
Independent Hospital Pricing Authority. pp. 4–11. 
13 Complications may arise during the hospital stay, while comorbidities are assumed to be prior existing conditions 
which were present at the time of admission. 
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4.3 ANALYSIS OF HIPE DATA BY CASE MIX 
The analysis presented in this section includes all discharges reported to HIPE. 
Analysis of 2017 HIPE data by MDC is presented in Table 4.2 and Figures 4.2 and 
4.3. Tables 4.3 to 4.27 represent each MDC (including unassignable to MDC and 
pre-MDC) and their associated AR-DRGs.14 
 
4.3.1 Analysis of Day Patients by MDC and AR-DRG 
• The MDC with the largest proportion of day patients reported was Neoplastic 
disorders (haematological and solid neoplasms) (MDC 17), which accounted for 
249,639 discharges or 23.2 per cent of day patients (see Tables 4.2 and 4.19 
and Figure 4.3). 
∗ Chemotherapy (AR-DRG R63Z) accounted for 46.1 per cent of day 
patients within this MDC, and 10.7 per cent of total day patients; 
Other Neoplastic Disorders, Minor Complexity (AR-DRG R62C) 
accounted for 42.4 per cent of day patients within this MDC and 9.8 
per cent of total day patients.15 
 
• Diseases and disorders of the kidney and urinary tract (MDC 11), with 199,291 
discharges, accounted for 18.5 per cent of day patients (see Tables 4.2 and 
4.13 and Figure 4.3). 
∗ Haemodialysis (AR-DRG L61Z) accounted for 86 per cent of day 
patients within this MDC and 15.9 per cent of total day patients. 
 
4.3.2 Analysis of In-Patients by MDC and AR-DRG 
• The MDC with the largest proportion of in-patient discharges was Pregnancy, 
Childbirth and the Puerperium (MDC 14), with 110,576 discharges, which 
accounted for 17.2 per cent of in-patients (see Tables 4.2 and 4.16 and Figure 
4.3).  
∗ Antenatal and Other Obstetric Admission (AR-DRGs O66A and O66B) 
accounted for 37.1 per cent of in-patients within this MDC and 6.4 per 
cent of total in-patient discharges. 
∗ Vaginal Delivery (AR-DRGs O60A, O60B and O60C) accounted for 36.2 
per cent of in-patients within this MDC and 6.2 per cent of total in-
patient discharges.  
                                                                                                                                                                                    
14  See Glossary & Abbreviations for details of the abbreviations used in this section.  
15      R62 Other Neoplastic Disorders is a new ADRG in Version 8.0 of the AR-DRG classification system; most cases in this 
ADRG were grouped to R64 Radiotherapy in AR-DRG Version 6.0. For an overview of changes between AR-DRG 
Version 6.0 and Version 8.0 see Appendix VIII. 
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∗ Caesarean Delivery (AR-DRGs O01A, O01B and O01C) accounted for 
17.7 per cent of in-patients within this MDC, with Caesarean Delivery, 
Minor Complexity (AR-DRG O01C) accounting for the majority of these 
cases (57.7 per cent). 
∗ For Vaginal Delivery (AR-DRGs O60A, O60B and O60C), the in-patient 
mean length of stay ranged from 2.1 days for Vaginal Delivery, Minor 
Complexity (AR-DRG O60C) to 4.8 days for Vaginal Delivery, Major 
Complexity (AR-DRG O60A).  
∗ For Caesarean Delivery (AR-DRGs O01A, O01B and O01C), the in-
patient mean length of stay ranged from 4.1 days for Caesarean 
Delivery, Minor Complexity (AR-DRG O01C) to 10.9 days for Caesarean 
Delivery, Major Complexity (AR-DRG O01A).  
 
• Diseases and Disorders of the Circulatory System (MDC 5), with 78,847 in-
patient discharges, accounted for 12.3 per cent of total in-patients (see Tables 
4.2 and 4.7 and Figure 4.3).  
• Diseases and Disorders of the Respiratory System (MDC 4), with 72,877 
discharges, accounted for 11.4 per cent of total in-patients (see Tables 4.2 and 
4.6 and Figure 4.3).  
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TABLE 4.2 Total Discharges: MDC by Patient Type (N, %) 
 
Major Diagnostic Category Day Patients In-Patients Total Discharges 
N % N % N % 
01 Diseases and disorders of the nervous system 22,934 2.1 51,232 8.0 74,166 4.3 
02 Diseases and disorders of the eye 53,271 4.9 6,066 0.9 59,337 3.5 
03 Diseases and disorders of the ear, nose, mouth and throat 26,514 2.5 29,184 4.5 55,698 3.2 
04 Diseases and disorders of the respiratory system 19,883 1.8 72,877 11.4 92,760 5.4 
05 Diseases and disorders of the circulatory system 27,678 2.6 78,847 12.3 106,525 6.2 
06 Diseases and disorders of the digestive system 135,489 12.6 66,844 10.4 202,333 11.8 
07 Diseases and disorders of the hepatobiliary system and pancreas 8,496 0.8 16,472 2.6 24,968 1.5 
08 Diseases and disorders of the musculoskeletal system and 
connective tissue 
64,483 6.0 53,517 8.3 118,000 6.9 
09 Diseases and disorders of the skin, subcutaneous tissue and breast 96,343 8.9 19,919 3.1 116,262 6.8 
10 Endocrine, nutritional and metabolic diseases and disorders 6,326 0.6 11,640 1.8 17,966 1.0 
11 Diseases and disorders of the kidney and urinary tract 199,291 18.5 30,235 4.7 229,526 13.4 
12 Diseases and disorders of the male reproductive system 13,092 1.2 4,506 0.7 17,598 1.0 
13 Diseases and disorders of the female reproductive system 32,544 3.0 11,587 1.8 44,131 2.6 
14 Pregnancy, childbirth and the puerperium 11,279 1.0 110,576 17.2 121,855 7.1 
15 Newborns and other neonates 447 0.0 13,987 2.2 14,434 0.8 
16 Diseases and disorders of blood, blood forming organs, 
immunological disorders 
43,973 4.1 7,912 1.2 51,885 3.0 
17 Neoplastic disorders (haematological and solid neoplasms)a 249,639 23.2 5,263 0.8 254,902 14.8 
18 Infectious and parasitic diseases, systemic or unspecified sites 1,001 0.1 11,697 1.8 12,698 0.7 
19 Mental diseases and disorders 655 0.1 2,436 0.4 3,091 0.2 
20 Alcohol/drug use and alcohol/drug induced organic mental 
disorders 
9 0.0 2,749 0.4 2,758 0.2 
21 Injuries, poisonings and toxic effects of drugs 1,432 0.1 15,813 2.5 17,245 1.0 
22 Burns 165 0.0 596 0.1 761 0.0 
23 Factors influencing health status and other contacts with health 
services 
61,575 5.7 13,433 2.1 75,008 4.4 
Unassignable to MDC 342 0.0 1,296 0.2 1,638 0.1 
Pre-MDC 153 0.0 2,825 0.4 2,978 0.2 
Total Discharges 1,077,014 100 641,509 100 1,718,523 100 
 
Notes:  Percentage columns are subject to rounding. 
 a From 2015 this data includes activity from St. Luke’s Radiation Oncology Network centres located in Beaumont and St. 
James’s Hospitals. These centres are operational since 2011, but data has only been included in HIPE from 2015.  
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FIGURE 4.2 Total Discharges: Major Diagnostic Category (MDC) (%) 
 
 
 
Notes: D&D = Diseases and disorders 
Percentages are subject to rounding. 
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FIGURE 4.3 Total Discharges: Major Diagnostic Category (MDC) by Patient Type (%)  
 
 
Note: D&D = Diseases and disorders 
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TABLE 4.3 Total Discharges: MDC 1 Diseases and Disorders of the Nervous System: AR-DRG Version 8.0 by Patient 
Type (N, In-Patient Length of Stay) 
 
MDC 1 Diseases and Disorders of the Nervous System 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
B01A Ventricular Shunt Revision, Major Complexity 0 29 4.5 3 
B01B Ventricular Shunt Revision, Minor Complexity ~ 86 4.7 3 
B02A Cranial Procedures, Major Complexity 0 167 28.7 17 
B02B Cranial Procedures, Intermediate Complexity ~ 704 10.8 8 
B02C Cranial Procedures, Minor Complexity ~ 1,049 5.8 5 
B03A Spinal Procedures, Major Complexity ~ 56 24.6 10 
B03B Spinal Procedures, Intermediate Complexity ~ 96 4.9 3 
B03C Spinal Procedures, Minor Complexity 29 81 4.5 2 
B04A Extracranial Vascular Procedures, Major Complexity 0 58 22.8 15 
B04B Extracranial Vascular Procedures, Intermediate Complexity 0 102 10.8 10 
B04C Extracranial Vascular Procedures, Minor Complexity ~ 200 4.8 4 
B05Z Carpal Tunnel Release 1,820 40 1.9 1 
B06A Procedures for Cerebral Palsy, Muscular Dystrophy and Neuropathy, Major Comp 7 36 41.2 21 
B06B Procedures for Cerebral Palsy, Muscular Dystrophy and Neuropathy, Interm Comp 9 54 12.9 5 
B06C Procedures for Cerebral Palsy, Muscular Dystrophy and Neuropathy, Minor Comp 225 143 4.0 1 
B07A Cranial or Peripheral Nerve and Other Nervous System Procedures, Major Comp ~ 77 27.6 10 
B07B Cranial or Peripheral Nerve and Other Nervous System Procedures, Minor Comp 179 325 2.1 1 
B40Z Plasmapheresis W Neurological Disease, Sameday 36 ~ ^ ^ 
B41Z Telemetric EEG Monitoring 12 257 6.8 6 
B42A Nervous System Disorders W Ventilator Support, Major Complexity 0 63 24.4 12 
B42B Nervous System Disorders W Ventilator Support, Minor Complexity 0 137 6.8 3 
B60A Acute Paraplegia and Quadriplegia W or W/O OR Procedures, Major Complexity 0 29 48.4 21 
B60B Acute Paraplegia and Quadriplegia W or W/O OR Procedures, Minor Complexity 8 68 23.6 8 
B61A Spinal Cord Conditions W or W/O OR Procedures, Major Complexity ~ 71 28.5 15 
B61B Spinal Cord Conditions W or W/O OR Procedures, Minor Complexity 17 125 7.7 4 
B62Z Apheresis 250 ~ ^ ^ 
B63A Dementia and Other Chronic Disturbances of Cerebral Function, Major Complexity 79 545 45.1 21 
B63B Dementia and Other Chronic Disturbances of Cerebral Function, Minor Complexity 216 420 19.8 9 
B64A Delirium, Major Complexity 10 955 15.7 8 
B64B Delirium, Minor Complexity 31 987 4.8 2 
B65A Cerebral Palsy, Major Complexity 57 34 4.7 4 
B65B Cerebral Palsy, Minor Complexity 204 18 23.2 1 
B66A Nervous System Neoplasms, Major Complexity 59 470 16.8 10 
B66B Nervous System Neoplasms, Minor Complexity 1,941 708 8.1 5 
B67A Degenerative Nervous System Disorders, Major Complexity 135 873 21.0 11 
B67B Degenerative Nervous System Disorders, Intermediate Complexity 384 698 6.8 4 
B67C Degenerative Nervous System Disorders, Minor Complexity 673 163 5.3 4 
B68A Multiple Sclerosis and Cerebellar Ataxia, Major Complexity 200 479 11.7 5 
B68B Multiple Sclerosis and Cerebellar Ataxia, Minor Complexity 5,016 450 4.5 3 
B69A TIA and Precerebral Occlusion, Major Complexity ~ 1,066 7.2 5 
B69B TIA and Precerebral Occlusion, Minor Complexity 39 1,951 3.2 2 
B70A Stroke and Other Cerebrovascular Disorders, Major Complexity ~ 948 39.2 25 
B70B Stroke and Other Cerebrovascular Disorders, Intermediate Complexity ~ 2,280 15.6 9 
B70C Stroke and Other Cerebrovascular Disorders, Minor Complexity 30 2,503 8.1 6 
B70D Stroke and Other Cerebrovascular Disorders, Transferred <5 Days ~ 346 1.6 1 
B71A Cranial and Peripheral Nerve Disorders, Major Complexity 1,640 1,380 5.5 2 
B71B Cranial and Peripheral Nerve Disorders, Minor Complexity 3,119 309 4.3 1 
B72A Nervous System Infection Except Viral Meningitis, Major Complexity 7 237 20.3 13 
B72B Nervous System Infection Except Viral Meningitis, Minor Complexity 122 235 8.8 6 
B73Z Viral Meningitis 11 330 5.0 4 
B74A Nontraumatic Stupor and Coma, Major Complexity 10 73 8.8 3 
B74B Nontraumatic Stupor and Coma, Minor Complexity 17 155 2.8 1 
B75Z Febrile Convulsions 24 675 1.7 1 
B76A Seizures, Major Complexity 100 2,355 7.6 4 
B76B Seizures, Minor Complexity 875 4,671 2.5 1 
B77A Headaches, Major Complexity 132 2,348 3.3 2 
B77B Headaches, Minor Complexity 1,496 8,048 1.6 1 
B78A Intracranial Injuries, Major Complexity 0 336 25.4 12 
B78B Intracranial Injuries, Minor Complexity ~ 707 6.2 3 
B78C Intracranial Injuries, Transferred <5 Days 0 65 1.7 1 
B79A Skull Fractures, Major Complexity 0 161 8.3 4 
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TABLE 4.3 Total Discharges: MDC 1 Diseases and Disorders of the Nervous System: AR-DRG Version 8.0 by Patient 
Type (N, In-Patient Length of Stay) (contd.) 
 
MDC 1 Diseases and Disorders of the Nervous System 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
B79B Skull Fractures, Minor Complexity ~ 184 2.2 1 
B80A Other Head Injuries, Major Complexity 0 434 7.8 3 
B80B Other Head Injuries, Minor Complexity 12 3,029 1.3 1 
B81A Other Disorders of the Nervous System, Major Complexity 55 1,111 15.8 8 
B81B Other Disorders of the Nervous System, Minor Complexity 3,345 3,766 4.0 1 
B82A Chronic & Unspec Para/Quadriplegia W or W/O OR Proc, Major Complexity 0 109 59.4 30 
B82B Chronic & Unspec Para/Quadriplegia W or W/O OR Proc, Intermediate Complexity 35 312 32.4 10 
B82C Chronic & Unspec Para/Quadriplegia W or W/O OR Proc, Minor Complexity 234 248 12.4 4 
Total Discharges 22,934 51,232 7.6 2 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 ^ Denotes that length of stay is suppressed where the number of discharges is not reported. 
 a Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
   
 
 
TABLE 4.4 Total Discharges: MDC 2 Diseases and Disorders of the Eye: AR-DRG Version 8.0 by Patient Type (N, In-
Patient Length of Stay) 
 
MDC 2 Diseases and Disorders of the Eye 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
C01A Procedures for Penetrating Eye Injury, Major Complexity ~ 57 4.6 4 
C01B Procedures for Penetrating Eye Injury, Minor Complexity 10 51 3.3 3 
C02Z Enucleations and Orbital Procedures 37 100 3.8 2 
C03A Retinal Procedures, Major Complexity 3,474 1,151 2.9 2 
C03B Retinal Procedures, Minor Complexity 24,799 309 1.4 1 
C04A Major Corneal, Scleral and Conjunctival Procedures, Major Complexity ~ 71 4.6 3 
C04B Major Corneal, Scleral and Conjunctival Procedures, Minor Complexity 18 93 2.0 2 
C05Z Dacryocystorhinostomy 70 129 1.2 1 
C10Z Strabismus Procedures 640 82 1.0 1 
C11Z Eyelid Procedures 920 102 1.9 1 
C12Z Other Corneal, Scleral and Conjunctival Procedures 335 113 4.6 3 
C13Z Lacrimal Procedures 422 17 1.5 1 
C14A Other Eye Procedures, Major Complexity 106 111 4.2 3 
C14B Other Eye Procedures, Minor Complexity 1,466 105 1.5 1 
C15Z Glaucoma and Complex Cataract Procedures 723 297 2.0 1 
C16Z Lens Procedures 11,735 313 1.7 1 
C60A Acute and Major Eye Infections, Major Complexity ~ 55 11.9 9 
C60B Acute and Major Eye Infections, Minor Complexity 52 166 5.4 4 
C61A Neurological and Vascular Disorders of the Eye, Major Complexity 301 425 4.1 2 
C61B Neurological and Vascular Disorders of the Eye, Minor Complexity 685 450 2.9 1 
C62A Hyphaema and Medically Managed Trauma to the Eye, Major Complexity 53 192 10.3 3 
C62B Hyphaema and Medically Managed Trauma to the Eye, Minor Complexity 62 366 1.8 1 
C63A Other Disorders of the Eye, Major Complexity 329 272 6.0 3 
C63B Other Disorders of the Eye, Intermediate Complexity 2,724 911 2.1 1 
C63C Other Disorders of the Eye, Minor Complexity 4,302 128 1.9 1 
Total Discharges 53,271 6,066 3.1 1 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 a Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.5 Total Discharges: MDC 3 Diseases and Disorders of the Ear, Nose, Mouth and Throat: AR-DRG Version 8.0 
by Patient Type (N, In-Patient Length of Stay) 
 
MDC 3 Diseases and Disorders of the Ear, Nose, Mouth and Throat 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
D01Z Cochlear Implant ~ 158 2.4 2 
D02A Head and Neck Procedures, Major Complexity ~ 75 16.7 11 
D02B Head and Neck Procedures, Intermediate Complexity ~ 57 9.5 6 
D02C Head and Neck Procedures, Minor Complexity 24 142 3.2 2 
D03Z Surgical Repair for Cleft Lip and Palate Disorders 19 149 2.6 2 
D04A Maxillo Surgery, Major Complexity 41 438 2.7 2 
D04B Maxillo Surgery, Minor Complexity 42 288 2.3 2 
D05Z Parotid Gland Procedures ~ 177 2.7 2 
D06Z Sinus and Complex Middle Ear Procedures 323 647 1.8 1 
D10Z Nasal Procedures 490 539 1.3 1 
D11Z Tonsillectomy and Adenoidectomy 747 3,815 1.3 1 
D12A Other Ear, Nose, Mouth and Throat Procedures, Major Complexity 83 121 7.8 3 
D12B Other Ear, Nose, Mouth and Throat Procedures, Minor Complexity 1,196 412 1.9 1 
D13Z Myringotomy W Tube Insertion 2,139 119 2.2 1 
D14A Mouth and Salivary Gland Procedures, Major Complexity 268 316 3.9 2 
D14B Mouth and Salivary Gland Procedures, Minor Complexity 744 76 1.6 1 
D15Z Mastoid Procedures 37 280 2.0 1 
D40Z Dental Extractions and Restorations 5,242 238 1.7 1 
D60A Ear, Nose, Mouth and Throat Malignancy, Major Complexity 42 325 23.2 15 
D60B Ear, Nose, Mouth and Throat Malignancy, Minor Complexity 1,178 439 10.7 4 
D61A Dysequilibrium, Major Complexity 17 904 4.6 2 
D61B Dysequilibrium, Minor Complexity 241 3,787 1.9 1 
D62A Epistaxis, Major Complexity 8 139 8.2 5 
D62B Epistaxis, Minor Complexity 484 823 2.5 2 
D63A Otitis Media and Upper Respiratory Infections, Major Complexity 197 2,253 3.9 2 
D63B Otitis Media and Upper Respiratory Infections, Minor Complexity 1,633 7,414 1.6 1 
D64A Laryngotracheitis and Epiglottitis, Major Complexity ~ 114 2.3 1 
D64B Laryngotracheitis and Epiglottitis, Minor Complexity 22 846 1.2 1 
D65A Nasal Trauma and Deformity, Major Complexity 19 135 6.2 3 
D65B Nasal Trauma and Deformity, Minor Complexity 960 313 1.5 1 
D66A Other Ear, Nose, Mouth and Throat Disorders, Major Complexity 718 584 5.4 2 
D66B Other Ear, Nose, Mouth and Throat Disorders, Minor Complexity 8,104 1,706 1.5 1 
D67A Oral and Dental Disorders, Major Complexity 87 428 4.8 2 
D67B Oral and Dental Disorders, Minor Complexity 1,398 927 1.8 1 
Total 26,514 29,184 2.6 1 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.6 Total Discharges: MDC 4 Diseases and Disorders of the Respiratory System: AR-DRG Version 8.0 by 
Patient Type (N, In-Patient Length of Stay) 
 
MDC 4 Diseases and Disorders of the Respiratory System 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
E01A Major Chest Procedures, Major Complexity 0 78 24.5 19 
E01B Major Chest Procedures, Intermediate Complexity 0 336 13.8 10 
E01C Major Chest Procedures, Minor Complexity 29 656 8.6 7 
E02A Other Respiratory System OR Procedures, Major Complexity 9 228 19.8 13 
E02B Other Respiratory System OR Procedures, Intermediate Complexity 207 245 8.0 5 
E02C Other Respiratory System OR Procedures, Minor Complexity 129 56 1.8 1 
E40A Respiratory System Disorders W Ventilator Support, Major Complexity 0 84 25.8 17 
E40B Respiratory System Disorders W Ventilator Support, Minor Complexity 0 196 12.1 8 
E41A Respiratory System Disorders W Non-Invasive Ventilation, Major Complexity 0 490 24.5 17 
E41B Respiratory System Disorders W Non-Invasive Ventilation, Minor Complexity 0 1,248 12.8 9 
E42A Bronchoscopy, Major Complexity 550 1,009 17.5 12 
E42B Bronchoscopy, Minor Complexity 6,214 539 6.0 4 
E60A Cystic Fibrosis, Major Complexity 346 689 13.5 14 
E60B Cystic Fibrosis, Minor Complexity 1,996 297 8.0 7 
E61A Pulmonary Embolism, Major Complexity ~ 683 10.0 7 
E61B Pulmonary Embolism, Minor Complexity 17 833 4.3 3 
E62A Respiratory Infections and Inflammations, Major Complexity 36 8,121 13.5 8 
E62B Respiratory Infections and Inflammations, Minor Complexity 66 5,788 5.2 4 
E63A Sleep Apnoea, Major Complexity 10 533 1.8 1 
E63B Sleep Apnoea, Minor Complexity 43 1,447 1.1 1 
E64A Pulmonary Oedema and Respiratory Failure, Major Complexity ~ 244 11.0 7 
E64B Pulmonary Oedema and Respiratory Failure, Minor Complexity ~ 269 6.3 3 
E65A Chronic Obstructive Airways Disease, Major Complexity 115 5,523 11.0 7 
E65B Chronic Obstructive Airways Disease, Minor Complexity 821 8,738 4.9 4 
E66A Major Chest Trauma, Major Complexity 0 275 10.5 7 
E66B Major Chest Trauma, Minor Complexity 0 318 3.5 2 
E67A Respiratory Signs and Symptoms, Major Complexity 279 1,409 3.6 1 
E67B Respiratory Signs and Symptoms, Minor Complexity 1,004 4,382 1.6 1 
E68A Pneumothorax, Major Complexity ~ 303 8.9 6 
E68B Pneumothorax, Minor Complexity 12 493 3.8 3 
E69A Bronchitis and Asthma, Major Complexity 65 558 5.9 4 
E69B Bronchitis and Asthma, Minor Complexity 3,316 3,952 2.1 1 
E70A Whooping Cough and Acute Bronchiolitis, Major Complexity 8 465 4.4 3 
E70B Whooping Cough and Acute Bronchiolitis, Minor Complexity 17 2,236 2.6 2 
E71A Respiratory Neoplasms, Major Complexity 114 874 14.1 9 
E71B Respiratory Neoplasms, Minor Complexity 3,025 1,114 6.9 4 
E72Z Respiratory Problems Arising from Neonatal Period 10 88 5.6 2 
E73A Pleural Effusion, Major Complexity ~ 205 16.5 12 
E73B Pleural Effusion, Intermediate Complexity 37 447 7.4 6 
E73C Pleural Effusion, Minor Complexity 100 302 4.2 2 
E74A Interstitial Lung Disease, Major Complexity 116 450 9.4 7 
E74B Interstitial Lung Disease, Minor Complexity 502 336 4.4 2 
E75A Other Respiratory System Disorders, Major Complexity 87 9,301 8.7 5 
E75B Other Respiratory System Disorders, Minor Complexity 556 6,917 2.7 1 
E76A Respiratory Tuberculosis, Major Complexity ~ 58 25.2 12 
E76B Respiratory Tuberculosis, Minor Complexity 28 64 7.2 5 
Total 19,883 72,877 7.1 4 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.7 Total Discharges: MDC 5 Diseases and Disorders of the Circulatory System: AR-DRG Version 8.0 by Patient 
Type (N, In-Patient Length of Stay) 
 
MDC 5 Diseases and Disorders of the Circulatory System 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
F01A Implantation and Replacement of AICD, Total System, Major Complexity ~ 71 19.1 15 
F01B Implantation and Replacement of AICD, Total System, Minor Complexity 237 294 4.4 1 
F02Z Other AICD Procedures 16 46 7.9 5 
F03A Cardiac Valve Procedures W CPB Pump W Invasive Cardiac Investigation, Major 
Comp 
0 56 30.1 27 
F03B Cardiac Valve Procedures W CPB Pump W Invasive Cardiac Investigation, Minor 
Comp 
~ 99 14.8 9 
F04A Cardiac Valve Procedures W CPB Pump W/O Invasive Cardiac Invest, Major Comp 0 36 27.2 20 
F04B Cardiac Valve Procedures W CPB Pump W/O Invasive Cardiac Invest, Interm Comp 0 202 16.7 13 
F04C Cardiac Valve Procedures W CPB Pump W/O Invasive Cardiac Invest, Minor Comp ~ 344 11.0 9 
F05A Coronary Bypass W Invasive Cardiac Investigation, Major Complexity 0 42 30.5 24 
F05B Coronary Bypass W Invasive Cardiac Investigation, Minor Complexity 0 106 20.7 20 
F06A Coronary Bypass W/O Invasive Cardiac Investigation, Major Complexity 0 76 23.1 17 
F06B Coronary Bypass W/O Invasive Cardiac Investigation, Minor Complexity 0 575 11.5 9 
F07A Other Cardiothoracic/Vascular Procedures W CPB Pump, Major Complexity 0 39 18.1 15 
F07B Other Cardiothoracic/Vascular Procedures W CPB Pump, Intermediate Complexity 0 63 13.8 11 
F07C Other Cardiothoracic/Vascular Procedures W CPB Pump, Minor Complexity 0 79 11.4 9 
F08A Major Reconstructive Vascular Procedures W/O CPB Pump, Major Complexity 0 113 31.8 19 
F08B Major Reconstructive Vascular Procedures W/O CPB Pump, Intermediate 
Complexity 
0 407 12.9 10 
F08C Major Reconstructive Vascular Procedures W/O CPB Pump, Minor Complexity 23 279 6.9 5 
F09A Other Cardiothoracic Procedures W/O CPB Pump, Major Complexity ~ * ^ ^ 
F09B Other Cardiothoracic Procedures W/O CPB Pump, Intermediate Complexity ~ 33 9.9 8 
F09C Other Cardiothoracic Procedures W/O CPB Pump, Minor Complexity 23 87 4.1 2 
F10A Interventional Coronary Procedures, Admitted for AMI, Major Complexity ~ 266 10.8 7 
F10B Interventional Coronary Procedures, Admitted for AMI, Minor Complexity 106 2,026 3.1 3 
F11A Amputation, Except Upper Limb and Toe, for Circulatory Disorders, Major Comp 0 100 64.4 44 
F11B Amputation, Except Upper Limb and Toe, for Circulatory Disorders, Minor Comp 0 123 27.4 22 
F12A Implantation and Replacement of Pacemaker, Total System, Major Complexity 23 310 12.0 8 
F12B Implantation and Replacement of Pacemaker, Total System, Minor Complexity 539 538 4.0 2 
F13A Amputation, Upper Limb and Toe, for Circulatory Disorders, Major Complexity 0 74 27.5 16 
F13B Amputation, Upper Limb and Toe, for Circulatory Disorders, Minor Complexity ~ 68 8.6 7 
F14A Vascular Procedures, Except Major Reconstruction, W/O CPB Pump, Major 
Complexity 
28 215 20.4 12 
F14B Vascular Procedures, Except Major Reconstruction, W/O CPB Pump, Interm Comp 32 510 7.6 5 
F14C Vascular Procedures, Except Major Reconstruction, W/O CPB Pump, Minor 
Complexity 
185 434 3.8 2 
F15A Interventional Coronary Procs, Not Adm for AMI, W Stent Implant, Major Comp 18 391 8.1 4 
F15B Interventional Coronary Procs, Not Adm for AMI, W Stent Implant, Minor Comp 1,008 2,178 2.2 1 
F16A Interventional Coronary Procs, Not Adm for AMI, W/O Stent Implant, Major Comp ~ ~ ^ ^ 
F16B Interventional Coronary Procs, Not Adm for AMI, W/O Stent Implant, Minor Comp 32 70 3.0 1 
F17A Insertion and Replacement of Pacemaker Generator, Major Complexity 25 37 9.7 4 
F17B Insertion and Replacement of Pacemaker Generator, Minor Complexity 248 59 1.6 1 
F18A Other Pacemaker Procedures, Major Complexity ~ 32 9.7 7 
F18B Other Pacemaker Procedures, Minor Complexity 34 52 3.3 2 
F19A Trans-Vascular Percutaneous Cardiac Intervention, Major Complexity 69 59 9.5 2 
F19B Trans-Vascular Percutaneous Cardiac Intervention, Minor Complexity 181 62 1.2 1 
F20Z Vein Ligation and Stripping 4,485 251 1.5 1 
F21A Other Circulatory System OR Procedures, Major Complexity 0 51 31.0 15 
F21B Other Circulatory System OR Procedures, Intermediate Complexity 8 59 9.0 6 
F21C Other Circulatory System OR Procedures, Minor Complexity ~ 39 5.6 2 
F40A Circulatory Disorders W Ventilator Support, Major Complexity 0 56 14.6 7 
F40B Circulatory Disorders W Ventilator Support, Minor Complexity 0 42 7.1 3 
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TABLE 4.7 Total Discharges: MDC 5 Diseases and Disorders of the Circulatory System: AR-DRG Version 8.0 by Patient 
Type (N, In-Patient Length of Stay) (contd.) 
 
MDC 5 Diseases and Disorders of the Circulatory System 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
F41A Circulatory Disorders, Adm for AMI W Invasive Cardiac Inves Proc, Major Comp ~ 201 8.2 6 
F41B Circulatory Disorders, Adm for AMI W Invasive Cardiac Inves Proc, Minor Comp 77 442 3.8 3 
F42A Circulatory Dsrds, Not Adm for AMI W Invasive Cardiac Inves Proc, Major Comp 586 1,228 8.7 6 
F42B Circulatory Dsrds, Not Adm for AMI W Invasive Cardiac Inves Proc, Minor Comp 9,636 2,881 2.9 2 
F43A Circulatory Disorders W Non-Invasive Ventilation, Major Complexity 0 97 27.2 20 
F43B Circulatory Disorders W Non-Invasive Ventilation, Minor Complexity 0 146 12.6 10 
F60A Circulatory Dsrd, Adm for AMI W/O Invas Card Inves Proc ~ 2,429 8.4 6 
F60B Circulatory Dsrd, Adm for AMI W/O Invas Card Inves Proc, Transf <5 Days 8 614 1.9 1 
F61A Infective Endocarditis, Major Complexity ~ 61 30.9 26 
F61B Infective Endocarditis, Minor Complexity 23 66 17.0 10 
F62A Heart Failure and Shock, Major Complexity 0 2,313 14.5 10 
F62B Heart Failure and Shock, Minor Complexity 87 3,545 6.3 5 
F62C Heart Failure and Shock, Transferred <5 Days 0 105 2.0 1 
F63A Venous Thrombosis, Major Complexity 7 533 7.7 5 
F63B Venous Thrombosis, Minor Complexity 51 1,363 2.0 1 
F64A Skin Ulcers in Circulatory Disorders, Major Complexity ~ 157 18.1 12 
F64B Skin Ulcers in Circulatory Disorders, Intermediate Complexity 77 236 9.2 7 
F64C Skin Ulcers in Circulatory Disorders, Minor Complexity 8 58 6.4 4 
F65A Peripheral Vascular Disorders, Major Complexity 56 591 11.0 7 
F65B Peripheral Vascular Disorders, Minor Complexity 1,017 908 3.8 1 
F66A Coronary Atherosclerosis, Major Complexity 59 402 8.2 5 
F66B Coronary Atherosclerosis, Minor Complexity 656 1,998 3.1 1 
F67A Hypertension, Major Complexity 10 387 5.0 3 
F67B Hypertension, Minor Complexity 145 2,038 1.8 1 
F68A Congenital Heart Disease, Major Complexity 527 93 3.8 2 
F68B Congenital Heart Disease, Minor Complexity 364 52 2.3 1 
F69A Valvular Disorders, Major Complexity 67 361 9.0 5 
F69B Valvular Disorders, Minor Complexity 811 3,116 1.8 1 
F72A Unstable Angina, Major Complexity ~ 299 7.0 5 
F72B Unstable Angina, Minor Complexity 30 1,136 3.7 2 
F73A Syncope and Collapse, Major Complexity 29 3,072 9.1 5 
F73B Syncope and Collapse, Minor Complexity 2,342 7,711 2.7 1 
F74A Chest Pain, Major Complexity 55 3,327 2.9 1 
F74B Chest Pain, Minor Complexity 667 14,480 1.4 1 
F75A Other Circulatory Disorders, Major Complexity 23 338 14.4 9 
F75B Other Circulatory Disorders, Intermediate Complexity 32 583 7.8 6 
F75C Other Circulatory Disorders, Minor Complexity 557 1,707 3.3 2 
F76A Arrhythmia, Cardiac Arrest and Conduction Disorders, Major Complexity 181 2,795 6.8 4 
F76B Arrhythmia, Cardiac Arrest and Conduction Disorders, Minor Complexity 2,135 5,800 2.4 1 
Total 27,678 78,847 4.8 2 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges. 
 ^ Denotes that length of stay is suppressed where the number of discharges is not reported. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.8 Total Discharges: MDC 6 Diseases and Disorders of the Digestive System: AR-DRG Version 8.0 by Patient 
Type (N, In-Patient Length of Stay) 
 
MDC 6 Diseases and Disorders of the Digestive System 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
G01A Rectal Resection, Major Complexity 0 97 38.5 32 
G01B Rectal Resection, Intermediate Complexity 0 203 22.1 18 
G01C Rectal Resection, Minor Complexity ~ 800 10.3 8 
G02A Major Small and Large Bowel Procedures, Major Complexity 0 281 43.8 31 
G02B Major Small and Large Bowel Procedures, Intermediate Complexity 0 871 18.8 15 
G02C Major Small and Large Bowel Procedures, Minor Complexity 54 1,540 9.8 8 
G03A Stomach, Oesophageal and Duodenal Procedures, Major Complexity 0 197 21.8 16 
G03B Stomach, Oesophageal and Duodenal Procedures, Intermediate Complexity 11 236 12.6 10 
G03C Stomach, Oesophageal and Duodenal Procedures, Minor Complexity 41 285 6.4 4 
G04A Peritoneal Adhesiolysis, Major Complexity 0 85 25.6 20 
G04B Peritoneal Adhesiolysis, Intermediate Complexity ~ 264 10.1 8 
G04C Peritoneal Adhesiolysis, Minor Complexity 94 509 4.1 3 
G05A Minor Small and Large Bowel Procedures, Major Complexity ~ 92 17.6 11 
G05B Minor Small and Large Bowel Procedures, Minor Complexity 17 308 6.3 5 
G06Z Pyloromyotomy 0 50 3.5 3 
G07A Appendicectomy, Major Complexity ~ 541 6.0 5 
G07B Appendicectomy, Minor Complexity 32 5,685 2.7 2 
G10A Hernia Procedures, Major Complexity 68 507 7.8 5 
G10B Hernia Procedures, Minor Complexity 3,366 2,301 1.9 1 
G11A Anal and Stomal Procedures, Major Complexity 49 327 5.8 3 
G11B Anal and Stomal Procedures, Minor Complexity 1,393 1,116 2.2 1 
G12A Other Digestive System OR Procedures, Major Complexity 0 102 29.5 20 
G12B Other Digestive System OR Procedures, Intermediate Complexity 36 346 11.2 8 
G12C Other Digestive System OR Procedures, Minor Complexity 304 342 5.0 3 
G46A Complex Endoscopy, Major Complexity 612 1,205 12.1 8 
G46B Complex Endoscopy, Minor Complexity 12,164 587 5.0 4 
G47A Gastroscopy, Major Complexity 253 1,769 10.8 7 
G47B Gastroscopy, Intermediate Complexity 2,109 1,651 4.3 3 
G47C Gastroscopy, Minor Complexity 38,143 1,899 2.9 2 
G48A Colonoscopy, Major Complexity 2,451 1,566 8.9 6 
G48B Colonoscopy, Minor Complexity 48,734 1,496 3.9 3 
G60A Digestive Malignancy, Major Complexity 335 765 12.4 8 
G60B Digestive Malignancy, Minor Complexity 3,692 626 6.2 3 
G61A Gastrointestinal Haemorrhage, Major Complexity 36 689 7.2 4 
G61B Gastrointestinal Haemorrhage, Minor Complexity 395 1,003 2.6 1 
G64A Inflammatory Bowel Disease, Major Complexity 205 362 6.9 5 
G64B Inflammatory Bowel Disease, Minor Complexity 12,683 729 3.6 3 
G65A Gastrointestinal Obstruction, Major Complexity ~ 479 10.5 7 
G65B Gastrointestinal Obstruction, Minor Complexity 11 927 4.3 3 
G66A Abdominal Pain and Mesenteric Adenitis, Major Complexity 108 2,916 2.8 1 
G66B Abdominal Pain and Mesenteric Adenitis, Minor Complexity 934 7,405 1.6 1 
G67A Oesophagitis and Gastroenteritis, Major Complexity 62 3,390 5.9 3 
G67B Oesophagitis and Gastroenteritis, Minor Complexity 753 7,994 1.9 1 
G70A Other Digestive System Disorders, Major Complexity 1,112 6,229 5.4 3 
G70B Other Digestive System Disorders, Minor Complexity 5,219 6,072 2.1 1 
Total 135,489 66,844 4.9 2 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.9 Total Discharges: MDC 7 Diseases and Disorders of the Hepatobiliary System and Pancreas: AR-DRG 
Version 8.0 by Patient Type (N, In-Patient Length of Stay) 
 
MDC 7 Diseases and Disorders of the Hepatobiliary System and Pancreas 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
H01A Pancreas, Liver and Shunt Procedures, Major Complexity 0 31 38.2 24 
H01B Pancreas, Liver and Shunt Procedures, Intermediate Complexity ~ 301 10.3 7 
H01C Pancreas, Liver and Shunt Procedures, Minor Complexity 6 112 5.8 4 
H02A Major Biliary Tract Procedures, Major Complexity ~ 110 19.5 17 
H02B Major Biliary Tract Procedures, Minor Complexity 25 178 9.8 8 
H05A Hepatobiliary Diagnostic Procedures, Major Complexity 8 64 14.8 12 
H05B Hepatobiliary Diagnostic Procedures, Minor Complexity 50 37 4.4 3 
H06A Other Hepatobiliary and Pancreas OR Procedures, Major Complexity 0 74 24.4 17 
H06B Other Hepatobiliary and Pancreas OR Procedures, Intermediate Complexity 17 92 8.1 4 
H06C Other Hepatobiliary and Pancreas OR Procedures, Minor Complexity 14 127 1.9 1 
H07A Open Cholecystectomy, Major Complexity ~ 24 15.5 11 
H07B Open Cholecystectomy, Intermediate Complexity 0 25 9.8 8 
H07C Open Cholecystectomy, Minor Complexity 19 127 5.8 5 
H08A Laparoscopic Cholecystectomy, Major Complexity 23 324 8.7 6 
H08B Laparoscopic Cholecystectomy, Minor Complexity 1,739 2,580 2.3 1 
H40A Endoscopic Procedures for Bleeding Oesophageal Varices, Major Complexity 0 53 18.8 18 
H40B Endoscopic Procedures for Bleeding Oesophageal Varices, Intermediate Complexity ~ 54 7.4 6 
H40C Endoscopic Procedures for Bleeding Oesophageal Varices, Minor Complexity 30 21 4.7 4 
H43A ERCP Procedures, Major Complexity 11 238 17.3 13 
H43B ERCP Procedures, Intermediate Complexity 275 398 9.2 7 
H43C ERCP Procedures, Minor Complexity 1,387 833 4.6 2 
H60A Cirrhosis and Alcoholic Hepatitis, Major Complexity 0 385 18.6 13 
H60B Cirrhosis and Alcoholic Hepatitis, Intermediate Complexity 58 593 7.8 5 
H60C Cirrhosis and Alcoholic Hepatitis, Minor Complexity 354 133 4.3 2 
H61A Malignancy of Hepatobiliary System and Pancreas, Major Complexity 41 492 14.2 11 
H61B Malignancy of Hepatobiliary System and Pancreas, Minor Complexity 1,197 691 6.3 3 
H62A Disorders of Pancreas, Except Malignancy, Major Complexity ~ 446 11.1 9 
H62B Disorders of Pancreas, Except Malignancy, Minor Complexity 398 1,369 4.7 4 
H63A Other Disorders of Liver, Major Complexity 28 537 12.3 8 
H63B Other Disorders of Liver, Intermediate Complexity 404 736 4.7 2 
H63C Other Disorders of Liver, Minor Complexity 1,741 490 2.2 1 
H64A Disorders of the Biliary Tract, Major Complexity 135 2,139 7.9 6 
H64B Disorders of the Biliary Tract, Minor Complexity 525 2,658 3.7 3 
Total 8,496 16,472 6.6 4 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.10 Total Discharges: MDC 8 Diseases and Disorders of the Musculoskeletal System and Connective Tissue: 
AR-DRG Version 8.0 by Patient Type (N, In-Patient Length of Stay) 
 
MDC 8 Diseases and Disorders of the Musculoskeletal System and Connective Tissue 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
I01A Bilateral and Multiple Major Joint Procedures of Lower Limb, Major Complexity 0 81 49.3 16 
I01B Bilateral and Multiple Major Joint Procedures of Lower Limb, Minor Complexity 0 17 6.8 5 
I02A Microvascular Tissue Transfers or Skin Grafts, Excluding Hand, Major Complexity 0 25 61.0 48 
I02B Microvascular Tissue Transfers or Skin Grafts, Excluding Hand, Intermediate Comp 7 65 19.0 13 
I02C Microvascular Tissue Transfers or Skin Grafts, Excluding Hand, Minor Complexity 23 24 5.5 2 
I03A Hip Replacement, Major Complexity 0 555 25.4 16 
I03B Hip Replacement, Minor Complexity ~ 4,991 8.2 5 
I04A Knee Replacement, Major Complexity 0 184 12.6 8 
I04B Knee Replacement, Minor Complexity ~ 2,186 4.9 4 
I05A Other Joint Replacement, Major Complexity 0 64 13.0 8 
I05B Other Joint Replacement, Minor Complexity ~ 256 3.7 3 
I06Z Spinal Fusion for Deformity 43 202 10.2 7 
I07Z Amputation ~ 61 36.0 20 
I08A Other Hip and Femur Procedures, Major Complexity ~ 650 28.7 17 
I08B Other Hip and Femur Procedures, Minor Complexity 61 2,071 11.8 9 
I09A Spinal Fusion, Major Complexity 0 36 47.4 20 
I09B Spinal Fusion, Intermediate Complexity ~ 146 9.9 7 
I09C Spinal Fusion, Minor Complexity ~ 327 5.2 4 
I10A Other Back and Neck Procedures, Major Complexity ~ 146 10.4 5 
I10B Other Back and Neck Procedures, Minor Complexity 689 1,029 3.2 2 
I11Z Limb Lengthening Procedures ~ 29 5.0 4 
I12A Misc Musculoskeletal Procs for Infect/Inflam of Bone/Joint, Major Complexity ~ 119 34.5 25 
I12B Misc Musculoskeletal Procs for Infect/Inflam of Bone/Joint, Intermediate Comp 8 266 15.2 11 
I12C Misc Musculoskeletal Procs for Infect/Inflam of Bone/Joint, Minor Complexity 145 249 7.1 3 
I13A Humerus, Tibia, Fibula and Ankle Procedures, Major Complexity 6 700 10.5 6 
I13B Humerus, Tibia, Fibula and Ankle Procedures, Minor Complexity 311 3,884 3.0 2 
I15A Cranio-Facial Surgery, Major Complexity 0 45 4.6 4 
I15B Cranio-Facial Surgery, Minor Complexity 0 26 3.7 3 
I16Z Other Shoulder Procedures 308 750 1.4 1 
I17A Maxillo-Facial Surgery, Major Complexity ~ 40 8.2 5 
I17B Maxillo-Facial Surgery, Minor Complexity 8 56 2.8 2 
I18A Other Knee Procedures, Major Complexity 106 324 5.7 3 
I18B Other Knee Procedures, Minor Complexity 1,755 257 1.5 1 
I19A Other Elbow and Forearm Procedures, Major Complexity ~ 251 7.0 3 
I19B Other Elbow and Forearm Procedures, Minor Complexity 557 3,104 1.8 1 
I20A Other Foot Procedures, Major Complexity 12 163 6.8 3 
I20B Other Foot Procedures, Minor Complexity 401 1,101 1.6 1 
I21Z Local Excision and Removal of Internal Fixation Devices of Hip and Femur 54 56 4.6 2 
I23A Local Excision & Removal of Internal Fixation Device, Except Hip & Fmr, Maj Comp 152 146 3.4 1 
I23B Local Excision & Removal of Internal Fixation Device, Except Hip & Fmr, Min Comp 2,238 298 1.4 1 
I24A Arthroscopy, Major Complexity 49 55 4.2 2 
I24B Arthroscopy, Minor Complexity 488 115 1.8 1 
I25A Bone and Joint Diagnostic Procedures Including Biopsy, Major Complexity 28 60 19.8 11 
I25B Bone and Joint Diagnostic Procedures Including Biopsy, Minor Complexity 186 66 4.1 2 
I27A Soft Tissue Procedures, Major Complexity 19 152 22.9 11 
I27B Soft Tissue Procedures, Minor Complexity 707 636 2.5 1 
I28A Other Musculoskeletal Procedures, Major Complexity 7 113 20.1 13 
I28B Other Musculoskeletal Procedures, Intermediate Complexity 151 436 4.2 2 
I28C Other Musculoskeletal Procedures, Minor Complexity 113 190 2.5 1 
I29Z Knee Reconstructions, and Revisions of Reconstructions 57 369 1.4 1 
I30Z Hand Procedures 2,060 1,871 1.5 1 
I31A Revision of Hip Replacement, Major Complexity 0 66 33.9 28 
I31B Revision of Hip Replacement, Intermediate Complexity 0 153 16.2 12 
I31C Revision of Hip Replacement, Minor Complexity 0 282 9.3 6 
I32A Revision of Knee Replacement, Major Complexity 0 30 39.2 29 
I32B Revision of Knee Replacement, Minor Complexity 0 129 8.4 5 
I40Z Infusions for Musculoskeletal Disorders, Sameday 39,175 88 1.0 1 
I60Z Femoral Shaft Fractures 0 52 5.0 3 
I61A Distal Femoral Fractures, Major Complexity 0 13 11.7 8 
I61B Distal Femoral Fractures, Minor Complexity 0 55 4.5 3 
I63A Sprains, Strains and Dislocations of Hip, Pelvis and Thigh, Major Complexity 0 58 9.1 7 
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TABLE 4.10 Total Discharges: MDC 8 Diseases and Disorders of the Musculoskeletal System and Connective Tissue: 
AR-DRG Version 8.0 by Patient Type (N, In-Patient Length of Stay) (contd.) 
 
MDC 8 Diseases and Disorders of the Musculoskeletal System and Connective 
Tissue 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
I63B Sprains, Strains and Dislocations of Hip, Pelvis and Thigh, Minor Complexity 0 103 3.0 2 
I64A Osteomyelitis, Major Complexity 0 150 26.2 16 
I64B Osteomyelitis, Minor Complexity 0 296 12.3 9 
I65A Musculoskeletal Malignant Neoplasms, Major Complexity 0 159 18.7 12 
I65B Musculoskeletal Malignant Neoplasms, Minor Complexity 0 695 7.1 4 
I66A Inflammatory Musculoskeletal Disorders, Major Complexity 0 89 19.1 12 
I66B Inflammatory Musculoskeletal Disorders, Intermediate Complexity 0 227 9.7 7 
I66C Inflammatory Musculoskeletal Disorders, Minor Complexity 0 623 4.9 4 
I67A Septic Arthritis, Major Complexity 0 81 18.3 13 
I67B Septic Arthritis, Minor Complexity 0 96 7.3 6 
I68A Non-surgical Spinal Disorders, Major Complexity 0 1,571 14.0 7 
I68B Non-surgical Spinal Disorders, Minor Complexity 0 2,164 4.6 3 
I69A Bone Diseases and Arthropathies, Major Complexity 0 432 12.2 7 
I69B Bone Diseases and Arthropathies, Minor Complexity 0 628 4.3 3 
I71A Other Musculotendinous Disorders, Major Complexity 0 568 11.0 6 
I71B Other Musculotendinous Disorders, Minor Complexity 0 1,163 3.7 2 
I72A Specific Musculotendinous Disorders, Major Complexity 0 225 10.4 7 
I72B Specific Musculotendinous Disorders, Minor Complexity 0 563 4.3 3 
I73A Aftercare of Musculoskeletal Implants or Prostheses, Major Complexity 0 114 27.3 16 
I73B Aftercare of Musculoskeletal Implants or Prostheses, Minor Complexity 0 235 9.7 4 
I74A Injuries to Forearm, Wrist, Hand and Foot, Major Complexity 0 295 15.7 7 
I74B Injuries to Forearm, Wrist, Hand and Foot, Minor Complexity 0 1,111 1.8 1 
I75A Injuries to Shoulder, Arm, Elbow, Knee, Leg and Ankle, Major Complexity 0 545 19.4 10 
I75B Injuries to Shoulder, Arm, Elbow, Knee, Leg and Ankle, Minor Complexity 0 1,261 3.3 2 
I76A Other Musculoskeletal Disorders, Major Complexity 0 132 30.8 14 
I76B Other Musculoskeletal Disorders, Intermediate Complexity 0 309 8.1 5 
I76C Other Musculoskeletal Disorders, Minor Complexity 0 380 3.7 2 
I77A Fractures of Pelvis, Major Complexity 0 433 24.5 15 
I77B Fractures of Pelvis, Minor Complexity 0 470 8.8 6 
I78A Fractures of Neck of Femur, Major Complexity 0 81 21.4 13 
I78B Fractures of Neck of Femur, Minor Complexity 0 131 9.5 5 
I79A Pathological Fractures, Major Complexity 0 109 21.8 16 
I79B Pathological Fractures, Minor Complexity 0 308 9.6 7 
I80Z Femoral Fractures, Transferred to Acute Facility <2 Days 0 42 1.0 1 
I81Z Musculoskeletal Injuries, Sameday 764 1,825 1.0 1 
I82Z Other Sameday Treatment for Musculoskeletal Disorders 13,757 5,934 1.0 1 
Total 64,483 53,517 6.5 2 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.11 Total Discharges: MDC 9 Diseases and Disorders of the Skin, Subcutaneous Tissue and Breast: AR-DRG 
Version 8.0 by Patient Type (N, In-Patient Length of Stay) 
 
MDC 9 Diseases and Disorders of the Skin, Subcutaneous Tissue and Breast 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
J01A Microvas Tiss Transf for Skin, Subcut Tiss & Breast Dsrds, Major Complexity 0 ~ ^ ^ 
J01B Microvas Tiss Transf for Skin, Subcut Tiss & Breast Dsrds, Minor Complexity ~ 54 7.7 7 
J06A Major Procedures for Breast Disorders, Major Complexity 44 327 5.2 4 
J06B Major Procedures for Breast Disorders, Minor Complexity 1,073 1,618 2.4 2 
J07A Minor Procedures for Breast Disorders, Major Complexity 765 167 1.9 1 
J07B Minor Procedures for Breast Disorders, Minor Complexity 1,256 83 1.2 1 
J08A Other Skin Grafts and Debridement Procedures, Major Complexity ~ 95 21.3 11 
J08B Other Skin Grafts and Debridement Procedures, Intermediate Complexity 42 144 5.3 3 
J08C Other Skin Grafts and Debridement Procedures, Minor Complexity 1,366 251 3.0 1 
J09Z Perianal and Pilonidal Procedures 541 247 1.7 1 
J10A Plastic OR Procs for Skin, Subcutaneous Tissue and Breast Disorders, Major 
Comp 
102 99 8.6 2 
J10B Plastic OR Procs for Skin, Subcutaneous Tissue and Breast Disorders, Minor 
Comp 
1,111 141 1.7 1 
J11A Other Skin, Subcutaneous Tissue and Breast Procedures, Major Complexity 1,458 478 5.9 2 
J11B Other Skin, Subcutaneous Tissue and Breast Procedures, Minor Complexity 37,319 528 1.5 1 
J12A Lower Limb Procedures W Ulcer or Cellulitis, Major Complexity ~ 51 36.7 19 
J12B Lower Limb Procedures W Ulcer or Cellulitis, Minor Complexity 19 80 11.2 9 
J13A Lower Limb Procedures W/O Ulcer or Cellulitis, Major Complexity 13 * ^ ^ 
J13B Lower Limb Procedures W/O Ulcer or Cellulitis, Minor Complexity 144 84 3.2 1 
J14Z Major Breast Reconstructions 21 224 4.5 4 
J60A Skin Ulcers, Major Complexity ~ 219 22.6 13 
J60B Skin Ulcers, Intermediate Complexity 31 259 8.7 6 
J60C Skin Ulcers, Minor Complexity 1,238 143 4.8 3 
J62A Malignant Breast Disorders, Major Complexity 54 199 11.9 8 
J62B Malignant Breast Disorders, Minor Complexity 5,776 405 12.2 7 
J63A Non-Malignant Breast Disorders, Major Complexity 288 300 3.2 2 
J63B Non-Malignant Breast Disorders, Minor Complexity 3,215 53 1.5 1 
J64A Cellulitis, Major Complexity 23 2,764 10.7 6 
J64B Cellulitis, Minor Complexity 597 5,409 3.2 2 
J65A Trauma to Skin, Subcutaneous Tissue and Breast, Major Complexity ~ 488 12.5 7 
J65B Trauma to Skin, Subcutaneous Tissue and Breast, Minor Complexity 64 1,197 2.2 1 
J67A Minor Skin Disorders, Major Complexity 1,434 573 4.7 2 
J67B Minor Skin Disorders, Minor Complexity 14,401 1,772 1.7 1 
J68A Major Skin Disorders, Major Complexity 936 887 5.1 2 
J68B Major Skin Disorders, Minor Complexity 20,209 321 2.2 1 
J69A Skin Malignancy, Major Complexity 44 74 20.2 14 
J69B Skin Malignancy, Intermediate Complexity 570 92 12.1 8 
J69C Skin Malignancy, Minor Complexity 2,179 51 10.3 7 
Total 96,343 19,919 5.3 2 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges. 
 ^ Denotes that length of stay is suppressed where the number of discharges is not reported. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.12 Total Discharges: MDC 10 Endocrine, Nutritional and Metabolic Diseases and Disorders: AR-DRG Version 
8.0 by Patient Type (N, In-Patient Length of Stay) 
 
MDC 10 Endocrine, Nutritional and Metabolic Diseases and Disorders 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
K01A OR Procedures for Diabetic Complications, Major Complexity 0 67 49.4 31 
K01B OR Procedures for Diabetic Complications, Intermediate Complexity 0 80 22.3 15 
K01C OR Procedures for Diabetic Complications, Minor Complexity ~ 91 12.4 10 
K02A Pituitary Procedures, Major Complexity 0 15 20.7 19 
K02B Pituitary Procedures, Minor Complexity ~ 62 7.1 5 
K03Z Adrenal Procedures ~ 64 7.0 4 
K05A Parathyroid Procedures, Major Complexity 0 45 5.1 3 
K05B Parathyroid Procedures, Minor Complexity 18 151 2.2 2 
K06A Thyroid Procedures, Major Complexity 0 75 6.4 4 
K06B Thyroid Procedures, Minor Complexity 34 609 2.5 2 
K08Z Thyroglossal Procedures 7 62 1.7 1 
K09A Other Endocrine, Nutritional and Metabolic OR Procedures, Major Complexity 7 37 26.7 19 
K09B Other Endocrine, Nutritional and Metabolic OR Procedures, Minor Complexity 25 42 9.0 7 
K10A Revisional and Open Bariatric Procedures, Major Complexity 0 ~ ^ ^ 
K10B Revisional and Open Bariatric Procedures, Minor Complexity 0 * ^ ^ 
K11A Major Laparoscopic Bariatric Procedures, Major Complexity 0 31 3.9 3 
K11B Major Laparoscopic Bariatric Procedures, Minor Complexity 0 22 2.8 3 
K12B Other Bariatric Procedures, Minor Complexity ~ 0 - - 
K13Z Plastic OR Procedures for Endocrine, Nutritional and Metabolic Disorders 9 36 3.3 3 
K40A Endoscopic and Investigative Procedures for Metabolic Disorders, Major Comp 14 313 16.7 10 
K40B Endoscopic and Investigative Procedures for Metabolic Disorders, Minor Comp 910 108 6.8 6 
K60A Diabetes, Major Complexity ~ 941 9.5 5 
K60B Diabetes, Minor Complexity 325 2,781 4.1 2 
K61A Severe Nutritional Disturbance, Major Complexity 0 25 32.0 21 
K61B Severe Nutritional Disturbance, Minor Complexity ~ 21 25.4 7 
K62A Miscellaneous Metabolic Disorders, Major Complexity 32 680 12.2 7 
K62B Miscellaneous Metabolic Disorders, Intermediate Complexity 136 1,603 5.3 3 
K62C Miscellaneous Metabolic Disorders, Minor Complexity 1,226 1,898 2.7 1 
K63A Inborn Errors of Metabolism, Major Complexity 331 183 5.5 3 
K63B Inborn Errors of Metabolism, Minor Complexity 550 59 2.6 1 
K64A Endocrine Disorders, Major Complexity 702 888 6.5 4 
K64B Endocrine Disorders, Minor Complexity 1,985 639 2.0 1 
Total 6,326 11,640 6.0 3 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges. 
 ^   Denotes that length of stay is suppressed where the number of discharges is not reported. 
 - Mean and median length of stay cannot be calculated as no in-patients are reported. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.13 Total Discharges: MDC 11 Diseases and Disorders of the Kidney and Urinary Tract: AR-DRG Version 8.0 
by Patient Type (N, In-Patient Length of Stay) 
 
MDC 11 Diseases and Disorders of the Kidney and Urinary Tract 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
L02A Operative Insertion of Peritoneal Catheter for Dialysis, Major Complexity ~ 40 8.2 7 
L02B Operative Insertion of Peritoneal Catheter for Dialysis, Minor Complexity 39 49 4.4 3 
L03A Kidney, Ureter and Major Bladder Procedures for Neoplasm, Major Complexity 0 88 27.9 19 
L03B Kidney, Ureter and Major Bladder Procedures for Neoplasm, Intermediate Comp ~ 235 11.7 9 
L03C Kidney, Ureter and Major Bladder Procedures for Neoplasm, Minor Complexity 17 328 6.1 5 
L04A Kidney, Ureter and Major Bladder Procedures for Non-Neoplasm, Major 
Complexity 
~ 210 23.5 13 
L04B Kidney, Ureter and Major Bladder Procedures for Non-Neoplasm, Intermediate 
Comp 
69 779 7.0 4 
L04C Kidney, Ureter and Major Bladder Procedures for Non-Neoplasm, Minor 
Complexity 
587 1,139 3.2 2 
L05A Transurethral Prostatectomy for Urinary Disorder, Major Complexity 0 21 12.0 10 
L05B Transurethral Prostatectomy for Urinary Disorder, Minor Complexity ~ 100 5.6 4 
L06A Minor Bladder Procedures, Major Complexity ~ 67 16.1 11 
L06B Minor Bladder Procedures, Intermediate Complexity 14 116 6.6 5 
L06C Minor Bladder Procedures, Minor Complexity 101 182 3.4 2 
L07A Other Transurethral Procedures, Major Complexity 25 315 9.6 5 
L07B Other Transurethral Procedures, Minor Complexity 657 908 3.2 2 
L08A Urethral Procedures, Major Complexity 8 34 6.7 3 
L08B Urethral Procedures, Minor Complexity 92 125 2.4 2 
L09A Other Procedures for Kidney and Urinary Tract Disorders, Major Complexity 0 45 37.3 23 
L09B Other Procedures for Kidney and Urinary Tract Disorders, Intermediate Complexity 11 65 12.0 9 
L09C Other Procedures for Kidney and Urinary Tract Disorders, Minor Complexity 262 134 3.4 1 
L40Z Ureteroscopy 94 77 3.1 2 
L41Z Cystourethroscopy for Urinary Disorder, Sameday 11,116 54 1.0 1 
L42Z ESW Lithotripsy 2,191 107 3.7 3 
L60A Kidney Failure, Major Complexity ~ 685 18.0 12 
L60B Kidney Failure, Intermediate Complexity 179 1,990 7.6 5 
L60C Kidney Failure, Minor Complexity 1,269 442 3.1 2 
L61Z Haemodialysis 171,418 15 3.4 1 
L62A Kidney and Urinary Tract Neoplasms, Major Complexity 60 240 14.3 9 
L62B Kidney and Urinary Tract Neoplasms, Minor Complexity 1,191 322 4.8 3 
L63A Kidney and Urinary Tract Infections, Major Complexity 37 6,900 12.1 7 
L63B Kidney and Urinary Tract Infections, Minor Complexity 1,184 7,367 4.5 3 
L64A Urinary Stones and Obstruction, Major Complexity 98 947 4.1 2 
L64B Urinary Stones and Obstruction, Minor Complexity 330 1,723 2.0 1 
L65A Kidney and Urinary Tract Signs and Symptoms, Major Complexity 50 662 8.9 6 
L65B Kidney and Urinary Tract Signs and Symptoms, Minor Complexity 2,152 1,606 3.1 2 
L66Z Urethral Stricture 128 104 3.3 2 
L67A Other Kidney and Urinary Tract Disorders, Major Complexity 515 977 8.3 4 
L67B Other Kidney and Urinary Tract Disorders, Intermediate Complexity 2,418 855 3.1 2 
L67C Other Kidney and Urinary Tract Disorders, Minor Complexity 2,860 182 2.3 1 
L68Z Peritoneal Dialysis 101 0 - - 
Total 199,291 30,235 7.1 4 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 - Mean and median length of stay cannot be calculated as no in-patients are reported. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.14 Total Discharges: MDC 12 Diseases and Disorders of the Male Reproductive System: AR-DRG Version 8.0 
by Patient Type (N, In-Patient Length of Stay) 
 
MDC 12 Diseases and Disorders of the Male Reproductive System 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
M01A Major Male Pelvic Procedures, Major Complexity 0 56 8.9 7 
M01B Major Male Pelvic Procedures, Minor Complexity 0 280 5.0 4 
M02A Transurethral Prostatectomy for Reproductive System Disorder, Major 
Complexity 
~ 95 9.6 5 
M02B Transurethral Prostatectomy for Reproductive System Disorder, Minor 
Complexity 
~ 547 3.9 3 
M03A Penis Procedures, Major Complexity 33 61 4.0 3 
M03B Penis Procedures, Minor Complexity 587 116 1.7 1 
M04Z Testes Procedures 1,473 749 2.1 1 
M05Z Circumcision 2,003 189 1.6 1 
M06A Other Male Reproductive System OR Procedures, Major Complexity 62 42 9.8 7 
M06B Other Male Reproductive System OR Procedures, Minor Complexity 73 * ^ ^ 
M40Z Cystourethroscopy for Male Reproductive System Disorder, Sameday 1,716 0 - - 
M60A Male Reproductive System Malignancy, Major Complexity 451 439 10.2 5 
M60B Male Reproductive System Malignancy, Minor Complexity 3,652 183 19.2 6 
M61A Benign Prostatic Hypertrophy, Major Complexity 35 46 6.7 5 
M61B Benign Prostatic Hypertrophy, Minor Complexity 1,342 66 2.7 1 
M62A Male Reproductive System Inflammation, Major Complexity ~ 197 7.7 5 
M62B Male Reproductive System Inflammation, Minor Complexity 769 801 2.4 2 
M63Z Male Sterilisation Procedures 200 ~ ^ ^ 
M64A Other Male Reproductive System Disorders, Major Complexity 54 106 4.7 2 
M64B Other Male Reproductive System Disorders, Minor Complexity 635 506 1.5 1 
Total 13,092 4,506 4.7 2 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges. 
 ^  Denotes that length of stay is suppressed where the number of discharges is not reported. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.15 Total Discharges: MDC 13 Diseases and Disorders of the Female Reproductive System: AR-DRG Version 
8.0 by Patient Type (N, In-Patient Length of Stay) 
 
MDC 13 Diseases and Disorders of the Female Reproductive System 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
N01A Pelvic Evisceration and Radical Vulvectomy, Major Complexity 0 35 22.3 14 
N01B Pelvic Evisceration and Radical Vulvectomy, Minor Complexity 0 155 6.9 5 
N04A Hysterectomy for Non-Malignancy, Major Complexity 0 248 6.6 6 
N04B Hysterectomy for Non-Malignancy, Minor Complexity ~ 1,498 4.1 4 
N05A Oophorectomy and Complex Fallopian Tube Procedures for Non-Malignancy, Maj 
Complexity 
~ 78 5.9 5 
N05B Oophorectomy and Complex Fallopian Tube Procedures for Non-Malignancy, Min 
Complexity 
179 534 2.8 2 
N06A Female Reproductive System Reconstructive Procedures, Major Complexity ~ 100 4.9 4 
N06B Female Reproductive System Reconstructive Procedures, Minor Complexity 207 1,343 2.5 2 
N07A Other Uterus and Adnexa Procedures for Non-Malignancy, Major Complexity 1,165 1,178 2.5 2 
N07B Other Uterus and Adnexa Procedures for Non-Malignancy, Minor Complexity 1,746 162 1.3 1 
N08Z Endoscopic and Laparoscopic Procedures, Female Reproductive System 925 420 2.5 1 
N09Z Other Vagina, Cervix and Vulva Procedures 12,249 737 5.1 2 
N10Z Diagnostic Curettage and Diagnostic Hysteroscopy 8,478 573 2.7 1 
N11A Other Female Reproductive System OR Procedures, Major Complexity 19 113 13.4 7 
N11B Other Female Reproductive System OR Procedures, Minor Complexity 8 7 3.6 3 
N12A Uterus and Adnexa Procedures for Malignancy, Major Complexity 0 41 19.8 16 
N12B Uterus and Adnexa Procedures for Malignancy, Intermediate Complexity 0 157 6.9 6 
N12C Uterus and Adnexa Procedures for Malignancy, Minor Complexity 28 371 4.1 4 
N60A Female Reproductive System Malignancy, Major Complexity 8 207 18.6 12 
N60B Female Reproductive System Malignancy, Minor Complexity 1,398 453 7.9 4 
N61A Female Reproductive System Infections, Major Complexity ~ 104 7.9 5 
N61B Female Reproductive System Infections, Minor Complexity 196 326 2.6 2 
N62A Menstrual and Other Female Reproductive System Disorders, Major Complexity 110 580 3.3 2 
N62B Menstrual and Other Female Reproductive System Disorders, Minor Complexity 5,817 2,167 1.8 1 
Total 32,544 11,587 3.9 2 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.16 Total Discharges: MDC 14 Pregnancy, Childbirth and the Puerperium: AR-DRG Version 8.0 by Patient 
Type (N, In-Patient Length of Stay) 
 
MDC 14 Pregnancy, Childbirth and the Puerperium 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
O01A Caesarean Delivery, Major Complexity 0 1,382 10.9 8 
O01B Caesarean Delivery, Intermediate Complexity 0 6,899 5.8 5 
O01C Caesarean Delivery, Minor Complexity 0 11,293 4.1 4 
O02A Vaginal Delivery W OR Procedures, Major Complexity 0 157 4.9 4 
O02B Vaginal Delivery W OR Procedures, Minor Complexity 0 723 3.3 3 
O03A Ectopic Pregnancy, Major Complexity 0 130 3.0 2 
O03B Ectopic Pregnancy, Minor Complexity 26 551 2.0 2 
O04A Postpartum and Post Abortion W OR Procedures, Major Complexityb ~ 75 6.1 4 
O04B Postpartum and Post Abortion W OR Procedures, Minor Complexityb 16 143 2.6 2 
O05Z Abortion W OR Proceduresb 1,518 2,625 1.3 1 
O60A Vaginal Delivery, Major Complexity 0 3,856 4.8 4 
O60B Vaginal Delivery, Intermediate Complexity 0 18,219 3.0 3 
O60C Vaginal Delivery, Minor Complexity 0 17,949 2.1 2 
O61A Postpartum and Post Abortion W/O OR Procedures, Major Complexityb 15 540 3.5 3 
O61B Postpartum and Post Abortion W/O OR Procedures, Minor Complexityb 1,012 2,637 2.1 1 
O63A Abortion W/O OR Procedures, Major Complexityb ~ 158 2.7 2 
O63B Abortion W/O OR Procedures, Minor Complexityb 254 2,180 1.3 1 
O66A Antenatal and Other Obstetric Admissions, Major Complexity 1,274 11,033 2.1 1 
O66B Antenatal and Other Obstetric Admissions, Minor Complexity 7,160 30,026 1.3 1 
Total 11,279 110,576 2.7 2 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 a Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
 b This includes spontaneous abortions and pregnancies with abortive outcome. 
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TABLE 4.17 Total Discharges: MDC 15 Newborns and Other Neonates: AR-DRG Version 8.0 by Patient Type (N, In-
Patient Length of Stay) 
 
MDC 15 Newborns and Other Neonates 
Day 
Patients 
In-
Patientsa 
In-Patient 
Length of Staya 
N N Mean Median 
P01Z Neonate W Sig OR Proc/Vent>=96hrs, Died or Transfer to Acute Faclity <5Days ~ 41 2.1 2 
P02Z Cardiothoracic and Vascular Procedures for Neonates 0 52 33.9 17 
P03A Neonate, AdmWt 1000-1499g W Significant OR Proc/Vent>=96hrs, Major Complexity 0 66 65.9 68 
P03B Neonate, AdmWt 1000-1499g W Significant OR Proc/Vent>=96hrs, Minor Complexity 0 160 39.7 41 
P04A Neonate, AdmWt 1500-1999g W Significant OR Proc/Vent>=96hrs, Major Complexity 0 22 72.0 45 
P04B Neonate, AdmWt 1500-1999g W Significant OR Proc/Vent>=96hrs, Minor Complexity 0 119 29.8 28 
P05A Neonate, AdmWt 2000-2499g W Significant OR Proc/Vent>=96hrs, Major Complexity 0 16 148.4 47 
P05B Neonate, AdmWt 2000-2499g W Significant OR Proc/Vent>=96hrs, Minor Complexity 0 88 21.5 18 
P06A Neonate, AdmWt >=2500g W Significant OR Proc/Vent>=96hrs, Major Complexity 0 98 38.2 22 
P06B Neonate, AdmWt >=2500g W Significant OR Proc/Vent>=96hrs, Minor Complexity ~ 189 11.6 10 
P07Z Neonate, AdmWt <750g W Significant OR Procedures 0 * ^ ^ 
P08Z Neonate, AdmWt 750-999g W Significant OR Procedures 0 ~ ^ ^ 
P60A Neonate W/O Sig OR/Vent>=96hrs, Died/Transfer Acute Facility <5 Days, MajC 0 85 2.1 2 
P60B Neonate W/O Sig OR/Vent>=96hrs, Died/Transfer Acute Facility <5 Days, MinC 9 520 1.4 1 
P61Z Neonate, AdmWt <750g W/O Significant OR procedure 0 71 71.0 71 
P62A Neonate, AdmWt 750-999g W/O Significant OR Procedures, Major Complexity 0 41 89.0 88 
P62B Neonate, AdmWt 750-999g W/O Significant OR Procedures, Minor Complexity 0 82 47.3 43 
P63A Neonate, AdmWt 1000-1249g W/O Significant OR Proc/Vent>=96hrs, Major Complexity 0 26 45.6 44 
P63B Neonate, AdmWt 1000-1249g W/O Significant OR Proc/Vent>=96hrs, Minor Complexity 0 22 33.1 35 
P64A Neonate, AdmWt 1250-1499g W/O Significant OR Proc/Vent>=96hrs, Major Complexity 0 31 41.3 39 
P64B Neonate, AdmWt 1250-1499g W/O Significant OR Proc/Vent>=96hrs, Minor Complexity 0 88 30.9 30 
P65A Neonate, AdmWt 1500-1999g W/O Significant OR Proc/Vent>=96hrs, Extreme Comp 0 47 32.1 32 
P65B Neonate, AdmWt 1500-1999g W/O Significant OR Proc/Vent>=96hrs, Major Complexity 0 99 25.6 24 
P65C Neonate, AdmWt 1500-1999g W/O Significant OR Proc/Vent>=96hrs, Intermediate Comp 0 321 19.1 18 
P65D Neonate, AdmWt 1500-1999g W/O Significant OR Proc/Vent>=96hrs, Minor Complexity ~ 177 12.0 11 
P66A Neonate, AdmWt 2000-2499g W/O Significant OR Proc/Vent>=96hrs, Extreme Comp ~ 94 18.9 17 
P66B Neonate, AdmWt 2000-2499g W/O Significant OR Proc/Vent>=96hrs, Major Complexity ~ 339 13.5 13 
P66C Neonate, AdmWt 2000-2499g W/O Significant OR Proc/Vent>=96hrs, Intermediate Comp ~ 669 8.6 7 
P66D Neonate, AdmWt 2000-2499g W/O Significant OR Proc/Vent>=96hrs, Minor Complexity 18 484 3.8 3 
P67A Neonate, AdmWt >=2500g W/O Sig OR Proc/Vent>=96hrs, <37 Comp Wks Gest, Extr 
Comp 
~ 87 14.7 12 
P67B Neonate, AdmWt >=2500g W/O Sig OR Proc/Vent>=96hrs, <37 Comp Wks Gest, Maj 
Comp 
8 181 9.0 8 
P67C Neonate, AdmWt >=2500g W/O Sig OR Proc/Vent>=96hrs, <37 Comp Wks Gest, Int Comp 10 200 8.0 7 
P67D Neonate, AdmWt >=2500g W/O Sig OR Proc/Vent>=96hrs, <37 Comp Wks Gest, Min 
Comp 
21 304 5.3 3 
P68A Neonate, AdmWt >=2500g W/O Sig OR Proc/Vent>=96hrs, >=37 Comp Wks Gest, Ext 
Comp 
11 502 10.3 7 
P68B Neonate, AdmWt >=2500g W/O Sig OR Proc/Vent>=96hrs, >=37 Comp Wks Gest, Maj 
Comp 
23 1,094 5.0 3 
P68C Neonate, AdmWt >=2500g W/O Sig OR Proc/Vent>=96hrs, >=37 Comp Wks Gest, Int 
Comp 
64 1,480 3.6 3 
P68D Neonate, AdmWt >=2500g W/O Sig OR Proc/Vent>=96hrs, >=37 Comp Wks Gest, Min 
Comp 
270 6,081 2.2 2 
Total 447 13,987 7.9 3 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges. 
 ^ Denotes that length of stay is suppressed where the number of discharges is not reported. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.18 Total Discharges: MDC 16 Diseases and Disorders of Blood, Blood Forming Organs, Immunological 
Disorders: AR-DRG Version 8.0 by Patient Type (N, In-Patient Length of Stay) 
 
MDC 16 Diseases and Disorders of Blood, Blood Forming Organs, Immunological  
Disorders 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
Q01A Splenectomy, Major Complexity 0 ~ ^ ^ 
Q01B Splenectomy, Minor Complexity 0 * ^ ^ 
Q02A Blood and Immune System Disorders W Other OR Procedures, Major Complexity ~ 69 23.3 10 
Q02B Blood and Immune System Disorders W Other OR Procedures, Minor Complexity 423 179 4.9 2 
Q60A Reticuloendothelial and Immunity Disorders, Major Complexity 569 1,280 6.8 4 
Q60B Reticuloendothelial and Immunity Disorders, Minor Complexity 3,264 437 2.8 1 
Q61A Red Blood Cell Disorders, Major Complexity 814 2,173 7.6 5 
Q61B Red Blood Cell Disorders, Intermediate Complexity 12,579 2,517 2.6 1 
Q61C Red Blood Cell Disorders, Minor Complexity 22,077 52 1.0 1 
Q62A Coagulation Disorders, Major Complexity * 536 5.4 2 
Q62B Coagulation Disorders, Minor Complexity 4,184 628 2.2 1 
Total 43,973 7,912 5.1 2 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges. 
 ^ Denotes that length of stay is suppressed where the number of discharges is not reported. 
 a Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
 
 
TABLE 4.19 Total Discharges: MDC 17 Neoplastic Disorders (Haematological and Solid Neoplasms): AR-DRG Version 
8.0 by Patient Type (N, In-Patient Length of Stay) 
 
MDC 17 Neoplastic Disorders (Haematological and Solid Neoplasms) 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
R01A Lymphoma and Leukaemia W Major OR Procedures, Major Complexity 0 74 31.3 17 
R01B Lymphoma and Leukaemia W Major OR Procedures, Minor Complexity 14 57 6.7 4 
R02A Other Neoplastic Disorders W Major OR Procedures, Major Complexity ~ 32 16.2 12 
R02B Other Neoplastic Disorders W Major OR Procedures, Intermediate Complexity ~ 100 8.0 7 
R02C Other Neoplastic Disorders W Major OR Procedures, Minor Complexity 49 144 3.9 3 
R03A Lymphoma and Leukaemia W Other OR Procedures, Major Complexity ~ 69 45.6 32 
R03B Lymphoma and Leukaemia W Other OR Procedures, Intermediate Complexity 20 115 13.5 12 
R03C Lymphoma and Leukaemia W Other OR Procedures, Minor Complexity 205 155 4.9 3 
R04A Other Neoplastic Disorders W Other OR Procedures, Major Complexity 20 66 17.8 11 
R04B Other Neoplastic Disorders W Other OR Procedures, Minor Complexity 901 103 4.9 3 
R60A Acute Leukaemia, Major Complexity 175 431 23.3 15 
R60B Acute Leukaemia, Minor Complexity 4,191 498 5.3 3 
R61A Lymphoma and Non-Acute Leukaemia, Major Complexity 982 1,451 14.1 8 
R61B Lymphoma and Non-Acute Leukaemia, Minor Complexity 17,348 1,678 4.5 3 
R62A Other Neoplastic Disorders, Major Complexityb 711 153 13.8 10 
R62B Other Neoplastic Disorders, Intermediate Complexityb 4,028 110 6.9 4 
R62C Other Neoplastic Disorders, Minor Complexityb 105,929 27 6.6 3 
R63Z Chemotherapy 115,060 0 - - 
Total 249,639 5,263 10.6 5 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 - Mean and median length of stay cannot be calculated as no in-patients are reported. 
 a Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
 b 
 
From 2015 this data includes activity from St. Luke’s Radiation Oncology Network centres located in Beaumont and St. James’s 
Hospitals. These centres are operational since 2011, but data has only been included in HIPE from 2015. 
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TABLE 4.20 Total Discharges: MDC 18 Infectious and Parasitic Diseases, Systemic or Unspecified Sites: AR-DRG 
Version 8.0 by Patient Type (N, In-Patient Length of Stay) 
 
MDC 18 Infectious and Parasitic Diseases, Systemic or Unspecified Sites 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
S65A Human Immunodeficiency Virus, Major Complexity 0 53 21.7 15 
S65B Human Immunodeficiency Virus, Intermediate Complexity ~ 119 9.7 6 
S65C Human Immunodeficiency Virus, Minor Complexity 46 40 4.3 3 
T01A Infectious and Parasitic Diseases W OR Procedures, Major Complexity ~ 128 38.9 25 
T01B Infectious and Parasitic Diseases W OR Procedures, Intermediate Complexity 7 199 22.4 13 
T01C Infectious and Parasitic Diseases W OR Procedures, Minor Complexity 31 261 10.4 7 
T40Z Infectious and Parasitic Diseases W Ventilator Support 0 33 15.8 9 
T60A Septicaemia, Major Complexity 0 421 26.5 17 
T60B Septicaemia, Intermediate Complexity ~ 1,190 12.5 8 
T60C Septicaemia, Minor Complexity ~ 1,801 7.5 6 
T61A Postoperative and Post-Traumatic Infections, Major Complexity 18 364 10.2 6 
T61B Postoperative and Post-Traumatic Infections, Minor Complexity 58 781 4.7 3 
T62A Fever of Unknown Origin, Major Complexity ~ 185 8.7 5 
T62B Fever of Unknown Origin, Minor Complexity 38 939 2.5 1 
T63A Viral Illnesses, Major Complexity 25 596 4.4 2 
T63B Viral Illnesses, Minor Complexity 618 4,152 1.8 1 
T64A Other Infectious and Parasitic Diseases, Major Complexity 0 21 23.0 13 
T64B Other Infectious and Parasitic Diseases, Intermediate Complexity 30 126 9.9 6 
T64C Other Infectious and Parasitic Diseases, Minor Complexity 110 288 4.8 2 
Total 1,001 11,697 6.8 3 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 a Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.21 Total Discharges: MDC 19 Mental Diseases and Disorders: AR-DRG Version 8.0 by Patient Type (N, In-
Patient Length of Stay) 
 
MDC 19 Mental Diseases and Disorders 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
U40Z Mental Health Treatment W ECT, Sameday 64 ~ ^ ^ 
U60A Mental Health Treatment W/O ECT, Sameday, Major Complexity 366 332 1.0 1 
U60B Mental Health Treatment W/O ECT, Sameday, Minor Complexity 225 483 1.0 1 
U61A Schizophrenia Disorders, Major Complexity 0 43 59.2 22 
U61B Schizophrenia Disorders, Minor Complexity 0 96 34.3 21 
U62A Paranoia and Acute Psychotic Disorders, Major Complexity 0 39 17.0 10 
U62B Paranoia and Acute Psychotic Disorders, Minor Complexity 0 106 12.9 7 
U63A Major Affective Disorders, Major Complexity 0 40 25.9 18 
U63B Major Affective Disorders, Minor Complexity 0 125 20.9 13 
U64A Other Affective and Somatoform Disorders, Major Complexity 0 48 20.1 11 
U64B Other Affective and Somatoform Disorders, Minor Complexity 0 130 9.0 4 
U65A Anxiety Disorders, Major Complexity 0 140 12.2 6 
U65B Anxiety Disorders, Minor Complexity 0 312 5.1 2 
U66A Eating and Obsessive-Compulsive Disorders, Major Complexity 0 51 35.1 28 
U66B Eating and Obsessive-Compulsive Disorders, Minor Complexity 0 152 13.4 6 
U67A Personality Disorders and Acute Reactions, Major Complexity 0 110 17.2 6 
U67B Personality Disorders and Acute Reactions, Minor Complexity 0 166 5.3 3 
U68A Childhood Mental Disorders, Major Complexity 0 33 9.9 2 
U68B Childhood Mental Disorders, Minor Complexity 0 * ^ ^ 
Total 655 2,436 10.2 2 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges. 
 ^ Denotes that length of stay is suppressed where the number of discharges is not reported. 
 a      Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
   
   
   
TABLE 4.22 Total Discharges: MDC 20 Alcohol/Drug Use and Alcohol/Drug Induced Organic Mental Disorders: AR-
DRG Version 8.0 by Patient Type (N, In-Patient Length of Stay) 
 
MDC 20 Alcohol/Drug Use and Alcohol/Drug Induced Organic Mental Disorders 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
V60A Alcohol Intoxication and Withdrawal, Major Complexity 0 434 8.6 5 
V60B Alcohol Intoxication and Withdrawal, Minor Complexity 0 1,090 3.2 2 
V61A Drug Intoxication and Withdrawal, Major Complexity 0 14 9.9 7 
V61B Drug Intoxication and Withdrawal, Minor Complexity 0 95 5.9 2 
V62A Alcohol Use and Dependence, Major Complexity 0 95 12.0 6 
V62B Alcohol Use and Dependence, Minor Complexity 0 382 4.5 3 
V63Z Opioid Use and Dependence 0 96 18.1 20 
V64Z Other Drug Use and Dependence 0 51 12.8 7 
V65Z Treatment for Alcohol Disorders, Sameday * 442 1.0 1 
V66Z Treatment for Drug Disorders, Sameday ~ 50 1.0 1 
Total 9 2,749 5.0 2 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges. 
 a Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.23 Total Discharges: MDC 21 Injuries, Poisonings and Toxic Effects of Drugs: AR-DRG Version 8.0 by Patient 
Type (N, In-Patient Length of Stay) 
 
MDC 21 Injuries, Poisonings and Toxic Effects of Drugs 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
W01A Vent, Trac & Cran Procs for Mult Sig Trauma, Major Complexity 0 14 74.2 49 
W01B Vent, Trac & Cran Procs for Mult Sig Trauma, Intermediate Complexity 0 39 47.2 33 
W01C Vent, Trac & Cran Procs for Mult Sig Trauma, Minor Complexity 0 31 21.5 15 
W02A Hip, Femur and Lower Limb Procedures for Multiple Sig Trauma, Major 
Complexity 
0 22 30.3 22 
W02B Hip, Femur and Lower Limb Procedures for Multiple Sig Trauma, Minor 
Complexity 
0 81 25.1 15 
W03Z Abdominal Procedures for Multiple Significant Trauma 0 18 52.4 13 
W04A Multiple Significant Trauma W Other OR Procedures, Major Complexity 0 17 29.1 16 
W04B Multiple Significant Trauma W Other OR Procedures, Minor Complexity 0 41 14.5 11 
W60A Multiple Sig Trauma, Died or Transferred to Acute Facility <5 Days, Major Comp 0 29 2.3 2 
W60B Multiple Sig Trauma, Died or Transferred to Acute Facility <5 Days, Minor Comp 0 24 2.2 2 
W61A Multiple Significant Trauma W/O OR Procedures, Major Complexity 0 88 34.3 24 
W61B Multiple Significant Trauma W/O OR Procedures, Minor Complexity 0 150 9.2 6 
X02A Microvascular Tissue Transfer and Skin Grafts for Injuries to Hand, Major Comp ~ 19 6.8 6 
X02B Microvascular Tissue Transfer and Skin Grafts for Injuries to Hand, Minor Comp 8 79 1.8 1 
X04A Other Procedures for Injuries to Lower Limb, Major Complexity 0 26 21.1 15 
X04B Other Procedures for Injuries to Lower Limb, Minor Complexity 11 146 2.7 1 
X05A Other Procedures for Injuries to Hand, Major Complexity 46 231 2.6 2 
X05B Other Procedures for Injuries to Hand, Minor Complexity 299 955 1.1 1 
X06A Other Procedures for Other Injuries, Major Complexity ~ 150 16.6 11 
X06B Other Procedures for Other Injuries, Intermediate Complexity 26 262 6.3 4 
X06C Other Procedures for Other Injuries, Minor Complexity 163 926 2.3 1 
X07A Skin Grafts for Injuries Excluding Hand, Major Complexity ~ 30 23.1 16 
X07B Skin Grafts for Injuries Excluding Hand, Intermediate Complexity ~ 38 11.1 7 
X07C Skin Grafts for Injuries Excluding Hand, Minor Complexity 13 54 5.6 3 
X40A Injuries, Poisoning and Toxic Effects of Drugs W Ventilator Support, Major Comp 0 34 12.9 10 
X40B Injuries, Poisoning and Toxic Effects of Drugs W Ventilator Support, Minor Comp 0 55 5.8 5 
X60A Injuries, Major Complexity 8 994 10.1 5 
X60B Injuries, Minor Complexity 357 3,495 1.8 1 
X61A Allergic Reactions, Major Complexity 0 115 3.3 1 
X61B Allergic Reactions, Minor Complexity ~ 292 1.3 1 
X62A Poisoning/Toxic Effects of Drugs and Other Substances, Major Complexity ~ 1,019 6.2 3 
X62B Poisoning/Toxic Effects of Drugs and Other Substances, Minor Complexity 108 3,175 1.8 1 
X63A Sequelae of Treatment, Major Complexity 23 692 8.1 4 
X63B Sequelae of Treatment, Minor Complexity 343 1,812 2.4 1 
X64A Other Injuries, Poisonings and Toxic Effects, Major Complexity 0 172 12.9 7 
X64B Other Injuries, Poisonings and Toxic Effects, Minor Complexity 9 488 3.1 1 
Total 1,432 15,813 4.2 1 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.24 Total Discharges: MDC 22 Burns: AR-DRG Version 8.0 by Patient Type (N, In-Patient Length of Stay) 
 
MDC 22 Burns 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
Y01Z Vent >=96hrs or Trach for Burns or OR Procs for Severe Full Thickness Burns 0 10 50.6 38 
Y02A Skin Grafts for Other Burns, Major Complexity 0 60 24.4 17 
Y02B Skin Grafts for Other Burns, Intermediate Complexity 7 60 10.8 8 
Y02C Skin Grafts for Other Burns, Minor Complexity ~ 25 6.6 6 
Y03A Other OR Procedures for Other Burns, Major Complexity 21 21 9.0 4 
Y03B Other OR Procedures for Other Burns, Minor Complexity ~ 14 3.1 1 
Y60Z Burns, Transferred to Acute Facility <5 Days 0 48 1.3 1 
Y61Z Severe Burns 0 52 11.7 3 
Y62A Other Burns, Major Complexity ~ 100 8.4 4 
Y62B Other Burns, Minor Complexity 125 206 3.1 2 
Total 165 596 8.7 3 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 a Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
 
 
 
TABLE 4.25 Total Discharges: MDC 23 Factors Influencing Health Status and Other Contacts with Health Services: 
AR-DRG Version 8.0 by Patient Type (N, In-Patient Length of Stay) 
 
MDC 23 Factors Influencing Health Status and Other Contacts with Health Services  
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
Z01A Other Contacts W Health Services W OR Procedures, Major Complexity 58 135 30.1 12 
Z01B Other Contacts W Health Services W OR Procedures, Minor Complexity 870 192 3.3 1 
Z40Z Other Contacts W Health Services W Endoscopy, Sameday 16,309 15 1.0 1 
Z60A Rehabilitation, Major Complexity 612 1,352 43.5 31 
Z60B Rehabilitation, Minor Complexity 746 2,324 28.1 19 
Z61A Signs and Symptoms, Major Complexity 54 690 9.9 5 
Z61B Signs and Symptoms, Intermediate Complexity 193 889 3.1 1 
Z61C Signs and Symptoms, Minor Complexity 1,172 1,298 2.0 1 
Z63A Other Follow Up After Surgery or Medical Care, Major Complexity 55 1,925 23.9 13 
Z63B Other Follow Up After Surgery or Medical Care, Minor Complexity 1,985 1,838 10.3 3 
Z64A Other Factors Influencing Health Status, Major Complexity 4,035 736 10.4 2 
Z64B Other Factors Influencing Health Status, Minor Complexity 35,384 1,328 1.8 1 
Z65Z Congenital Anomalies and Problems Arising from Neonatal Period 84 53 3.5 1 
Z66Z Sleep Disorders 18 658 1.1 1 
Total 61,575 13,433 16.2 4 
 
Note: a Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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TABLE 4.26 Total Discharges: Unassignable to MDC: AR-DRG Version 8.0 by Patient Type (N, In-Patient Length of 
Stay) 
 
Unassignable to MDCb 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
801A OR Procedures Unrelated to Principal Diagnosis, Major Complexity ~ 423 49.2 31 
801B OR Procedures Unrelated to Principal Diagnosis, Intermediate Complexity * 504 16.8 12 
801C OR Procedures Unrelated to Principal Diagnosis, Minor Complexity 300 369 5.1 3 
Total 342 1,296 24.0 12 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges. 
 a Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
 b 
 
 
 
 
 
 
 
 
 
 
 
As not all discharges can be assigned directly to an MDC, there is a category entitled 'unassignable to MDC'. These cases are 
always queried by the HPO.  
Unrelated OR DRGs: Patients whose OR procedures are unrelated to the patient’s principal diagnosis are assigned to one of 
three OR DRGs: 801A OR Procedures Unrelated to Principal Diagnosis Major Complexity, 801B OR Procedures Unrelated to 
Principal Diagnosis Intermediate Complexity or  801C OR Procedures Unrelated to Principal Diagnosis Minor Complexity.  An 
example of when this may be assigned is when a patient is admitted for a medical treatment; they develop a complication 
unrelated to the principal diagnosis and later have an OR procedure performed for the additional diagnoses associated with the 
complication.  
Error DRGs: Episodes that contain clinically atypical or invalid information are assigned to one of three error DRGs: 960Z 
Ungroupable, 961Z Unacceptable Principal Diagnosis or 963Z Neonatal Diagnosis Not Consistent W Age/Weight. 
Australian Consortium for Classification Development, 2015, Australian Refined Diagnosis Related Groups, Version 8.0, 
Definitions Manual, Volume 1. Independent Hospital Pricing Authority. p.11. 
 
 
 
 
TABLE 4.27 Total Discharges: Pre-MDC: AR-DRG Version 8.0 by Patient Type (N, In-Patient Length of Stay) 
 
Pre-MDC 
Day Patients In-Patientsa In-Patient 
Length of Staya 
N N Mean Median 
A01Z Liver Transplant 0 58 27.4 17 
A03Z Lung or Heart-Lung Transplant 0 40 32.6 20 
A05Z Heart Transplant 0 12 71.1 30 
A06A Tracheostomy and/or Ventilation >=96hours, Major Complexity 0 257 109.4 68 
A06B Tracheostomy and/or Ventilation >=96hours, Intermediate Complexity 0 801 51.9 33 
A06C Tracheostomy and/or Ventilation >=96hours, Minor Complexity ~ 1,031 29.3 19 
A07A Allogeneic Bone Marrow Transplant, Age <=16 Years or Major Complexity 0 50 55.7 44 
A07B Allogeneic Bone Marrow Transplant, Age >=17 Years and Minor Complexity ~ 86 25.2 30 
A08A Autologous Bone Marrow Transplant, Major Complexity 0 115 26.5 22 
A08B Autologous Bone Marrow Transplant, Minor Complexity ~ 45 8.9 5 
A09A Kidney Transplant, Age <=16 Years or Major Complexity 0 29 14.7 14 
A09B Kidney Transplant, Age >=17 Years and Minor Complexity 0 155 9.6 9 
A10Z Insertion of Ventricular Assist Device 0 ~ ^ ^ 
A11A Insertion of Implantable Spinal Infusion Device, Major Complexity 0 9 4.9 4 
A11B Insertion of Implantable Spinal Infusion Device, Minor Complexity 0 * ^ ^ 
A12Z Insertion of Neurostimulator Device 148 102 5.6 1 
A40A ECMO, Major Complexity 0 13 70.7 52 
A40B ECMO, Minor Complexity 0 12 20.0 14 
Total 153 2,825 41.2 23 
 
Notes: ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges. 
 ^  Denotes that length of stay is suppressed where the number of discharges is not reported. 
 a 
 
Based on total in-patients (sameday and overnight in-patients). Excludes day patients. 
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DIABETES DISCHARGE PROFILE, 2017 
 INTRODUCTION A.1.1
As noted in Section One, this Annex is designed to highlight particular topics of 
interest that merit more focused supplementary analysis. The focus of this year's 
Annex is discharges with a principal diagnosis1,2 of diabetes. While recognising 
that services relating to diabetes are mostly delivered in the community, this 
Annex provides a snapshot of acute hospital services delivered for this condition 
in 2017. 
 
What is Diabetes?3 
Diabetes is a chronic disease that occurs either when the pancreas does not produce 
enough insulin or when the body cannot effectively use the insulin it produces. Insulin is 
a hormone that regulates blood sugar. Hyperglycaemia, or raised blood sugar, is a 
common effect of uncontrolled diabetes and over time leads to serious damage to 
many of the body's systems, especially the nerves and blood vessels. 
Type 1 diabetes (previously known as insulin-dependent, juvenile or childhood-onset) is 
characterized by deficient insulin production and requires daily administration of 
insulin. The cause of type 1 diabetes is not known and it is not preventable with current 
knowledge. 
Type 2 diabetes (formerly called non-insulin-dependent or adult-onset) results from 
the body’s ineffective use of insulin. Type 2 diabetes comprises the majority of people 
with diabetes around the world, and is largely the result of excess body weight and 
physical inactivity. Symptoms may be similar to those of type 1 diabetes, but are often 
less marked. As a result, the disease may be diagnosed several years after onset, once 
complications have already arisen. Until recently, this type of diabetes was seen only in 
adults but it is now also occurring increasingly frequently in children. 
Other categories of diabetes include gestational diabetes (hyperglycaemia with blood 
glucose values above normal but below those diagnostic of diabetes, occurring during 
pregnancy) and impaired glucose tolerance and impaired fasting glycaemia 
(intermediate conditions in the transition between normality and diabetes). There are 
other rarer causes including genetic syndromes, acquired processes such as 
pancreatitis, diseases such as cystic fibrosis, exposure to certain drugs, viruses, and 
unknown causes. 
 
This Annex will focus on the two main types of diabetes using ICD-10-AM 
diagnosis codes E10 type 1 diabetes mellitus and E11 type 2 diabetes mellitus. In 
2017, 9,939 discharges had a principal diagnosis of either type 1 diabetes mellitus 
                                                                                                                                                                                                                              
1  A principal diagnosis is defined as, 'the diagnosis established after study to be chiefly responsible for occasioning an 
episode of admitted patient care, an episode of residential care or attendance at the healthcare establishment, as 
represented by a code'. Diabetes may be reported as a secondary diagnosis in HIPE but analysis of this activity is 
beyond the scope of this Annex. See Section Three for details of clinical coding and classifications. 
2    In 2015 there were new guidelines in ICD-10-AM 8th Edition for coding Diabetes under ACS 0401. Diabetes Mellitus 
must always be coded when documented (see Appendix IX). 
3  Source: http://www.who.int/en/news-room/fact-sheets/detail/diabetes [Accessed 8th August 2018]. 
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(31.2 per cent) or type 2 diabetes mellitus (68.8 per cent) – referred to hereafter 
as diabetes discharges. Due to the implementation of new coding guidelines for 
diabetes in 8th Edition of the ICD-10-AM Classification the sequencing of codes 
has resulted in a higher proportion of diabetes discharges with an additional 
diagnosis of diabetes (see coding guidelines under ACS 0401 in Appendix IX). In 
2017, there were 101,736 discharges with an additional diagnosis of E10 type 1 
diabetes mellitus and E11 type 2 diabetes mellitus. 
 
 DIABETES – DEMOGRAPHIC ANALYSIS  A.1.2
Table A 1.1 shows the distribution of diabetes discharges by selected variables. 
The following points are a brief summary of diabetes discharges in 2017: 
• Males accounted for the majority of discharges (60.8 per cent) while 
females accounted for the remaining 39.2 per cent of discharges. 
• The largest proportion of diabetes discharges were aged between 65 and 
74 years (23.9 per cent). 
• Discharges with Type 2 diabetes comprised the majority of total diabetes 
discharges (68.8 per cent) compared to 31.2 per cent of discharges with 
Type 1 diabetes. 
• As per figure A 1.1, discharges with Type 1 diabetes were mainly treated 
as in-patients (61.5 per cent) compared to discharges with Type 2 
diabetes who were mainly treated as day patients (62.3 per cent). 
• Overnight in-patients with Type 1 diabetes stayed on average 6.1 days in 
hospital compared to 10.9 days for discharges with Type 2 diabetes. 
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TABLE A 1.1  Diabetes Discharges: Acute Public Hospital Discharges in HIPE (N, %, In-patient Length of Stay) 
 
 
Day 
Patients 
In-patients 
Total Discharges   Same Day In-
patients Overnight In-patients 
Total In-
patients 
N N N Mean 
LOS 
Med 
LOS 
N N % 
Total 5,453 650 3,836 8.7 4 4,486 9,939 100 
Sex         
Male 3,356 387 2,296 9.6 4 2,683 6,039 60.8 
Female 2,097 263 1,540 7.4 4 1,803 3,900 39.2 
Age Group         
0-16 Years 36 33 552 4.1 4 585 621 6.2 
17-24 Years 85 34 256 2.9 2 290 375 3.8 
25-34 Years 283 69 280 3.5 2 349 632 6.4 
35-44 Years 316 84 337 5.6 3 421 737 7.4 
45-54 Years 683 122 424 9.1 4 546 1,229 12.4 
55-64 Years 1,282 119 526 9.2 5 645 1,927 19.4 
65-74 Years 1,617 87 671 12.2 6 758 2,375 23.9 
75 Years and 
Over 1,151 102 790 13.6 7 892 2,043 20.6 
Public/Private 
Statusa         
Public 4,778 608 3,295 8.8 4 3,903 8,681 87.3 
Private 675 42 541 8.6 4 583 1,258 12.7 
Hospital Group         
Ireland East 634 191 819 7.7 4 1,010 1,644 16.5 
RCSI 50 97 539 8.7 4 636 686 6.9 
Dublin Midlands ~ 51 597 9.6 5 648 * – 
South/South 
West 1,464 110 691 9.4 4 801 2,265 22.8 
UL 656 73 335 9.8 6 408 1,064 10.7 
Saolta 2,638 114 681 9.5 5 795 3,433 34.5 
Children’s * 14 174 3.4 3 188 * – 
Admission Type         
Type 1b 1,192 196 1,708 6.1 3 1,904 3,096 100 
Day Patients 1,192 – – – – – 1,192 38.5 
In-patients – 196 1,708 6.1 3 1,904 1,904 61.5 
Elective  – ~ 117 5.7 3 * * – 
Emergency – * 1,591 6.1 3 * * – 
Type 2c 4,261 454 2,128 10.9 6 2,582 6,843 100 
Day Patients 4,261 – – – – – 4,261 62.3 
In-patients – 454 2,128 10.9 6 2,582 2,582 37.7 
Elective  – 9 248 11.8 4 257 257 3.8 
Emergency – 445 1,880 10.8 6 2,325 2,325 34.0 
 
Note:  Percentage columns are subject to rounding. 
 ~ Denotes five or fewer discharges reported to HIPE. 
 * Further suppression required to prevent disclosure of five or fewer discharges 
 a Public/Private status refers to whether the patient saw the consultant on a private or public basis. It does not relate to the 
type of bed occupied nor is it an indicator of private health insurance. 
 b Discharges with a principal diagnosis of E10 (type 1 diabetes mellitus) 
 c Discharges with a principal diagnosis of E11 (type 2 diabetes mellitus) 
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FIGURE A 1.1  Diabetes Discharges: Patient Type (N, Overnight In-patient Length of Stay) 
 
 
 
 
Note:  See Table A 1.1 for data. 
 
 TYPE OF DIABETES A.1.3
As shown in Table A 1.2, the distribution of diabetes discharges by type of diabetes 
differs by age: 
• For discharges with Type 1 Diabetes, the majority were aged between 0 
and 16 years (19.9 per cent). When disaggregated by patient type the 
majority of these were in-patient discharges. 
• For discharges with Type 2 diabetes, the majority were aged between 65 
and 74 years, with the majority of these treated as day patients. 
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TABLE A 1.2 Diabetes Discharges: Type of Diabetes by Age Group (N, %) 
 
 Day Patients Total In-Patients Total Discharges 
 N % N % N % 
To
ta
l D
ia
be
te
s  
0-16 Years 36 0.7 585 13.0 621 6.2 
17-24 Years 85 1.6 290 6.5 375 3.8 
25-34 Years 283 5.2 349 7.8 632 6.4 
35-44 Years 316 5.8 421 9.4 737 7.4 
45-54 Years 683 12.5 546 12.2 1,229 12.4 
55-64 Years 1,282 23.5 645 14.4 1,927 19.4 
65-74 Years 1,617 29.7 758 16.9 2,375 23.9 
75 Years and Over 1,151 21.1 892 19.9 2,043 20.6 
Total 5,453 100 4,486 100 9,939 100 
E1
0 
Ty
pe
 1
  
0-16 Years 36 3.0 579 30.4 615 19.9 
17-24 Years 77 6.5 264 13.9 341 11.0 
25-34 Years 226 19.0 268 14.1 494 16.0 
35-44 Years 179 15.0 249 13.1 428 13.8 
45-54 Years 238 20.0 208 10.9 446 14.4 
55-64 Years 230 19.3 134 7.0 364 11.8 
65-74 Years 145 12.2 110 5.8 255 8.2 
75 Years and Over 61 5.1 92 4.8 153 4.9 
Total 1,192 100 1,904 100 3,096 100 
E1
1 
Ty
pe
 2
 
0-16 Years 0 0.0 6 0.2 6 0.1 
17-24 Years 8 0.2 26 1.0 34 0.5 
25-34 Years 57 1.3 81 3.1 138 2.0 
35-44 Years 137 3.2 172 6.7 309 4.5 
45-54 Years 445 10.4 338 13.1 783 11.4 
55-64 Years 1,052 24.7 511 19.8 1,563 22.8 
65-74 Years 1,472 34.5 648 25.1 2,120 31.0 
75 Years and Over 1,090 25.6 800 31.0 1,890 27.6 
Total 4,261 100 2,582 100 6,843 100 
 
Note: Percentage columns are subject to rounding. 
  
FIGURE A 1.2 Total Diabetes Discharges: Age Group by Type of Diabetes (%) 
 
 
Note:  See Table A 1.2 for data. 
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 PRINCIPAL PROCEDURES A.1.4
Table A 1.3 presents the top 20 principal procedures for total diabetes discharges 
based on the ICD-10-AM classification.4 
• Over 96 per cent of day patient diabetes discharges had a principal 
procedure, compared to 69.3 per cent of in-patient diabetes discharges. 
• Procedure block Application, insertion or removal procedures on retina, 
choroid or posterior chamber accounted for the highest proportion of day 
patient diabetes discharges (69.9 per cent). 
• Generalised allied health interventions were reported as a principal 
procedure block for 52.3 per cent of in-patient discharges.5 
                                                                                                                                                                                                                              
4 See Section Three for details of clinical coding and classification. 
5 Generalised allied health interventions include interventions such as diabetes education, dietetics, physiotherapy,  
pharmacy, occupational therapy, and social work. 
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   DIAGNOSIS RELATED GROUPS A.1.5
 
Table A 1.4 presents the top 20 AR-DRG’s for total diabetes discharges by patient 
type.6 
• Retinal Procedures, Minor Complexity (AR-DRG C03B) accounted for the 
majority of day patient discharges (61.1 per cent). 
• Diabetes, Minor Complexity (AR-DRG K60B) accounted for the majority of in-
patient discharges (61.5 per cent). 
                                                                                                                                                                                                                              
6 See Section Three for details of clinical coding and classification. 
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GLOSSARY 
Acute hospital An acute hospital provides medical and surgical treatment of relatively short duration 
(Department of Health and Children, 2001). 
  
Additional 
diagnosis 
This is a condition or complaint either coexisting with the principal diagnosis or arising 
during the episode of admitted patient care, episode of residential care or attendance 
at a health care establishment, as represented by a code (Australian Institute of Health 
and Welfare (2012), National Health Data Dictionary, Version 16, AIHW). 
  
Admission type 
 
 
 
The type of admission may generally be classified as a planned or emergency admission. 
Unlike emergency admissions, planned admissions are arranged in advance by the 
patient and/or service provider. 
 
Australian Coding 
Standards 
Australian Coding Standards (ACS) is a document developed to provide guidance in the 
application of ICD-10-AM and ACHI codes. Standards are provided with general 
guidelines and are categorised by site and/or body system according to the clinical 
specialty to which a disease or procedure relates. 
  
Case mix Case mix is a method of quantifying hospital workload taking account of the complexity 
and resource-intensity of the services provided. 
  
Complications Complications may arise during the hospital stay. 
  
Comorbidities Comorbidities are assumed to be prior existing conditions, which were present at the 
time of admission. 
  
Day patient A day patient is admitted to hospital for treatment on an elective (rather than an 
emergency) basis and is discharged alive, as scheduled, on the same day (Department 
of Health and Children, 2001). Deliveries are not included. 
  
Delivery 
discharges 
Refers to Maternity discharges where the woman had a diagnosis of delivery (ICD-10-
AM diagnosis code Z37 Outcome of delivery). 
  
Delivery status Refers to the disaggregation of Maternity discharges into delivery and non-delivery 
status determined by the presence of a diagnosis of delivery (ICD-10-AM diagnosis code 
Z37 Outcome of delivery). 
  
Diagnosis Related 
Group (DRG) 
DRGs are clusters of cases with similar clinical attributes and resource requirements. In 
Ireland, Australian Refined Diagnosis Related Group (AR-DRG) have been in use in 
Ireland since 2005. 
  
Discharge rate Discharge rate is the ratio of discharges to the corresponding population. The formula 
for calculating the discharge rate is: 
Discharges in group i x 1,000 Population of group i  
Age-specific discharge rates are calculated as the number of discharges within a 
particular age group divided by the population within that particular age group 
multiplied by 1,000. Sex-specific discharge rates are calculated as the number of male 
(female) discharges divided by the male (female) population multiplied by 1,000.  
Age- and sex-specific discharge rates are calculated as the number of male (female) 
discharges within a particular age group divided by the number of males (females) in 
the population within that particular age group multiplied by 1,000.  
 
  
Elective admission This is an admission or procedure that has been arranged in advance (Department of 
Health and Children, 2001). This term is generally used to refer to in-patient discharges. 
The term planned admission may also be used. 
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Emergency 
admission 
An emergency admission is unforeseen and requires urgent care. This term is used to 
refer to in-patient discharges. 
  
GMS status Refers to whether a patient holds a medical card.  
  
Hospital Groups The organisational structure of public hospitals was revised in 2013 with the 
establishment of hospital groups on a non-statutory administrative basis.  
  
Hospital In-Patient 
Enquiry (HIPE) 
HIPE is a health information system that collates data on discharges from, and deaths 
in, acute hospitals in Ireland.  
  
In-Patient  
 
An in-patient is admitted to hospital for treatment or investigation on a planned or 
emergency basis.  
 Overnight In-Patient: These discharges are in-patient discharges who stayed at least 
one night in hospital. 
 Sameday In-Patient: These discharges admitted as in-patients and discharged on the 
same day. They do not meet the criteria to be classified as a day patient. 
  
Irish Coding 
Standards 
Irish Coding Standards (ICS) is a document which provides guidance and instruction on 
all aspects of HIPE data collection by addressing issues specific to the Irish hospital 
setting. It is revised regularly to reflect changing clinical practice. ICS is designed to 
complement the Australian Coding Standards. ICS V9.0 was used in the collection of 
HIPE data in 2017. 
  
Length of stay Length of stay refers to the time, expressed in days, between admission to and 
discharge from hospital. For day patients or where the dates of admission and discharge 
are the same, length of stay is set equal to one day. 
Mean and median lengths of stay are provided for in-patients only.  
Mean length of stay is computed by dividing the number of days stayed by the number 
of discharges. 
The median length of stay is the middle value among the ordered lengths of stay, such 
that half of the values for length of stay are below the median and half the values for 
length of stay are above the median. 
  
Major Diagnostic 
Category (MDC) 
The MDC is a category generally based on a single body system or aetiology that is 
associated with a particular medical specialty. However, records assigned to MDCs 01, 
15, 18 and 21 may have principal diagnoses associated with other categories. In AR-DRG 
Version 8.0, there are 23 MDCs. 
 
Medical 
Assessment Unit 
A medical assessment unit (MAU) also referred to as an Acute Medical Assessment Unit 
(AMAU) or an Acute Medical Unit (AMU), is a consultant led unit that accepts direct 
referrals from GPs. It offers priority access to diagnostic facilities. 
  
Maternity 
discharges 
These discharges are admitted in relation to their obstetrical experience (from 
conception to six weeks post-delivery), that is, they are allocated to Admission Type 
Maternity. 
  
Non-delivery Non-delivery discharges are Maternity discharges where the admission was related to 
their obstetrical experience but who did not deliver during that episode of care. 
  
Parity HIPE collects the number of previous live births and number of previous stillbirths (over 
500g) for all cases with admission type code Maternity.  
 Primiparous: These are women who have had no previous pregnancy resulting in a live 
birth or stillbirth.  
Multiparous: These are women who have had at least one previous pregnancy resulting 
in a live birth or stillbirth. 
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Patient type A patient may be admitted to hospital as a day patient (which is planned and does not 
involve an overnight stay), or an in-patient. 
 
Principal diagnosis This is the diagnosis established after study to be chiefly responsible for occasioning an 
episode of admitted patient care, an episode of residential care, or an attendance at 
the health care establishment, as represented by a code (Australian Institute of Health 
and Welfare (2012), National Health Data Dictionary, Version 16, AIHW). 
  
Principal and 
additional 
procedure 
A procedure is defined as a clinical intervention that 
• is surgical in nature, and/or 
• carries a procedural risk, and/or 
• carries an anaesthetic risk, and/or 
• requires specialised training, and/or 
• requires special facilities or equipment only available in an acute care setting. 
 
The order of codes should be determined using the following hierarchy: 
• procedure performed for treatment of the principal diagnosis 
• procedure performed for treatment of an additional diagnosis 
• diagnostic/exploratory procedure related to the principal diagnosis 
• diagnostic/exploratory procedure related to an additional diagnosis for the episode 
of care (NCCC, 2013). 
  
Public/private 
status 
Refers to whether the patient is a public or private patient of the consultant. It does not 
relate to the type of bed occupied nor is it an indicator of possession of private health 
insurance. 
 
Sources: The above definitions are taken directly from, or based on, those provided in the following: 
Department of Health and Children, 2001. Quality and Fairness a Health System for You: Health Strategy. Dublin: The 
Stationery Office. 
'Hospital Services – Introduction': Citizen's Information; date consulted: 9 December 2011. 
www.citizensinformation.ie/categories/health/hospital-services/hospital_services_introduction 
For further information on the definitions of diagnoses see National Casemix and Classification Centre (NCCC), 2013: 
Australian Coding Standards (ACS) (8th Ed): NCCC, Australian Health Services Research Institute, University of Wollongong. 
 General Standards for Diseases.p 1-14. 
For further information on the definitions of procedures see National Casemix and Classification Centre (NCCC), 2013: 
Australian Coding Standards (ACS) (8th Ed): NCCC, Australian Health Services Research Institute, University of Wollongong. 
General Standards for Interventions. P 21-36 
For further information on AR-DRG Version 8.0 see Australian Consortium for Classification Development website 
https://www.accd.net.au/ArDrg.aspx?page=2 [Accessed 26th July 2018]. 
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ABBREVIATIONS 
Adm Admission 
Admwt Admission Weight 
ACHI Australian Classification of Health Interventions 
ACS Australian Coding Standards 
ADRG Adjacent Diagnosis Related Groups  
AICD Automatic Implantable Cardioverter-Defibrillator 
AMI Acute Myocardial Infarction  
AR-DRG Australian Refined Diagnosis Related Group 
CABG Coronary Artery Bypass Graft 
CC Complication and/or Comorbidity 
CDE Common Bile Duct Exploration 
Circ Circulatory 
Comp Complexity 
CPB Cardiopulmonary Bypass 
Cran Cranial 
CSO Central Statistics Office 
D&D Diseases and Disorders 
CPB pump Cardiopulmonary bypass pump 
Dsrds Disorders 
DoH Department of Health  
DRG Diagnosis Related Group 
EEG Electroencephalography 
ECMO Extra corporeal membrane oxygenation 
ECT Electroconvulsive therapy 
ENT Ear, Nose and Throat 
ERCP Endoscopic Retrograde Cholangio Pancreatography 
ESRI Economic and Social Research Institute 
ESW Extracorporeal Shock Waves 
excl Excluding 
Ext Extreme 
Fmr Femur 
Gest Gestation 
GI Gastro-intestinal 
g Grams 
GMS General Medical Services 
GP General Practitioner 
HIPE Hospital In-Patient Enquiry 
HIV 
HPO 
Human Immunodeficiency Virus 
Healthcare Pricing Office 
HSE Health Service Executive 
ICD-10-AM Tenth Revision of the International Classification of Diseases, Australian Modification 
ICS Irish Coding Standards 
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Incl Including 
Infect/inflam Infection/inflammation 
Inhal Inhalation 
Int/Interm Intermediate 
Inves/Invest Investigative 
IT Information Technology 
LOS Length of Stay 
Maj Major 
MAJC Major Complexity 
MDC Major Diagnostic Category 
Med Median 
Microvas Microvascular 
Min Minor 
MINC Minor Complexity 
misc Miscellaneous 
Mod Moderate 
Mult Multiple 
n/a Not applicable 
NCCC National Casemix and Classification Centre  
NCCH National Centre for Classification in Health 
N Number of Observations/Discharges 
Non-malig Non-malignant 
NPRS National Perinatal Reporting System 
NTPF National Treatment Purchase Fund 
Obs Obstetric 
OR Operating Room 
Pr/Proc(s) Procedure(s) 
Psych Psychiatric 
RCSI Royal College of Surgeons in Ireland 
Sev Severe 
Sig Significant 
TIA Transient Ischaemic Attack 
Tiss Tissue 
Tfr/Transf  Transfer 
Trac Tracheostomy 
UL University of Limerick Hospital Group 
URI Upper Respiratory Infection 
Vent Ventilation 
WHO World Health Organisation 
W With 
W/O Without 
 
 
   
 
 
 
 
 
 
 
 
Appendices 
 
140 |  Act ivi ty  in  Acute Publ ic  Hospi ta l s  2017 
 
Table of Contents 
Appendix I: HIPE Hospitals ______________________________________________________________ 141 
Appendix II: HIPE Data Collected __________________________________________________________ 143 
Appendix III: HIPE Data Entry Form ________________________________________________________ 145 
Appendix IV: Derived Variables ____________________________________________________________ 146 
Appendix V: Australian Coding Standard 0042 _______________________________________________ 147 
Appendix VI: Further Information on HIPE Scheme____________________________________________ 149 
Appendix VII: Overview of changes from 6th Edition to 8th Edition ICD-10-AM/ACHI/ACS ____________ 150 
Appendix VIII: Overview of changes between Version 6.0 and Version 8.0 of the AR-DRG Classification 
System ____________________________________________________________________ 153 
Appendix IX: Australian Coding Standard 0401 _______________________________________________ 156 
 
 
App endices | 141  
APPENDIX I: HIPE HOSPITALS 
TABLE I.1 Listing of Hospitals Participating in the HIPE Scheme by Hospital Group 
 
Hospital Name County Hospital Type 
Ireland East Hospital Group    St. Columcille's Hospital Dublin Non-Voluntary 
Mater Misericordiae University Hospital Dublin Voluntary 
St. Vincent's University Hospital Dublin Voluntary 
Cappagh National Orthopaedic Hospital Dublin Voluntary 
St. Michael's Hospital, Dun Laoghaire Dublin Voluntary 
Royal Victoria Eye and Ear Hospital, Dublin Dublin Voluntary 
National Maternity Hospital, Holles St, Dublin Dublin Voluntary 
St. Luke's General Hospital, Kilkenny Kilkenny Non-Voluntary 
Wexford General Hospital Wexford Non-Voluntary 
Midland Regional Hospital, Mullingar Westmeath Non-Voluntary 
Our Lady's Hospital, Navan Meath Non-Voluntary 
RCSI Hospital Group    Connolly Hospital, Blanchardstown Dublin Non-Voluntary 
Beaumont Hospital, Dublin Dublin Voluntary 
Rotunda Hospital, Dublin Dublin Voluntary 
St. Joseph's Hospital, Raheny Dublin Voluntary 
Our Lady of Lourdes Hospital, Drogheda Louth Non-Voluntary 
Cavan General Hospital Cavan Non-Voluntary 
Louth County Hospital, Dundalk Louth Non-Voluntary 
Monaghan Hospital Monaghan Non-Voluntary 
Dublin Midlands Hospital Group    Naas General Hospital Kildare Non-Voluntary 
St. Luke's Hospital, Rathgara Dublin Voluntary 
St. James's Hospital, Dublin Dublin Voluntary 
Coombe Women & Infants University Hospital Dublin Voluntary 
Tallaght University Hospitalb Dublin Voluntary 
Midland Regional Hospital, Tullamore Offaly Non-Voluntary 
Midland Regional Hospital, Portlaoise Laois Non-Voluntary 
South/South West Hospital Group    University Hospital Waterford Waterford Non-Voluntary 
Kilcreene Orthopaedic Hospital Kilkenny Non-Voluntary 
South Tipperary General Hospital, Clonmel Tipperary Non-Voluntary 
Bantry General Hospital Cork Non-Voluntary 
Mercy University Hospital, Cork Cork Voluntary 
South Infirmary Victoria University Hospital Cork Voluntary 
Mallow General Hospital Cork Non-Voluntary 
Cork University Hospital Cork Non-Voluntary 
University Hospital Kerry Kerry Non-Voluntary 
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TABLE I.1 Listing of Hospitals Participating in the HIPE Scheme by Hospital Group (contd.) 
 
Hospital Name County Hospital Type 
University of Limerick Hospital Group    University Maternity Hospital Limerick Limerick Non-Voluntary 
University Hospital Limerick Limerick Non-Voluntary 
Croom Orthopaedic Hospital, Limerick Limerick Non-Voluntary 
St. John's Hospital, Limerick Limerick Voluntary 
UL Hospitals, Ennis Hospital Clare Non-Voluntary 
UL Hospitals, Nenagh Hospital Tipperary Non-Voluntary 
Saolta Hospital Group    Roscommon County Hospital Roscommon Non-Voluntary 
Portiuncula Hospital, Ballinasloe Galway Non-Voluntary 
Galway University Hospitals  Galway Non-Voluntary 
Mayo University Hospital Mayo Non-Voluntary 
Letterkenny University Hospital Donegal Non-Voluntary 
Sligo University Hospital Sligo Non-Voluntary 
Children’s Hospital Group   Our Lady's Children's Hospital, Crumlin Dublin Voluntary 
Temple Street Children's University Hospital Dublin Voluntary 
Tallaght University Hospitalb Dublin Voluntary 
No group   Peamount Hospital Dublin Voluntary 
National Rehabilitation Hospital (NRH), Dun Laoghaire Dublin Voluntary 
Incorporated Orthopaedic Hospital, Clontarf Dublin Voluntary 
St. Finbarr's Hospital Cork Non-Voluntary 
 
Notes:  Total number of hospitals participating in 2017: 53 
 a Includes St. Luke’s Radiation Oncology Network centres located in Beaumont and St. James’s Hospitals. These centres are 
operational since 2011 but activity has only been included in HIPE from 2015. 
 b For reporting purposes, discharges aged 17 years and older from Tallaght University Hospital are included in the Dublin 
Midlands Hospital Group, while discharges aged less than 17 years from Tallaght University Hospital are included in the 
Children’s Hospital Group. 
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APPENDIX II: HIPE DATA COLLECTED 
TABLE II.1 Data Collected by HIPE* 
 
Type of 
Data 
Parameters Notes 
De
m
og
ra
ph
ic 
Da
ta
 
Date of birth Full date of birth not exported outside the hospital. 
Sex  
Marital/Civil status Values include single, married, widowed, other (including separated), 
unknown, divorced, civil partner, former civil partner or surviving civil 
partner. 
Infant admission 
weight 
Weight in whole grams on admission is collected for neonates (0–27 days 
old) and infants up to 1 year of age with admission weight of less than 
2,500 grams. 
Area of residence by 
county or country 
If resident in Ireland but outside Dublin, captures county of residence. If 
resident in Dublin, captures postal code. If usually resident outside 
Ireland, captures country of residence. 
Cl
in
ica
l D
at
a 
One principal 
diagnosis 
Uses the International Statistical Classification of Diseases and Related 
Health Problems, 10th Revision, Australian Modification (ICD-10-AM), 8th 
Edition, July 2013. 
Twenty-nine 
additional diagnoses 
Uses the International Statistical Classification of Diseases and Related 
Health Problems, 10th Revision, Australian Modification (ICD-10-AM), 8th 
Edition, July 2013. 
One principal 
procedure 
Uses the Australian Classification of Health Interventions (ACHI) of the 
International Statistical Classification of Diseases and Related Health 
Problems, 10th Revision, Australian Modification (ICD-10-AM), 8th 
Edition, July 2013. 
Nineteen additional 
procedures 
Uses the Australian Classification of Health Interventions (ACHI) of the 
International Statistical Classification of Diseases and Related Health 
Problems, 10th Revision, Australian Modification (ICD-10-AM), 8th 
Edition, July 2013. 
Hospital Acquired 
Diagnosis 
Condition not present prior to admission to hospital. 
Ad
m
in
ist
ra
tiv
e 
Da
ta
 
Patient name Is not exported outside the hospital. 
Hospital number  
Chart number Is unique to hospital of discharge. 
Admission and 
discharge dates 
 
Dates of procedures Collected for each procedure. 
Day case indicator  
Day ward indicator Indicates if a day case patient was admitted to a dedicated named day 
ward. 
Day ward identifier If the answer to day ward indicator is 'Yes', the day ward identifier must 
be entered to identify where the patient was treated. 
Type of admission Values include elective, elective readmission, emergency, emergency 
readmission, maternity, or newborn. 
Waiting list indicator Indicates if an elective admission case is funded by the National 
Treatment Purchase Fund (NTPF). 
Mode of emergency 
admission 
Indicates where the patient with admission codes emergency, emergency 
readmission, or newborn was treated prior to being admitted to the 
hospital as an in-patient, or when the patient was treated only in a 
registered Medical Assessment Unit (MAU). Values include Emergency 
Department of the admitting hospital, AMAU admitted as in-patient, 
other, unknown, AMAU only and Local Injury Unit. 
Source of admission Values include home, transfer from nursing home/convalescent home or 
other long stay accommodation, transfer from hospital (in HIPE), transfer 
from other hospital (not in HIPE), transfer from hospice (not in HIPE), 
transfer from psychiatric hospital/unit, newborn, temporary place of  
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Data Collected by HIPE (contd.) 
 
Type of 
Data 
Parameters Notes 
  residence, prison, or other. 
Ad
m
in
ist
ra
tiv
e 
Da
ta
 (c
on
td
.) 
Discharge 
destination 
Values include self discharge, home, nursing home, convalescent home or 
long stay accommodation, transfer to hospital (in HIPE) as emergency, 
transfer to hospital (in HIPE) as non-emergency, transfer to psychiatric 
hospital/unit, died with post-mortem, died without post-mortem, 
transfer to other hospital (not in HIPE) as emergency, transfer to other 
hospital (not in HIPE) as non-emergency, rehabilitation facility, hospice, 
prison, absconded, other, or temporary place of residence (e.g. hotel). 
Discharge status Refers to the public/private status of the patient on discharge and not to 
the type of bed occupied. 
Health Insurer Collected where discharge status of the patient is private. 
General Medical 
Service status 
Refers to whether the patient is a medical card holder. 
Days in an intensive 
care environment 
 
Days in a private bed Single Occupancy 
Multiple Occupancy 
Days in a semi-
private bed 
Single Occupancy 
Multiple Occupancy 
Days in a public bed Single Occupancy 
Multiple Occupancy 
Parity Parity: Live births Mandatory for all cases with admission type 
maternity. Parity: Still births 
Specialty Refers to specialty of consultant associated with the principal diagnosis 
and is assigned locally based on a list provided by the Department of 
Health and Children. 
Primary consultant Encrypted. 
Anaesthetist Encrypted. Collected for each procedure performed under anaesthetic.  
Intensive care 
consultant 
Encrypted. Up to ten may be recorded. 
Admitting consultant Encrypted. 
Discharge consultant Encrypted. 
Consultant 
responsible for each 
diagnosis 
Encrypted. 
Consultant 
responsible for each 
procedure 
Encrypted. 
Date of transfer to a 
pre-discharge unit 
Date may be collected to identify when a patient was transferred to a 
pre-discharge unit prior to being discharged as planned. This is an 
optional variable collected since 2004. 
Ward Identification Admitting ward: The ward to which the patient was admitted. 
Discharge ward: The ward from which the patient was discharged. 
Temporary leave 
days 
Refers to the number of days the patient was absent from the hospital 
during an episode of care. 
 
Note: *  For details of all variables collected by HIPE see HIPE Data Dictionary 2017 Version 9.1. 
Source:     HIPE Data Dictionary 2017 Version 9.1, available at www.hpo.ie  
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APPENDIX III: HIPE DATA ENTRY FORM 
FIGURE III.1 HIPE Data Entry Form, 2017 
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APPENDIX IV: DERIVED VARIABLES 
For some of the categorical administrative variables, aggregation of categories 
has been necessary to ensure confidentiality. Table IV.1 shows how the 
categories for these variables have been aggregated. For example, the admission 
type variables have been reduced from six categories to three categories. 
 
TABLE IV.1 Derived Variables 
 
HIPE Variable Derived Variable for Report 
Admission Type  
1 'Elective' 1 'Elective' (1, 2) 
2 'Elective Readmission' 2 'Emergency' (4, 5, 7) 
4 'Emergency' 3 'Maternity' (6) 
5 'Emergency Readmission'   
6 'Maternity'   
7 'New born'   
Admission Source  
1 'Home' 1 'Home' (1) 
2 'Transfer from nursing home/convalescent home or 
other long stay accommodation' 
2 Long stay accommodation (2, 5) 
3 'Transfer from hospital - in HIPE listing' 3 'Transfer from other hospital' (3,4,6) 
4 'Transfer from other hospital - not in HIPE listing' 4  'Other' (7, 8, 9, 0) 
5 'Transfer from hospice - not in HIPE listing'   
6 'Transfer from psychiatric hospital/unit'   
7 'New born'   
8 'Temporary place of residence'   
9 'Prison'   
0 'Other'   
Discharge Destination  
00 'Self discharge' 1 'Home' (01) 
01 'Home' 2 ’Long stay accommodation’ (02, 11) 
02 'Nursing home, convalescent home or long stay 
accommodation' 
3 'Transfer to other  hospital' (03, 04, 
05,08, 09, 10) 
03 'Transfer to hospital – in HIPE Hospital Listings – 
Emergency ' 
4 'Died' (06, 07) 
04 'Transfer to hospital – in HIPE Hospital Listings – Non 
Emergency' 
5 'Other' (00, 12, 13, 14, 15) 
05 'Transfer to psychiatric hospital/unit'   
06 'Died with post mortem'   
07 'Died no post mortem'   
08 'Transfer to other hospital – not in HIPE Hospital Listings 
– Emergency' 
  
09 'Transfer to other hospital – not in HIPE Hospital Listings 
– Non Emergency' 
  
10 'To rehabilitation facility – not in HIPE Hospital Listings'   
11 'Hospice – not in HIPE Hospital Listings'   
12 'Prison'   
13 'Absconded'   
14 'Other – example Foster care'   
15 'Temporary Place of Residence'   
 
Note:  For further information on all variables collected by HIPE see HIPE Data Dictionary 2017 Version 9.1 available at 
www.hpo.ie 
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APPENDIX V: AUSTRALIAN CODING STANDARD 0042 
Australian Coding Standard 0042 Procedures normally not coded1 
These procedures are normally not coded because they are usually routine in 
nature, performed for most patients and/or can occur multiple times during an 
episode. Most importantly, the resources used to perform these procedures are 
often reflected in the diagnosis or in an associated procedure. That is, for a 
particular diagnosis or procedure there is a standard treatment which is 
unnecessary to code. For example: 
 
• X-ray and application of plaster is expected with a diagnosis of Colles’ 
fracture 
• Intravenous antibiotics are expected with a diagnosis of septicaemia/sepsis 
• Cardioplegia in cardiac surgery is performed routinely 
 
Note: 
• Some codes on this list may be required in certain standards elsewhere in the 
Australian Coding Standards. In such cases, the standard overrides this list 
and the stated code should therefore be assigned as described in the relevant 
standard. 
• The listed procedures should be coded if cerebral anaesthesia is required in 
order for the procedure to be performed (see ACS 0031 Anaesthesia). 
• These procedures should be coded if they are the principal reason for 
admission in same-day episodes of care. This includes patients who are 
admitted the day before or discharged on the day after a procedure because 
a same-day admission is not possible or practicable for them (eg elderly 
patients, those who live in remote locations). 
 
1. Application of plaster 
  
2. Bladder washout via indwelling catheter 
  
3. Cardioplegia when associated with cardiac surgery 
  
4. Cardiotocography (CTG) except fetal scalp electrodes 
  
5. Catheterisation: 
 • arterial or venous (such as Hickman's, PICC, CVC, Swan Ganz) 
except cardiac catheterisation (blocks [667] and [668]), surgical 
catheterisation (block [741]) or catheterisation in neonates (see 
ACS 1615 Specific interventions for the sick neonate) 
• urinary except if suprapubic 
                                                                                                                                                                                     
1 Extracted from NCCC eBook, July 2013, General Standards for Interventions. 
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6. Doppler recordings 
  
7. Dressings 
  
8. Drug treatment/pharmacotherapy 
 Drug treatment should not be coded except if: 
 • the substance is given as the principal treatment in same-day 
episodes of care 
 • drug treatment is specifically addressed in a coding standard 
(see ACS 0044 Chemotherapy, ACS 1316 Cement spacer/beads and 
ACS 1615 Specific interventions for the sick neonate) 
  
9. Electrocardiography (ECG) except patient-activated implantable cardiac 
event monitoring (loop recorder) 
  
10. Electrodes (pacing wires) – temporary: insertion of temporary trans-
cutaneous or transvenous electrodes when associated with cardiac 
surgery; adjustment, repositioning, manipulation or removal of 
temporary electrodes 
  
11. Electromyography (EMG) 
  
12. Hypothermia when associated with cardiac surgery 
  
13. Imaging services – all codes in ACHI Chapter 20 Imaging services and 
block [451] Dental radiological examination and interpretation except:  
 • transoesophageal echocardiogram (TOE) (55118-00 [1942]) 
 • when instructed to do so 
  
14. Monitoring: cardiac, electroencephalography (EEG), vascular pressure 
except radiographic/video EEG monitoring ≥ 24 hours 
  
15. Nasogastric intubation, aspiration and feeding, except nasogastric 
feeding in neonates (see ACS 1615 Specific interventions for the sick 
neonate) 
  
16. Perfusion when associated with cardiac surgery 
  
17. Primary suture of surgical and traumatic wounds 
 Code only for traumatic wounds which are not associated with an 
underlying injury (e.g. suture of lacerated forearm would be coded if 
there is no other associated injury repair) (see ACS 1217 Repair of 
wound of skin and subcutaneous tissue) 
  
18. Procedure components (see also ACS 0016 General procedure 
guidelines) 
  
19. Stress test 
  
20. Traction if associated with another procedure 
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APPENDIX VI: FURTHER INFORMATION ON HIPE SCHEME 
Previously published reports can be downloaded at www.hpo.ie. 
 
Documentation relating to the operation of the HIPE scheme is available online at 
www.hpo.ie. 
• Coding Notes: This quarterly bulletin is distributed to all coders 
nationally. It contains important updates on coding queries, changes in 
coding practice and any other relevant information including the 
scheduling of training courses. 
 
• HIPE Data Dictionary: This dictionary provides definitions and codes for 
data collected within HIPE as of a specified year (e.g. 2017 relates to 
discharges reported for 2017). It provides standard definitions for 
variables with the objective of ensuring that consistency and data quality 
are maintained.  
 
• HIPE Instruction Manual: This manual provides instruction on the capture 
of administrative and demographic data for each HIPE discharge record. 
Clinical data are captured in accordance with the classification and 
associated standards. 
 
• Irish Coding Standards: Irish Coding Standards (ICS) apply to activity 
coded in HIPE and provide guidance and instruction on all aspects of HIPE 
data collection by addressing issues relevant to the Irish hospital setting. 
ICS are developed to complement the Australian Coding Standards (ACS) 
and are revised regularly to reflect changing clinical practice.  
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APPENDIX VII: OVERVIEW OF CHANGES FROM 6TH EDITION TO 
8TH EDITION ICD-10-AM/ACHI/ACS 
 
VII.1 Introduction 
Ireland updated to the 8th edition of ICD-10-AM/ACHI/ACS for all discharges from 
1st January 2015. For practical reasons Ireland does not update each time the 
classification is updated in Australia therefore on this occasion Ireland has 
adopted updates from both the 7th and the 8th Edition of ICD-10-AM/ACHI/ACS. 
Extensive training was held for all HIPE staff throughout all hospitals in a series of 
training sessions in 2014 and 2015 to ensure understanding of and compliance 
with the update. 
 
In summary in the 8th Edition there were diagnosis codes (ICD-10-AM) and 
procedure codes (ACHI) added and there was a general review of grammar to 
ensure consistency throughout the classification. Sixty-three Australian Coding 
Standards were deleted and the information from these has been replaced with 
index entries or tabular instructional notes in the classifications.  Two new ACS 
were created; ACS 0742 Orbital and periorbital cellulitis and ACS 2114 
Prophylactic surgery. 
 
There were changes to the ACS 0001 Principal Diagnosis, particularly with regard 
to the dagger and asterisk (Aetiology and Manifestation) sequencing rules.  There 
were also major enhancements to the coding of Obstetrics and Diabetes Mellitus. 
The following lists include the areas in the classifications and standards where the 
main changes occurred with some detail provided for illustration. Further details 
are available on application to the HPO. 
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VII.2 Main Changes in ICD-10-AM/ACHI/ACS 8th edition 
ICD-10-AM Diagnoses 
• Obstetrics 
• Diabetes 
• Cystic Fibrosis 
• Sepsis 
• Sunburn  
• MRSA 
• Appendicitis  
• Respiratory Failure Types 
• Anaemia in chronic diseases 
• Neoplasm update – cancer of unknown primary     
New codes 
   C79.9 Secondary malignant neoplasm, unspecified site 
   C80.0  Malignant neoplasm, primary site unknown, so stated 
   C80.9  Malignant neoplasm, unspecified 
 
• Appendicitis  
• Respiratory Failure Types 
• Anaemia in chronic diseases 
• Neoplasm update – leukaemia & lymphoma 
• Respiratory failure, type I and type II 
• Sunburn 
• Atrial fibrillation 
• Congenital malformations, deformations and chromosomal abnormalities 
(Q00-Q99) 
• Duration of pregnancy 
• Haemorrhoids 
• Hernia 
• Resistance to antimicrobial and antineoplastic drugs 
• Viral Hepatitis 
 
ACHI Procedures 
• Minimally invasive procedures proceeding to open procedure 
New generic codes  
90343-00 [1011] Endoscopic procedure proceeding to open procedure 
90343-01 [1011] Laparoscopic procedure proceeding to open procedure 
90613-00 [1579] Arthroscopic procedure proceeding to open procedure 
    ACS 0019 Procedures not completed or interrupted expanded to provide guidelines 
 
• Change in Standard: ACS 0020 Bilateral/Multiple Procedures 
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• Change in Standard: ACS 0042 Procedures normally not coded    
A major review of ACS 0042 Procedures normally not coded was undertaken due to  
the many queries received as to what components should or should not be coded in 
major surgeries. As a result the following instruction has been added to ACS 0042 
Imaging services – all codes in ACHI Chapter 20 Imaging services and block [451] 
Dental radiological examination and interpretation except: 
• transoesophageal echocardiogram (TOE) (55118-00 [1942]) 
• when instructed to do so 
  
• Insertion of seeds/fiducial markers into prostate 
• Percutaneous heart valve replacement 
• Laparoscopic colectomy & ileocolic resection 
• Coronary artery procedures 
• Transcatheter thrombectomy of intracranial arteries 
• Endoluminal fundoplication (ELF) 
• Procedures for obesity - New ACHI Block 889 with 27 new procedure codes for 
treatment of obesity  
• Sacral nerve stimulation (SNS) 
• Sentinel lymph node biopsy (SLNB) 
 
Australian Coding Standards (ACS) 
• Conventions 
• ACS 0001 Principal diagnosis – dagger/asterisk 
• ACS 0001 Principal diagnosis – obstetrics 
• ACS 0401 Diabetes mellitus and intermediate hyperglycaemia 
• ACS 0402 Cystic fibrosis 
• ACS 1615 Specific interventions for the sick neonate   
• ACS 0042 Procedures normally not coded 
• ACS 0020 Bilateral/multiple procedures – skin lesions 
• ACS 0104 Viral hepatitis 
• ACS 0110 Sepsis, severe sepsis and septic shock 
• ACS 0111 Healthcare associated Staphylococcus Aureus bacteraemia 
• ACS 2114 Prophylactic surgery (New) 
 
Irish Coding Standards (ICS) (V8.0 January 2016) 
• New standard ICS 01X0 Zika virus provides guidance on the WHO alert on the 
coding of Zika virus and the use of U06.9 Emergency use of U06.9 for same.  
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APPENDIX VIII: OVERVIEW OF CHANGES BETWEEN VERSION 6.0 
AND VERSION 8.0 OF THE AR-DRG CLASSIFICATION SYSTEM 
 
VIII.1 Introduction 
Ireland updated to Version 8.0 of the Australian Refined Diagnosis Related Group 
(AR-DRG) classification system in 2016. A number of changes took place during 
this update; the largest change was the complete revision of the case complexity 
methodology within the AR-DRG classification.2 This appendix gives a brief 
outline of the major changes in AR-DRG Version 8.0 compared to Version 6.0.   
 
VIII.2 Summary  
VIII.2.1 Revision of ADRG Splitting 
The number of Diagnosis Related Groups (DRGs) has increased from 698 in AR-
DRG Version 6.0 to 807 in AR-DRG Version 8.0, while the number of Adjacent 
Diagnosis Related Groups (ADRGs) has increased from 399 in AR-DRG Version 6.0 
to 406 in AR-DRG Version 8.0. 
 
In AR-DRG Version 8.0, 14 ADRGs were added and 7 ADRGs were removed; while 
194 splits were added and 22 splits were removed. Table VIII.1 outlines the 
increase in splits in AR-DRG Version 8.0 compared to AR-DRG Version 6.0. This 
increase results in greater granularity in AR-DRG Version 8.0. 
 
TABLE VIII.1 Changes in ADRG splits  
ADRG Splitting Number of ADRGs Version 6.0 Version 8.0 
No Split (Z) 156 85 
Two Levels (A,B) 192 246 
Three Levels (A,B,C) 46 70 
Four Levels (A,B,C,D) 5 5 
Total ADRGs  399 406 
 
  
                                                                                                                                                                                     
2  Further information on AR-DRG Version 8.0 can be found on the Australian Consortium for Classification 
Development website https://www.accd.net.au/ArDrg.aspx?page=2 [Accessed 26th July 2018]. 
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VIII.2.2 ADRGs Added and Removed in Version 8.0 of the AR-DRG Classification 
System 
There were 14 ADRGs added in AR-DRG Version 8.0 (see Table VIII.2). These 
include a number of musculoskeletal codes, bariatric codes, neonate codes, 
alcohol and drug sameday, and sleep disorders.  
 
TABLE VIII.2 ADRGs Added in Version 8.0 of the AR-DRG Classification System  
ADRG ADRG Description 
I40 Infusions for Musculoskeletal Disorders, Sameday 
I80 Femoral Fractures, Transferred to Acute Facility <2 Days 
I81 Musculoskeletal Injuries, Sameday 
I82 Other Sameday Treatment for Musculoskeletal Disorders 
K10 Revisional and Open Bariatric Procedures 
K11 Major Laparoscopic Bariatric Procedures 
K12 Other Bariatric Procedures 
K13 Plastic OR Procedures for Endocrine, Nutritional and Metabolic Disorders 
P07 Neonate, AdmWt <750g W Significant OR Procedure 
P08 Neonate, AdmWt 750-999g W Significant OR Procedure 
P68 Neonate, AdmWt >=2500g W/O Sig OR Proc/Vent>=96hrs, >=37 Completed 
Wks Gestation 
V65 Treatment for Alcohol Disorders, Sameday 
V66 Treatment for Drug Disorders, Sameday 
Z66 Sleep Disorders 
 
 
There were 7 ADRGs removed in AR-DRG Version 8.0 (see Table VIII.3). These 
include peptic ulcer codes, obesity procedures, false labour, radiotherapy, and 
HIV, sameday. Some of the cases previously grouped to these DRGs have grouped 
to pre-existing DRGs, while some have grouped to new DRGs.  For example, all 
cases previously grouped to R64 Radiotherapy have grouped to R62 Other 
Neoplastic Disorders in AR-DRG Version 8.0; the majority of these have grouped 
to R62C Other Neoplastic Disorders, Minor Complexity. 
 
TABLE VIII.3 ADRGs Removed in Version 8.0 of the AR-DRG Classification System  
ADRG ADRG Description 
G62 Complicated Peptic Ulcer 
G63 Uncomplicated Peptic Ulcer 
K04 Major Procedures for Obesity 
K07 Obesity Procedures 
O64 False Labour 
R64 Radiotherapy 
S60 HIV, Sameday 
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VIII.2.3 Naming Convention of AR-DRGs 
The terminology used to name AR-DRGs has been updated. The descriptive terms 
mild, moderate, severe and catastrophic CC have been replaced with minor, 
intermediate, major and extreme complexity. An example of this is shown in 
Table VIII.4 below which compares the naming of ADRG B02 Cranial Procedures in 
both versions of the classification system.  
 
TABLE VIII.4 Example of change in naming convention between AR-DRG Version 6.0 and 
Version 8.0 
Version 6.0 Version 8.0 
B02A Cranial Procedures W Catastrophic CC B02A Cranial Procedures, Major 
Complexity 
B02B Cranial Procedures W Severe CC B02B Cranial Procedures, Intermediate 
Complexity 
B02C Cranial Procedures W/O Catastrophic 
or Severe CC 
B02C Cranial Procedures, Minor 
Complexity 
 
 
VIII.2.3 Changes in Complexity Split 
All AR-DRG splits have been revised using the Episode Clinical Complexity (ECC) 
Model.3 As a result, an ADRG may have the same description in both versions but 
may have different DRG splits.  For example, O60 Vaginal Delivery is present in 
both Version 6.0 and Version 8.0, with a different number of splits in each. AR-
DRG Version 6.0 has no split (O60Z Vaginal Delivery) whereas AR-DRG Version 8.0 
has three end classes: 
• O60A Vaginal Delivery, Major Complexity 
• O60B Vaginal Delivery, Intermediate Complexity 
• O60C Vaginal Delivery, Minor Complexity 
  
                                                                                                                                                                                     
3  Further information on the ECC Model in AR-DRG Version 8.0 can be found at 
https://www.ihpa.gov.au/sites/g/files/net636/f/publications/review_of_the_ar-drg_case_complexity_process.pdf 
[Accessed 26th July 2018] 
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 APPENDIX IX: AUSTRALIAN CODING STANDARD 0401 
Australian Coding Standard: 0401 Diabetes Mellitus and Intermediate 
Hyperglycaemia  4 
Diabetes Mellitus 
Categories of diabetes mellitus (DM) in this classification are: 
• Type 1 diabetes mellitus (T1DM) previously referred to as insulin 
dependent diabetes mellitus (IDDM) 
• Type 2 diabetes mellitus (T2DM) previously referred to as noninsulin 
dependent diabetes mellitus (NIDDM) 
• Other specific forms of diabetes mellitus (includes diabetes mellitus 
secondary to other disorders) 
• Unspecified diabetes mellitus 
Gestational diabetes mellitus (GDM) any degree of glucose intolerance 
during pregnancy 
 
Intermediate Hyperglycaemia    
 Intermediate hyperglycaemia (IH), also described as impaired glucose regulation 
(IGR), prediabetes, impaired glucose tolerance (IGT) and impaired fasting glycaemia 
(IFG), refers to abnormal metabolic states, intermediate and transitional, between 
normal glucose homeostasis and DM that may remain static but may (infrequently) 
revert to normal.   
                                                                                                                                                                                     
4 Extracted from NCCC eBook, July 2013, Endocrine, nutritional and metabolic diseases. This is an extract from the 
standard to illustrate the change to the general classification principles; it excludes coding guidelines  relating to 
specific classification principles, features of insulin resistance and specific multiple complications. 
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General Classification Rules for DM and IH 
Rule 1.  DM and IH should always be coded when documented (demonstrated in all 
examples). 
 
Rule 2.  
 
The terms 'diabetic', 'due to' or 'secondary to' infer a causal relationship 
between the DM and other conditions. Where such terms are used check the 
Alphabetic Index for appropriate codes indexed directly under Diabetes, 
diabetic or appropriate codes indexed under the lead term for the condition 
with a subterm diabetic (see example 1).  
 
If there is not an appropriate direct 'diabetic' entry in the Alphabetic Index for 
the 'diabetic' term, then follow Rule 3 and Rule 4a to assign a DM code. 
 
An additional code for the 'other condition' may be assigned following Rule 4b 
and Rule 6. 
 
Rule 3.  The classification includes conditions (often termed 'complications') which 
occur commonly with DM or IH. These conditions may or may not have been a 
direct consequence of the metabolic disturbance and are indexed under 
Diabetes, with or Hyperglycaemia/intermediate/with. Always refer to these 
index entries to classify DM or IH (see examples 2-7). 
 
Rule 4a.  All complications of DM or IH classified to category E09–E14 should always be 
coded to reflect the severity of DM or IH (see examples 3-6). 
 
Rule 4b.  Complications or conditions associated with DM or IH classified outside of 
category E09–E14 should only be coded when the condition meets the criteria 
in ACS 0001 Principal diagnosis or ACS 0002 Additional diagnoses (see examples 
3 and 4). 
 
Rule 5.  Where the classification (Alphabetic Index) has linked a condition with DM, yet 
a specific cause other than DM is documented as the cause of the condition, 
then a code for the causal condition should be sequenced before the DM 
code(s) (see examples 5 and 6). 
 
Rule 6.  Multiple codes should not be used when the classification provides a 
combination code (see ACS 0015) for the DM or IH that clearly identifies all of 
the elements documented in the diagnosis (see examples 7 and 11). 
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